{
    "questions": [
        {
            "body": "What is the alternative lengthening of telomeres?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                "http://www.ncbi.nlm.nih.gov/pubmed/20403221",
                "http://www.ncbi.nlm.nih.gov/pubmed/19154407",
                "http://www.ncbi.nlm.nih.gov/pubmed/18215414",
                "http://www.ncbi.nlm.nih.gov/pubmed/19095716",
                "http://www.ncbi.nlm.nih.gov/pubmed/27726944",
                "http://www.ncbi.nlm.nih.gov/pubmed/21574432",
                "http://www.ncbi.nlm.nih.gov/pubmed/26581522",
                "http://www.ncbi.nlm.nih.gov/pubmed/24531712"
            ],
            "id": "5ab908d4fcf456587200001a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21574432",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 53,
                    "text": "[Mechanisms of alternative lengthening of telomeres]."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26581522",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Molecular mechanisms of activity and derepression of alternative lengthening of telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24531712",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1252,
                    "offsetInEndSection": 1371,
                    "text": "We concluded that alternative lengthening of telomeres is important in epidermal homeostasis and tumorigenesis in vivo."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18215414",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "Telomere uncapping and alternative lengthening of telomeres."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19095716",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19154407",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "Maintenance of telomeric ends by the telomerase ribonucleoprotein complex or the telomerase-independent alternative lengthening of telomeres is necessary for the immortalization of human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27726944",
                    "endSection": "abstract",
                    "offsetInBeginSection": 843,
                    "offsetInEndSection": 1000,
                    "text": "Silence of alternative lengthening of telomeres mechanism and telomerase mechanism related genes resulted in the shortening of telomere length in HEp-2 cell."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20403221",
                    "endSection": "abstract",
                    "offsetInBeginSection": 233,
                    "offsetInEndSection": 364,
                    "text": "However, some cancer cells maintain telomere length through an alternative mechanism termed 'alternative lengthening of telomeres'."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26022452",
                    "endSection": "abstract",
                    "offsetInBeginSection": 455,
                    "offsetInEndSection": 552,
                    "text": "The mechanism leading to the alternative lengthening of telomeres in liposarcoma remains unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26428317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 197,
                    "text": "Alternative lengthening of telomeres is a telomere-maintenance mechanism common in sarcomas."
                }
            ]
        },
        {
            "body": "Which organ express and secretes the hormone FGF21?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22917661",
                "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                "http://www.ncbi.nlm.nih.gov/pubmed/25215270",
                "http://www.ncbi.nlm.nih.gov/pubmed/23066506",
                "http://www.ncbi.nlm.nih.gov/pubmed/17623664",
                "http://www.ncbi.nlm.nih.gov/pubmed/25811804",
                "http://www.ncbi.nlm.nih.gov/pubmed/24697521",
                "http://www.ncbi.nlm.nih.gov/pubmed/26116622",
                "http://www.ncbi.nlm.nih.gov/pubmed/18467542"
            ],
            "id": "5ad3aa47133db5eb78000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24697521",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "Fibroblast growth factor 21 (FGF21) is a peptide hormone secreted by the liver, adipocytes, pancreas and skeletal muscle."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23066506",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "Fibroblast growth factor-21 (FGF21) is a hormone secreted by the liver during fasting that elicits diverse aspects of the adaptive starvation response."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17623664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 237,
                    "text": "The fibroblast growth factor (FGF) 19 subfamily of ligands, FGF19, FGF21, and FGF23, function as hormones that regulate bile acid, fatty acid, glucose, and phosphate metabolism in target organs through activating FGF receptors (FGFR1-4)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18467542",
                    "endSection": "abstract",
                    "offsetInBeginSection": 790,
                    "offsetInEndSection": 998,
                    "text": "Of the 379 genes robustly regulated by two structurally distinct PPARgamma agonists in the epididymal white adipose tissue (EWAT) of db/db mice, 33 encoded for known secreted proteins, one of which was FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25215270",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "Fibroblast growth factor 21 (FGF21) is an endocrine hormone that is primarily expressed in the liver and exerts beneficial effects on obesity and related metabolic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25811804",
                    "endSection": "abstract",
                    "offsetInBeginSection": 137,
                    "offsetInEndSection": 231,
                    "text": "Although the pancreas is an FGF21 target organ, its role in pancreatic islets remains obscure."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26116622",
                    "endSection": "abstract",
                    "offsetInBeginSection": 324,
                    "offsetInEndSection": 529,
                    "text": "In addition to its role as a stress hormone, FGF21 appears to function as a mediator of the therapeutic effects of currently available drugs and those under development for treatment of metabolic diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26654352",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "Fibroblast growth factor 21 (FGF21) is a peptide hormone that is synthesized by several organs and regulates energy homeostasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24432989",
                    "endSection": "abstract",
                    "offsetInBeginSection": 90,
                    "offsetInEndSection": 198,
                    "text": "The placenta actively synthesizes and secretes many hormones, but it is unknown whether this includes FGF21."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22917661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 127,
                    "offsetInEndSection": 263,
                    "text": "FGF21 is mainly expressed in the liver, but is also found in other tissues including the intestine, which expresses \u03b2-klotho abundantly."
                }
            ]
        },
        {
            "body": "What is the biological role of Neddylation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25628956",
                "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                "http://www.ncbi.nlm.nih.gov/pubmed/18247557",
                "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                "http://www.ncbi.nlm.nih.gov/pubmed/25742093",
                "http://www.ncbi.nlm.nih.gov/pubmed/25531226",
                "http://www.ncbi.nlm.nih.gov/pubmed/27956554",
                "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                "http://www.ncbi.nlm.nih.gov/pubmed/29074978",
                "http://www.ncbi.nlm.nih.gov/pubmed/18793140"
            ],
            "id": "5ace3e3f0340b9f058000012",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26260793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Neddylation is a posttranslational modification that controls diverse biological processes by covalently conjugating the ubiquitin-like protein NEDD8 to specific targets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18793140",
                    "endSection": "abstract",
                    "offsetInBeginSection": 564,
                    "offsetInEndSection": 788,
                    "text": "The present review describes the biological significance of NEDDylation for the novel identified substrates and the emerging evidence for the co-operation between the ubiquitin and NEDD8 pathways to control protein function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25531226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 260,
                    "offsetInEndSection": 430,
                    "text": "However, overexpression of exogenous NEDD8 can trigger NEDD8 conjugation through the ubiquitylation machinery, which makes validating potential NEDD8 targets challenging."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29074978",
                    "endSection": "abstract",
                    "offsetInBeginSection": 728,
                    "offsetInEndSection": 861,
                    "text": "Our data firmly establish a previously unrecognized specific role of the DCN1-UBC12 interaction for cellular neddylation of cullin 3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23148618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "The neddylation conjugation pathway has a pivotal role in mediating ubiquitination of proteins and regulation of numerous biological processes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25742093",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 261,
                    "text": "Protein neddylation, a newly characterized posttranslational modification that adds the ubiquitin-like molecule NEDD8 to substrates, modulates important biological processes, whereas dysfunction of neddylation may cause several serious diseases, such as cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27956554",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Protein posttranslational modifications such as neddylation play crucial roles in regulating protein function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18247557",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1705,
                    "offsetInEndSection": 1897,
                    "text": "The vast amount of proteomic information obtained here can provide clues on the biological role of Nedd8 and lay the foundation for an in-depth analysis of the regulation of the Nedd8 pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25918018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "Neural-precursor-cell-expressed developmentally down-regulated 8 (NEDD8) is a ubiquitin-like modifier, which forms covalent conjugates on lysines of its substrates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25628956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 124,
                    "offsetInEndSection": 305,
                    "text": "Similar to ubiquitination, neddylation is mediated by a cascade of three NEDD8 specific enzymes, an E1 activating enzyme, an E2 conjugating enzyme and one of the several E3 ligases."
                }
            ]
        },
        {
            "body": "What is break induced replication?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                "http://www.ncbi.nlm.nih.gov/pubmed/12660252",
                "http://www.ncbi.nlm.nih.gov/pubmed/27078578",
                "http://www.ncbi.nlm.nih.gov/pubmed/17280685",
                "http://www.ncbi.nlm.nih.gov/pubmed/21183718",
                "http://www.ncbi.nlm.nih.gov/pubmed/16888651",
                "http://www.ncbi.nlm.nih.gov/pubmed/23573231",
                "http://www.ncbi.nlm.nih.gov/pubmed/17671506"
            ],
            "id": "5ab9050bfcf4565872000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16888651",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 232,
                    "text": "Molecular studies on double-strand break (DSB) repair in mitosis are usually performed with enzymatically induced DSBs, but spontaneous DSBs might arise because of replication failures, for example when replication encounters nicks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23573231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1156,
                    "offsetInEndSection": 1511,
                    "text": "In contrast with DSB-repair-deficient cells, chicken DT40 cells deficient in PIF1 or ATRIP, which molecules contribute to the completion of DNA replication, displayed higher numbers of mitotic chromosomal breaks induced by aphidicolin than did wild-type cells, suggesting that single-strand gaps left unreplicated may result in mitotic chromosomal breaks."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17280685",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "DNA-PK is involved in repairing a transient surge of DNA breaks induced by deceleration of DNA replication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17671506",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 195,
                    "text": "Break-induced replication (BIR) is an efficient homologous recombination process to initiate DNA replication when only one end of a chromosome double-strand break shares homology with a template."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21183718",
                    "endSection": "abstract",
                    "offsetInBeginSection": 102,
                    "offsetInEndSection": 314,
                    "text": "We propose that a critical function of transcription termination factors is to prevent TEC from blocking DNA replication and inducing replication fork arrest, one consequence of which is DNA double-strand breaks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27078578",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1272,
                    "offsetInEndSection": 1538,
                    "text": "Therefore, double-strand breaks induced by oxidative damage happen at the sites of unrepaired primary one-strand DNA lesions, are independent of replication and are highly lethal, supporting the model of clustered ss-breaks at the sites of stable DNA-iron complexes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28427283",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "Break induced replication in eukaryotes: mechanisms, functions, and consequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12660252",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 315,
                    "text": "Here we show that gammaH2AX formation is also a cellular response to topoisomerase I cleavage complexes known to induce DNA double-strand breaks during replication."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 468,
                    "offsetInEndSection": 599,
                    "text": "The targeting preference for the terminus of replication and DNA double-strand breaks is dependent on the Tn7-encoded protein TnsE."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25329304",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Broken replication forks result in DNA breaks that are normally repaired via homologous recombination or break induced replication (BIR)."
                }
            ]
        },
        {
            "body": "What is a fibrocyte?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                "http://www.ncbi.nlm.nih.gov/pubmed/23795584",
                "http://www.ncbi.nlm.nih.gov/pubmed/26351669",
                "http://www.ncbi.nlm.nih.gov/pubmed/24885373",
                "http://www.ncbi.nlm.nih.gov/pubmed/28720095",
                "http://www.ncbi.nlm.nih.gov/pubmed/19464351",
                "http://www.ncbi.nlm.nih.gov/pubmed/18427397",
                "http://www.ncbi.nlm.nih.gov/pubmed/28915889",
                "http://www.ncbi.nlm.nih.gov/pubmed/29081339"
            ],
            "id": "5ad247720340b9f058000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18427397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1360,
                    "offsetInEndSection": 1689,
                    "text": "With fibrocytes being a monocyte derived cell, we suggest that monocytes may play a more crucial role in the clinical outcome of atherosclerosis than previously realized as they not only contribute directly to plaque instability (through foam cell formation), but also promote plaque stability by transformation into a fibrocyte."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23795584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 319,
                    "offsetInEndSection": 387,
                    "text": "However, the mechanism of fibrocyte differentiation remains unclear."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28915889",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26351669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 881,
                    "offsetInEndSection": 969,
                    "text": "\u03b12\u03b21, \u03b1M\u03b22, and \u03b1X\u03b22 integrins are needed for lumican-induced fibrocyte differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24885373",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1655,
                    "offsetInEndSection": 1780,
                    "text": "In particular, the PDGF-BB-PDGFR-\u03b2 biological axis might play a critical role in fibrocyte migration into the fibrotic lungs."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28720095",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29081339",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "Crystalline Silica Promotes Rat Fibrocyte Differentiation in Vitro, and Fibrocytes Participate in Silicosis in Vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22022512",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1196,
                    "offsetInEndSection": 1356,
                    "text": "The fibrocyte differentiation-inhibiting factor serum amyloid P (SAP) inhibits HMWHA-induced fibrocyte differentiation and potentiates LMWHA-induced inhibition."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19464351",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "There are several subtypes of fibrocyte in the spiral ligament and spiral limbus of the cochlea that may contribute to fluid homeostasis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27435108",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis."
                }
            ]
        },
        {
            "body": "Which cellular functions are affected by lncRNA H19 in the heart?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                "http://www.ncbi.nlm.nih.gov/pubmed/28790415",
                "http://www.ncbi.nlm.nih.gov/pubmed/27895893",
                "http://www.ncbi.nlm.nih.gov/pubmed/27084844",
                "http://www.ncbi.nlm.nih.gov/pubmed/29036538",
                "http://www.ncbi.nlm.nih.gov/pubmed/26853553",
                "http://www.ncbi.nlm.nih.gov/pubmed/27796346",
                "http://www.ncbi.nlm.nih.gov/pubmed/28203482",
                "http://www.ncbi.nlm.nih.gov/pubmed/28376483",
                "http://www.ncbi.nlm.nih.gov/pubmed/27140855"
            ],
            "id": "5ac7185f0340b9f058000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28376483",
                    "endSection": "abstract",
                    "offsetInBeginSection": 476,
                    "offsetInEndSection": 753,
                    "text": "LncRNAs including Chaer, Chast, Mhrt, CHRF, ROR, H19, and MIAT have been implicated in cardiac hypertrophy while NRF, H19, APF, CARL, UCA, Mhrt and several other lncRNAs (n379599, n379519, n384640, n380433 and n410105) in cardiomyocyte loss and extracellular matrix remodeling."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27140855",
                    "endSection": "abstract",
                    "offsetInBeginSection": 331,
                    "offsetInEndSection": 505,
                    "text": "However, studies over the past 5 years have shown that lncRNAs interfere with tissue homeostasis and have a role in pathological processes, including in the kidney and heart."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27796346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 147,
                    "text": "We previously established a rat model of diabetic cardiomyopathy (DCM) and found that the expression of lncRNA H19 was significantly downregulated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28203482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Long non-coding RNA H19 (lncRNA H19) was found to be upregulated by hypoxia, its expression and function have never been tested in cerebral ischemia and reperfusion (I/R) injury."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27895893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1338,
                    "offsetInEndSection": 1643,
                    "text": "CONCLUSION\nDownregulation of H19 promoted cell proliferation and inhibited cell apoptosis during late-stage cardiac differentiation by regulating the negative role of miR-19b in Sox6 expression, which suggested that the manipulation of H19 expression could serve as a potential strategy for heart disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27084844",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 200,
                    "text": "However, the function of H19 in the heart remains unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28790415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1102,
                    "offsetInEndSection": 1268,
                    "text": "Further studies identified that plasma levels of H19 and LIPCAR were also increased in CAD patients with heart failure compared to those with normal cardiac function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26853553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1222,
                    "offsetInEndSection": 1438,
                    "text": "To sum up, these observations indicate that the lncRNA H19 modulates Wnt/\u03b2-catenin pathway by acting as a competing endogenous RNA, which may shed light on the functional role of lncRNAs in coordinating osteogenesis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29036538",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "sTLR4/MD-2 complex inhibits colorectal cancer migration and invasiveness in vitro and in vivo by lncRNA H19 down-regulation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1337,
                    "offsetInEndSection": 1457,
                    "text": "Intriguingly, among the conserved lncRNAs, h19, rmrp and hotair were also induced in a mouse model of heart hypertrophy."
                }
            ]
        },
        {
            "body": "Dinutuximab is used for treatment of which disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                "http://www.ncbi.nlm.nih.gov/pubmed/28549783",
                "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                "http://www.ncbi.nlm.nih.gov/pubmed/26934530",
                "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                "http://www.ncbi.nlm.nih.gov/pubmed/28061552",
                "http://www.ncbi.nlm.nih.gov/pubmed/27485082",
                "http://www.ncbi.nlm.nih.gov/pubmed/27456981"
            ],
            "id": "589a247078275d0c4a000035",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27456981",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Dinutuximab: A Novel Immunotherapy in the Treatment of Pediatric Patients With High-Risk Neuroblastoma [Formula: see text]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27485082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 293,
                    "offsetInEndSection": 483,
                    "text": "In 2015, dinutuximab (an anti-GD2 mAb) was approved by the US FDA and is currently used in a combination immunotherapeutic regimen for the treatment of children with high-risk neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28061552",
                    "endSection": "abstract",
                    "offsetInBeginSection": 128,
                    "offsetInEndSection": 323,
                    "text": "Dinutuximab (formerly called ch14.18), a monoclonal antibody targeting the disialoganglioside GD2, has been shown to significantly improve survival rates in patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29238760",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 71,
                    "text": "Dinutuximab for the treatment of pediatric patients with neuroblastoma."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26934530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26891967",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 49,
                    "text": "Dinutuximab: A Review in High-Risk Neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25940913",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "United Therapeutics Corporation and the National Cancer Institute are developing dinutuximab (Unituxin\u2122; ch14.18), a monoclonal antibody targeting GD2, for the treatment of neuroblastoma."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28389455",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 63,
                    "text": "Dinutuximab for maintenance therapy in pediatric neuroblastoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28549783",
                    "endSection": "abstract",
                    "offsetInBeginSection": 982,
                    "offsetInEndSection": 1325,
                    "text": "Computer-based randomisation with sequence generation defined by permuted block randomisation (block size two) was used to randomly assign patients (1:1) to irinotecan and temozolomide plus either temsirolimus or dinutuximab, stratified by disease category, previous exposure to anti-GD2 antibody therapy, and tumour MYCN amplification status."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26917818",
                    "endSection": "abstract",
                    "offsetInBeginSection": 939,
                    "offsetInEndSection": 1343,
                    "text": "Dinutuximab is a chimeric, human-murine, anti-GD2 monoclonal antibody approved in combination with granulocyte-macrophage colony-stimulating factor (GM-CSF), aldesleukin (interleukin-2 [IL-2]), and isotretinoin (13-cis-retinoic acid [RA]) for maintenance treatment of pediatric patients with high-risk neuroblastoma who achieve at least a partial response to first-line multiagent, multimodality therapy."
                }
            ]
        },
        {
            "body": "What is the ChIP-exo method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                "http://www.ncbi.nlm.nih.gov/pubmed/27814676",
                "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                "http://www.ncbi.nlm.nih.gov/pubmed/25249628",
                "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                "http://www.ncbi.nlm.nih.gov/pubmed/27246337",
                "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                "http://www.ncbi.nlm.nih.gov/pubmed/28911122",
                "http://www.ncbi.nlm.nih.gov/pubmed/24475069"
            ],
            "id": "5ac24c9495d0062724000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24475069",
                    "endSection": "abstract",
                    "offsetInBeginSection": 817,
                    "offsetInEndSection": 1103,
                    "text": "Empirical studies on synthetic samples and applications using several ChIP data sets including 16 TF (transcription factor) ChIP-seq data sets and five TF ChIP-exo data sets have demonstrated that our proposed method is capable of finding these motifs with high efficiency and accuracy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26404150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 531,
                    "offsetInEndSection": 869,
                    "text": "A significant improvement of the ChIP-seq technique results from the addition of an exonuclease treatment during the immunoprecipitation step (ChIP-exo) that lowers background noise and more importantly increases the identification of binding sites to a level near to single-base resolution by effectively footprinting DNA-bound proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28911122",
                    "endSection": "abstract",
                    "offsetInBeginSection": 351,
                    "offsetInEndSection": 532,
                    "text": "We develop a novel statistical quality control pipeline and accompanying R/Bioconductor package, ChIPexoQual, to enable exploration and analysis of ChIP-exo and related experiments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27246337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1065,
                    "offsetInEndSection": 1264,
                    "text": "In this chapter, we provide a brief commentary on these methodological changes and describe a detailed ChIP-exo method able to generate narrower peaks and greater peak coverage from ChIPped material."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25720775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 142,
                    "offsetInEndSection": 297,
                    "text": "To identify sequences responsible for recruitment of this transcription factor (TF) to individual loci, we turned to the high-resolution ChIP-exo approach."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24373287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "ChIP-exonuclease (ChIP-exo) is a modified ChIP-seq approach for high resolution mapping of transcription factor DNA sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27814676",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 240,
                    "text": "BACKGROUND\nChIP-nexus, an extension of the ChIP-exo protocol, can be used to map the borders of protein-bound DNA sequences at nucleotide resolution, requires less input DNA and enables selective PCR duplicate removal using random barcodes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25249628",
                    "endSection": "abstract",
                    "offsetInBeginSection": 667,
                    "offsetInEndSection": 795,
                    "text": "Here we describe a novel analysis framework, termed MACE (model-based analysis of ChIP-exo) dedicated to ChIP-exo data analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 171,
                    "text": "This unit describes the ChIP-exo methodology, which combines chromatin immunoprecipitation (ChIP) with lambda exonuclease digestion followed by high-throughput sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28060339",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1138,
                    "text": "Here, we describe the ChIP-exo method that we have optimized and streamlined for mammalian systems and next-generation sequencing-by-synthesis platform."
                }
            ]
        },
        {
            "body": "Where do mitochondrial DNA deletion breakpoints tend to occur?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                "http://www.ncbi.nlm.nih.gov/pubmed/22661583",
                "http://www.ncbi.nlm.nih.gov/pubmed/9726008",
                "http://www.ncbi.nlm.nih.gov/pubmed/9876894",
                "http://www.ncbi.nlm.nih.gov/pubmed/22529999",
                "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                "http://www.ncbi.nlm.nih.gov/pubmed/7605803",
                "http://www.ncbi.nlm.nih.gov/pubmed/12090301",
                "http://www.ncbi.nlm.nih.gov/pubmed/21187929"
            ],
            "id": "5abc9ecffcf4565872000021",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21187929",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Sequence homology at the breakpoint and clinical phenotype of mitochondrial DNA deletion syndromes."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9726008",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "AT-rich sequences flanking the 5'-end breakpoint of the 4977-bp deletion of human mitochondrial DNA are located between two bent-inducing DNA sequences that assume distorted structure in organello."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9876894",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 216,
                    "text": "OBJECTIVES\nTo develop a protocol capable of identifying deletions in mitochondrial DNA and use it to identify the breakpoints of a mtDNA deletion in a patient with chronic progressive external ophthalmoplegia (CPEO)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12090301",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 268,
                    "text": "The identification of several mitochondrial DNA (mtDNA) deletions and the accumulation of the \"common\" 4.8-kb mitochondrial DNA deletion (mtDNA(4834)) with aging and experimental streptozotocin-induced diabetes (STZ) were studied in the rat dorsal root ganglion (DRG)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7605803",
                    "endSection": "abstract",
                    "offsetInBeginSection": 274,
                    "offsetInEndSection": 505,
                    "text": "Direct sequencing of the breakpoint region revealed that the deletion extended 5025 bp from nt 10,050 in the tRNA Gly gene to nt 15,076 in the cytochrome b gene, thus 30% of the total mitochondrial genome was lost by this deletion."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9128755",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "Direct repeat sequences are not required at the breakpoints of age-associated mitochondrial DNA deletions in rhesus monkeys."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22529999",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 161,
                    "text": "Deletion mutations within mitochondrial DNA (mtDNA) have been implicated in degenerative and aging related conditions, such as sarcopenia and neuro-degeneration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25193669",
                    "endSection": "abstract",
                    "offsetInBeginSection": 348,
                    "offsetInEndSection": 635,
                    "text": "In this work, we performed a computational analysis of the human mitochondrial genome using the \"Pattern Finder\" G-quadruplex (G4) predictor algorithm to assess whether G4-forming sequences reside in close proximity (within 20 base pairs) to known mitochondrial DNA deletion breakpoints."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22661583",
                    "endSection": "abstract",
                    "offsetInBeginSection": 653,
                    "offsetInEndSection": 848,
                    "text": "Furthermore, we discover that the most frequent deletion breakpoints occur within or near predicted structures, a result that is supported by data from transgenic mice with mitochondrial disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25124333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 554,
                    "offsetInEndSection": 824,
                    "text": "RESULTS\nHere, we show an association between human mtDNA deletion breakpoint locations (sites where DNA ends rejoin after deletion of a section) and sequences with G-quadruplex forming potential (QFP), and establish the ability of selected sequences to form GQ in vitro."
                }
            ]
        },
        {
            "body": "Name 4 circular RNA molecules associated with carcinogenesis.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28185365",
                "http://www.ncbi.nlm.nih.gov/pubmed/26874353",
                "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                "http://www.ncbi.nlm.nih.gov/pubmed/19010924",
                "http://www.ncbi.nlm.nih.gov/pubmed/23692083",
                "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                "http://www.ncbi.nlm.nih.gov/pubmed/28970820",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774"
            ],
            "id": "5ac721230340b9f058000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675105",
                    "endSection": "abstract",
                    "offsetInBeginSection": 768,
                    "offsetInEndSection": 965,
                    "text": "Although, the precise contribution of RNA molecules by themselves and RNA-regulated processes on cancer development is currently unknown, recent data suggest their important role in carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28970820",
                    "endSection": "abstract",
                    "offsetInBeginSection": 128,
                    "offsetInEndSection": 411,
                    "text": "Accumulating evidence indicates that long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs) may play key roles in the carcinogenesis of different cancers; however, little is known about the mechanisms of lncRNAs and circRNAs in the progression and metastasis of cervical cancer."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Circular RNA participates in the carcinogenesis and the malignant behavior of cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979421",
                    "endSection": "abstract",
                    "offsetInBeginSection": 339,
                    "offsetInEndSection": 545,
                    "text": "Studies on the recently discovered of EBV-encoded microRNAs (ebv-miRNAs) showed that these small molecules function as post-transcriptional gene regulators and may play a role in the carcinogenesis process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23692083",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1238,
                    "offsetInEndSection": 1331,
                    "text": "Regucalcin may be a key molecule suppressor protein in cell proliferation and carcinogenesis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26874353",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "The understanding of circular RNAs as special triggers in carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28185365",
                    "endSection": "abstract",
                    "offsetInBeginSection": 388,
                    "offsetInEndSection": 600,
                    "text": "By serving as sponges of microRNAs, interacting with long non-coding RNAs, mRNA, or proteins, circRNAs regulate gene expression at transcriptional and post-transcriptional levels and contribute to carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19010924",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "Suppression of the late gene expression, usually by integration of the viral DNA into the host genome, is a critical step in DNA tumor virus carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 542,
                    "offsetInEndSection": 756,
                    "text": "Emerging evidence shows that circRNAs play important roles in several diseases, particularly in cancer where they act through regulating protein expression of the pivotal genes that are critical for carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28342987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 731,
                    "offsetInEndSection": 886,
                    "text": "An in-depth study of circRNA will provide a better understanding of carcinogenesis and assist in developing clinical diagnostic and therapeutic strategies."
                }
            ]
        },
        {
            "body": "Which is the enzymatic activity of nardilysin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                "http://www.ncbi.nlm.nih.gov/pubmed/21801775",
                "http://www.ncbi.nlm.nih.gov/pubmed/16805830",
                "http://www.ncbi.nlm.nih.gov/pubmed/15866516",
                "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                "http://www.ncbi.nlm.nih.gov/pubmed/15629122",
                "http://www.ncbi.nlm.nih.gov/pubmed/23219461",
                "http://www.ncbi.nlm.nih.gov/pubmed/16923819",
                "http://www.ncbi.nlm.nih.gov/pubmed/27051521"
            ],
            "id": "5ac138aa95d0062724000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27051521",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1725,
                    "offsetInEndSection": 1971,
                    "text": "CONCLUSIONS\nThe strong and specific accumulation of Nardilysin in the manchette and axoneme suggests that the enzyme probably contributes either to the establishment of these specific microtubular structures and/or to their functional properties."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15629122",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "We have previously shown that the peptidase, nardilysin, contains a bipartite nuclear localization signal that permits the enzyme to cycle between the nucleus and cytoplasm."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1471,
                    "offsetInEndSection": 1628,
                    "text": "The alcohol-dependent reduction of nardilysin in cell culture and nervous tissue points to an implication of the enzyme in the pathophysiology of alcoholism."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16923819",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15809022",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 221,
                    "text": "Gel filtration chromatography showed that nardilysin activity in a rat testis or rat brain extract exhibited an apparent molecular weight of approximately 300 kDa compared to approximately 187 kDa for the purified enzyme."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15866516",
                    "endSection": "abstract",
                    "offsetInBeginSection": 645,
                    "offsetInEndSection": 773,
                    "text": "Thus, like insulysin and nardilysin, but contrary to bacterial pitrilysin, ppBH4 is inactivated by sulfhydryl alkylating agents."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16805830",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Interaction of the brain-specific protein p42IP4/centaurin-alpha1 with the peptidase nardilysin is regulated by the cognate ligands of p42IP4, PtdIns(3,4,5)P3 and Ins(1,3,4,5)P4, with stereospecificity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19234765",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "The peptidase nardilysin is involved in degradation of neuropeptides and limited intracellular proteolysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15544571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 353,
                    "offsetInEndSection": 499,
                    "text": "Since for those processes its enzymatic activity is not required, it is now evident that nardilysin fulfills at least two distinct functions, i.e."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21801775",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 191,
                    "text": "Retinoic acid-induced upregulation of the metalloendopeptidase nardilysin is accelerated by co-expression of the brain-specific protein p42(IP4) (centaurin \u03b1 1; ADAP1) in neuroblastoma cells."
                }
            ]
        },
        {
            "body": "The Mantoux test detects what latent infection/disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                "http://www.ncbi.nlm.nih.gov/pubmed/19475629",
                "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
                "http://www.ncbi.nlm.nih.gov/pubmed/17158278",
                "http://www.ncbi.nlm.nih.gov/pubmed/16956501",
                "http://www.ncbi.nlm.nih.gov/pubmed/7747304",
                "http://www.ncbi.nlm.nih.gov/pubmed/24398852",
                "http://www.ncbi.nlm.nih.gov/pubmed/18579028",
                "http://www.ncbi.nlm.nih.gov/pubmed/27643978"
            ],
            "id": "5ab147edfcf4565872000013",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27643978",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1824,
                    "offsetInEndSection": 2059,
                    "text": "CONCLUSION\nTargeted preemptive therapy in patients with perceived higher risk for cytomegalovirus infection/disease was effective in preventing severe clinical presentation, including tissue invasive and late cytomegalovirus infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24398852",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 217,
                    "text": "BACKGROUND\nCMV-D+/R- serostatus is the only well-established risk factor for late-onset cytomegalovirus (CMV) infection/disease (i.e., incident CMV infection/disease after cessation of prophylactic antiviral therapy)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19475629",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1371,
                    "offsetInEndSection": 1601,
                    "text": "Using established serological assays, different \"at-risk\" populations for HHV-8 infection/disease were detected in this geographic area, confirming HIV/AIDS and identifying patients with chronic kidney disease as high-risk groups."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7747304",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 342,
                    "text": "A cross-sectional study to estimate the prevalence of latent tuberculosis (TB) in a group of Zambians at high risk of human immunodeficiency virus type 1 (HIV-1) infection and to examine the effect of HIV-1 infection on the tuberculin response was conducted in the University Teaching Hospital in Lusaka, Zambia during July to September 1990."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18579028",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1395,
                    "offsetInEndSection": 1544,
                    "text": "In Mantoux positive patients, it is very useful for ruling-out false positives due to BCG-vaccination and/or non-tuberculous mycobacterial infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12238571",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 288,
                    "text": "In order to determine the prevalence of latent infection due to Mycobacterium tuberculosis in drug users and to provide centres for drug users with a practical tool for tuberculosis screening, 237 drug users were subjected to the Monotest and, for reference purposes, to the Mantoux test."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17158278",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Effect of HIV-1 infection on T-Cell-based and skin test detection of tuberculosis infection."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16307510",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Diagnosis of latent Mycobacterium tuberculosis infection: is the demise of the Mantoux test imminent?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16956501",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1312,
                    "offsetInEndSection": 1552,
                    "text": "CONCLUSIONS\nGiven that the tuberculin skin test is a good screening test despite its limitations in the control of latent tuberculin infection in children, its indications should be adjusted to ever-changing epidemiological characteristics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22527447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 96,
                    "text": "The tuberculin skin test, used to detect latent systemic tuberculosis (TB), has its limitations."
                }
            ]
        },
        {
            "body": "What is measured with the Proseek panels?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
                "http://www.ncbi.nlm.nih.gov/pubmed/28694499",
                "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                "http://www.ncbi.nlm.nih.gov/pubmed/28083617"
            ],
            "id": "5a9d99ac4e03427e73000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28930774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 738,
                    "offsetInEndSection": 948,
                    "text": "The samples were analyzed with a multiplex proximity extension assay in which 92 inflammation-related proteins were measured simultaneously (Proseek Multiplex Inflammation I; Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                    "endSection": "abstract",
                    "offsetInBeginSection": 543,
                    "offsetInEndSection": 828,
                    "text": "Serum concentrations of 92 inflammation-associated proteins were measured in samples obtained from 80 aHSCT patients 14\u00a0days after transplantation and from 23 healthy control subjects by a novel sensitive proximity extension assay technology using Proseek Multiplex Inflammation I kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 304,
                    "offsetInEndSection": 449,
                    "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120\u00a0min afterward with the Proseek Multiplex Neurology\u00a0I kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28694499",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 814,
                    "text": "Using the Proseek Multiplex Inflammation assay, we measured in patients that had suffered mild TBI (n\u2009=\u200910) or severe TBI (n\u2009=\u200910) with extra-cranial injury or extracranial injury only (EC) (n\u2009=\u200910), 92 inflammation-associated proteins in serum obtained: <1\u2009hr (within 1-hour), 4-12\u2009hr and 48-72\u2009hr post injury."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 750,
                    "offsetInEndSection": 962,
                    "text": "Blood samples were obtained at baseline (0 hour), 6, 24, and 96 hours post PCI, and stored at -80\u00b0C until they were analyzed by PROSEEK Multiplex CVD and PROSEEK Multiplex INF (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28586402",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 362,
                    "text": "A total of 92 biomarkers were measured before a standardized meal as well as 30 and 120 minutes afterwards with the Proseek Multiplex CVD III kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 542,
                    "text": "To simultaneously measure 92 inflammatory biomarkers, we used the proximity extension assay with the Proseek Multiplex Inflammation I panel (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 654,
                    "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards."
                }
            ]
        },
        {
            "body": "Is Enlimomab effective for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                "http://www.ncbi.nlm.nih.gov/pubmed/19849665",
                "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                "http://www.ncbi.nlm.nih.gov/pubmed/9744839",
                "http://www.ncbi.nlm.nih.gov/pubmed/12365824",
                "http://www.ncbi.nlm.nih.gov/pubmed/10096530",
                "http://www.ncbi.nlm.nih.gov/pubmed/12777909",
                "http://www.ncbi.nlm.nih.gov/pubmed/10847250",
                "http://www.ncbi.nlm.nih.gov/pubmed/1688257"
            ],
            "id": "58ec6eb5eda5a5767200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1688257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 539,
                    "offsetInEndSection": 657,
                    "text": "Combined glutamate antagonist and thrombolytic therapy may provide increased efficacy and safety for stroke treatment."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10847250",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 53,
                    "text": "Update on antiplatelet therapy for stroke prevention."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12777909",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 174,
                    "text": "Clinical effects of inhibiting leukocyte adhesion with monoclonal antibody to intercellular adhesion molecule-1 (enlimomab) in the treatment of partial-thickness burn injury."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10096530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 258,
                    "text": "A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9744839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1441,
                    "offsetInEndSection": 1524,
                    "text": "However, this treatment failed to show benefit in the Enlimomab Acute Stroke Trial."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12365824",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Anti-leukocyte antibodies: LeukArrest (Hu23F2G) and Enlimomab (R6.5) in acute stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11692032",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 199,
                    "text": "Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1 antibody: a bedside-to-bench study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19849665",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1772,
                    "offsetInEndSection": 1933,
                    "text": "Treatment with a murine anti-ICAM-1 antibody (enlimomab) has been investigated in patients with acute ischemic stroke in the Enlimomab Acute Stroke Trial (EAST)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9693236",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 165,
                    "text": "Safety, pharmacokinetics and biological activity of enlimomab (anti-ICAM-1 antibody): an open-label, dose escalation study in patients hospitalized for acute stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11673584",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial."
                }
            ]
        },
        {
            "body": "Are AAV vectors considered for the treatment of retinal dystrophies?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                "http://www.ncbi.nlm.nih.gov/pubmed/21880665",
                "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                "http://www.ncbi.nlm.nih.gov/pubmed/28510482",
                "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                "http://www.ncbi.nlm.nih.gov/pubmed/27653967",
                "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                "http://www.ncbi.nlm.nih.gov/pubmed/19626133"
            ],
            "id": "5a74acd80384be9551000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27416076",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Gene therapy using adeno-associated viral (AAV) vectors for the treatment of retinal degenerations has shown safety and efficacy in clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15960597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Recombinant adeno-associated viral (AAV) vectors have become powerful gene delivery tools for the treatment of retinal degeneration in a variety of animal models that mimic corresponding human diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19626133",
                    "endSection": "abstract",
                    "offsetInBeginSection": 864,
                    "offsetInEndSection": 1075,
                    "text": "To evaluate AAV-9 transduction in a diseased retina, we injected subretinally 1x10(9) viral genome particles of AAV-9.CMV.R4-23/C to mdx(3cv) mice, which we used as a model for Duchenne muscular dystrophy (DMD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28510482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 228,
                    "text": "AAVs have been applied successfully in various models of PR dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27653967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 287,
                    "offsetInEndSection": 595,
                    "text": "In animal models of RPE65 deficiency, subretinal injection of recombinant adeno-associated virus (AAV) 2/2 vectors carrying RPE65 cDNA improves rod photoreceptor function, and intervention at an early stage of disease provides sustained benefit by protecting cone photoreceptors against retinal degeneration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21980317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 407,
                    "offsetInEndSection": 834,
                    "text": "Here, we review immunity against AAV vector and transgene in the context of gene delivery specific to muscles for treating muscular dystrophies and non-muscle diseases in large animal models and human trials, factors that influence the intensity of the immune responses, and immune modulatory strategies to prevent unwanted immune responses and induce tolerance to the vector and therapeutic gene for a successful gene therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26609316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 285,
                    "offsetInEndSection": 530,
                    "text": "These novel gene vectors aim to more safely and efficiently transduce retinal cells, expand the gene packaging capacity of AAV, and utilize new strategies to correct the varying mechanisms of dysfunction found with inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21880665",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1313,
                    "offsetInEndSection": 1495,
                    "text": "Our results provide important considerations for viral vectors to be used in future gene therapy clinical trials targeting a wider severity spectrum of inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21818300",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "BACKGROUND\nGene transfer using adeno-associated viral (AAV) vectors has been successfully applied in the retina for the treatment of inherited retinal dystrophies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24327302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 803,
                    "offsetInEndSection": 915,
                    "text": "This article gives an overview of the current state of specific gene therapy for hereditary retinal dystrophies."
                }
            ]
        },
        {
            "body": "Does International Citicoline Trial on acUte Stroke trial supports efficacy of citicoline for stroke treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                "http://www.ncbi.nlm.nih.gov/pubmed/27072975",
                "http://www.ncbi.nlm.nih.gov/pubmed/10582983",
                "http://www.ncbi.nlm.nih.gov/pubmed/18637642",
                "http://www.ncbi.nlm.nih.gov/pubmed/12468781",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                "http://www.ncbi.nlm.nih.gov/pubmed/9305321",
                "http://www.ncbi.nlm.nih.gov/pubmed/23600725"
            ],
            "id": "58ec709aeda5a5767200000e",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9305321",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "A randomized dose-response trial of citicoline in acute ischemic stroke patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351232",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Efficacy of citicoline as an acute stroke treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23600725",
                    "endSection": "abstract",
                    "offsetInBeginSection": 68,
                    "offsetInEndSection": 455,
                    "text": "In humans, although a recent trial International Citicoline Trial on Acute Stroke (ICTUS) has shown that global recovery is similar in CDP-choline and placebo groups, CDP-choline was shown to be more beneficial in some patients, such as those with moderate stroke severity and not treated with t-PA. Several mechanisms have been proposed to explain the beneficial actions of CDP-choline."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12468781",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18637642",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 213,
                    "text": "The International Citicoline Trial in acUte Stroke is a sequential phase III study of the use of the drug citicoline in the treatment of acute ischaemic stroke, which was initiated in 2006 in 56 treatment centres."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10582983",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "A randomized efficacy trial of citicoline in patients with acute ischemic stroke."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27072975",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Early application of citicoline in the treatment of acute stroke: A meta-analysis of randomized controlled trials."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11706098",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 378,
                    "text": "OBJECTIVE\nTo determine the safety and efficacy of citicoline treatment in acute stroke patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22691567",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27234918",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "BACKGROUND\nCiticoline is a drug approved for the treatment of acute ischemic stroke."
                }
            ]
        },
        {
            "body": "Is human lysyl oxidase-like 2 a glycoprotein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                "http://www.ncbi.nlm.nih.gov/pubmed/24764069",
                "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                "http://www.ncbi.nlm.nih.gov/pubmed/18929111",
                "http://www.ncbi.nlm.nih.gov/pubmed/27063404",
                "http://www.ncbi.nlm.nih.gov/pubmed/7689553"
            ],
            "id": "5ad240f70340b9f058000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18929111",
                    "endSection": "abstract",
                    "offsetInBeginSection": 742,
                    "offsetInEndSection": 1309,
                    "text": "The characteristic fibrils, composed of microfibrillar subunits surrounded by an amorphous matrix comprising various glycoconjugates, contain predominantly epitopes of elastic fibers, such as elastin, tropoelastin, amyloid P, vitronectin, and components of elastic microfibrils, such as fibrillin-1, fibulin-2, vitronectin, microfibril-associated glycoprotein (MAGP-1), and latent TGF-beta binding proteins (LTBP-1 and LTBP-2), the proteoglycans syndecan and versican, the extracellular chaperone clusterin, the cross-linking enzyme lysyl oxidase, and other proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23319596",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 119,
                    "text": "Post-translational modifications of recombinant human lysyl oxidase-like 2 (rhLOXL2) secreted from Drosophila S2 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27063404",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Lysyl oxidase-like 2 (LOXL2) is a member of the lysyl oxidase family, which plays an important role in extracellular matrix protein biosynthesis and tumor progression."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21954900",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "A general protease digestion procedure for optimal protein sequence coverage and post-translational modifications analysis of recombinant glycoproteins: application to the characterization of human lysyl oxidase-like 2 glycosylation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7689553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "A novel human cDNA with a predicted protein homologous to the carboxyl end of lysyl oxidase, an extracellular enzyme involved in the maturation of collagen and elastin, has been isolated."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17018530",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "A tissue-specific variant of the human lysyl oxidase-like protein 3 (LOXL3) functions as an amine oxidase with substrate specificity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28112368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 413,
                    "text": "The LOXL3\u00a0protein contains four scavenger receptor cysteine-rich\u00a0(SRCR) domains in the N-terminus in addition to the C-terminal characteristic domains of the lysyl oxidase\u00a0(LOX) family, such as a copper-binding domain, a cytokine receptor\u2011like domain and residues for the lysyl-tyrosyl quinone cofactor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24764069",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1017,
                    "offsetInEndSection": 1129,
                    "text": "The level of lysyl oxidase-like 2 protein was significantly correlated with that of TGF-\u03b2 in the Tenon's tissue."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20306300",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "The human lysyl oxidase-like 2 protein functions as an amine oxidase toward collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7706256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 193,
                    "text": "We have isolated a number of recombinant clones from a human skin fibroblast cDNA library that contain extensive sequence homology to several coding domains within the human lysyl oxidase mRNA."
                }
            ]
        },
        {
            "body": "Can GDF15 be a biomarker for metformin treatment?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                "http://www.ncbi.nlm.nih.gov/pubmed/24669014",
                "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                "http://www.ncbi.nlm.nih.gov/pubmed/22675198",
                "http://www.ncbi.nlm.nih.gov/pubmed/25446397",
                "http://www.ncbi.nlm.nih.gov/pubmed/28801589",
                "http://www.ncbi.nlm.nih.gov/pubmed/17185363",
                "http://www.ncbi.nlm.nih.gov/pubmed/27018280",
                "http://www.ncbi.nlm.nih.gov/pubmed/23710769",
                "http://www.ncbi.nlm.nih.gov/pubmed/26230285"
            ],
            "id": "5ad3013d0340b9f058000019",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27018280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 261,
                    "offsetInEndSection": 470,
                    "text": "As the primary cause of mitochondrial diseases is mitochondrial dysfunction, the blood level of GDF15 might reflect mitochondrial function in patients, and thus could be a marker for mitochondrial dysfunction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23710769",
                    "endSection": "abstract",
                    "offsetInBeginSection": 233,
                    "offsetInEndSection": 425,
                    "text": "However, serum GDF15 levels in patients with oral leukoplakia and GDF15 as a potential predictive biomarker for response to induction chemotherapy in patients with OSCC have not been reported."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28801589",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "Accumulating evidence suggests that GDF15 is a biomarker for ageing and morbidity of many somatic disorders such as cancer and inflammatory disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26230285",
                    "endSection": "abstract",
                    "offsetInBeginSection": 390,
                    "offsetInEndSection": 502,
                    "text": "Therefore, our aim was to assess the prognostic value of the biomarker growth differentiation factor 15 (GDF15)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25446397",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17185363",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1551,
                    "offsetInEndSection": 1813,
                    "text": "The reference limits and confounding variables defined for apparently healthy elderly individuals and the favorable preanalytic characteristics of GDF15 are expected to facilitate future studies of GDF15 as a biomarker in various disease settings, including CHF."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22675198",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 209,
                    "text": "BACKGROUND\nGrowth differentiation factor 15 (GDF15) is a stress-responsive cytokine and biomarker that is produced after myocardial infarction and that is related to prognosis in acute coronary syndrome (ACS)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25541611",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "GDF15 Is a Novel Biomarker for Impaired Fasting Glucose."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24669014",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "GDF15 is a potential predictive biomarker for TPF induction chemotherapy and promotes tumorigenesis and progression in oral squamous cell carcinoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27974345",
                    "endSection": "abstract",
                    "offsetInBeginSection": 863,
                    "offsetInEndSection": 1010,
                    "text": "CONCLUSIONS\nGDF15 levels are a biomarker for the use of metformin in people with dysglycemia, and its concentration reflects the dose of metformin."
                }
            ]
        },
        {
            "body": "Has rituximab been considered as a treatment for chronic fatigues syndrome? (November 2017)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28243993",
                "http://www.ncbi.nlm.nih.gov/pubmed/21247220",
                "http://www.ncbi.nlm.nih.gov/pubmed/29250930",
                "http://www.ncbi.nlm.nih.gov/pubmed/28782884",
                "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                "http://www.ncbi.nlm.nih.gov/pubmed/14601692",
                "http://www.ncbi.nlm.nih.gov/pubmed/30353902",
                "http://www.ncbi.nlm.nih.gov/pubmed/20392977",
                "http://www.ncbi.nlm.nih.gov/pubmed/26341251"
            ],
            "id": "5aa395fcd6d6b54f79000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/30353902",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 755,
                    "text": "On the first half (January 1, 2015 to July 31, 2016) of the study period, the cases were given 3mg of warfarin as initial dose (Group 1); while in the second half (August 1, 2016 to November 31, 2017) cases were given 5mg as the initial dose (Group 2)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29250930",
                    "endSection": "abstract",
                    "offsetInBeginSection": 986,
                    "offsetInEndSection": 1129,
                    "text": "However, of note, at the date of this publication venetoclax is not PBS reimbursed, and ibrutinib will not be reimbursed until 1 December 2017."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26341251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 395,
                    "text": "METHODS\nWe administered a single dose of RTX to patients with refractory SDNS from November 2007 to December 2013 and continued with immunosuppressants."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14601692",
                    "endSection": "abstract",
                    "offsetInBeginSection": 211,
                    "offsetInEndSection": 402,
                    "text": "PATIENTS AND METHODS\nWe retrospectively reviewed the medical charts of all patients treated with rituximab for immune cytopenia at the Mayo Clinic in Rochester, Minn, through January 1, 2003."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20392977",
                    "endSection": "abstract",
                    "offsetInBeginSection": 276,
                    "offsetInEndSection": 518,
                    "text": "RESULTS\nSince 2004, 10 patients with generalised myasthenia gravis (three of whom were positive for muscle-specific tyrosine kinase (MuSK) antibodies) and two patients with Lambert-Eaton myasthenic syndrome (LEMS) were treated with rituximab."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28782884",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21247220",
                    "endSection": "abstract",
                    "offsetInBeginSection": 564,
                    "offsetInEndSection": 1089,
                    "text": "OBJECTIVE\nTo assess the incidence of infusion-associated reactions in our MS patients receiving rituximab infusions and compare it to previous trials investigating rituximab for treating MS.\n\n\nMETHODS\nFrom 1 to 30 November 2009, we retrospectively reviewed medical charts from Partners Multiple Sclerosis Centre, Brookline, MA, USA, of patients being treated with rituximab for MS between 20 November 2007 and 24 November 2009 for evidence of infusion-associated reactions and further classified reactions on a grading scale."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28243993",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 76,
                    "text": "What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10589082",
                    "endSection": "abstract",
                    "offsetInBeginSection": 253,
                    "offsetInEndSection": 395,
                    "text": "Recently, however, tumor lysis syndrome (TLS) resulting from rituximab has been reported in a patient with chronic lymphocytic leukemia (CLL)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22007328",
                    "endSection": "abstract",
                    "offsetInBeginSection": 378,
                    "offsetInEndSection": 560,
                    "text": "Under a third had received any medical training regarding chemical sensitivity, only 7% were \"very satisfied\" with their knowledge, and 6% had a treatment protocol for the condition."
                }
            ]
        },
        {
            "body": "Does oncogene-induced DNA replication stress inhibit genomic instability?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                "http://www.ncbi.nlm.nih.gov/pubmed/28073589",
                "http://www.ncbi.nlm.nih.gov/pubmed/21311564",
                "http://www.ncbi.nlm.nih.gov/pubmed/20098673",
                "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                "http://www.ncbi.nlm.nih.gov/pubmed/24845676",
                "http://www.ncbi.nlm.nih.gov/pubmed/26292731"
            ],
            "id": "5ab9032afcf4565872000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1641,
                    "offsetInEndSection": 1756,
                    "text": "Our results demonstrate how oncogene-induced replication stress contributes to genomic instability in human cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204322",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "Oncogene-induced DNA replication stress is thought to drive genomic instability in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20098673",
                    "endSection": "abstract",
                    "offsetInBeginSection": 461,
                    "offsetInEndSection": 677,
                    "text": "Although oncogene acceleration primarily induces DNA replication stress and the resulting lesions in the S phase, these lesions are carried over into the M phase and cause cytokinesis failure and genomic instability."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28073589",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 51,
                    "text": "Mechanisms of oncogene-induced genomic instability."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26292731",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 124,
                    "text": "Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24845676",
                    "endSection": "abstract",
                    "offsetInBeginSection": 639,
                    "offsetInEndSection": 908,
                    "text": "Here, we review our current understanding of replication initiation and its regulation, describe mechanisms by which activated oncogenes might interfere with these processes and discuss how replicative stress might contribute to the genomic instability seen in cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21311564",
                    "endSection": "abstract",
                    "offsetInBeginSection": 307,
                    "offsetInEndSection": 482,
                    "text": "We have previously shown that expression of oncogenes leads to DNA replication stress and genomic instability, explaining the high frequency of p53 mutations in human cancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27725641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 931,
                    "offsetInEndSection": 1148,
                    "text": "Consequently, we reveal that increased transcription can be a mechanism of oncogene-induced DNA damage, providing a molecular link between upregulation of the transcription machinery and genomic instability in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20177397",
                    "endSection": "abstract",
                    "offsetInBeginSection": 489,
                    "offsetInEndSection": 846,
                    "text": "Instead, the mutation patterns of the tumour suppressor TP53 (which encodes p53), ataxia telangiectasia mutated (ATM) and cyclin-dependent kinase inhibitor 2A (CDKN2A; which encodes p16INK4A and p14ARF) support the oncogene-induced DNA replication stress model, which attributes genomic instability and TP53 and ATM mutations to oncogene-induced DNA damage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25959793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 492,
                    "text": "Aberrant oncogene expression induces replication stress, leading to DNA breaks and genomic instability."
                }
            ]
        },
        {
            "body": "Is the petrous bone used in ancient DNA sampling?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                "http://www.ncbi.nlm.nih.gov/pubmed/26595274",
                "http://www.ncbi.nlm.nih.gov/pubmed/28526291",
                "http://www.ncbi.nlm.nih.gov/pubmed/27810583",
                "http://www.ncbi.nlm.nih.gov/pubmed/21855309",
                "http://www.ncbi.nlm.nih.gov/pubmed/26081994",
                "http://www.ncbi.nlm.nih.gov/pubmed/17641642",
                "http://www.ncbi.nlm.nih.gov/pubmed/23595645"
            ],
            "id": "5abd3707fcf456587200002d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23595645",
                    "endSection": "abstract",
                    "offsetInBeginSection": 296,
                    "offsetInEndSection": 643,
                    "text": "Since the survival of DNA is explained by complex interrelations of multiple variables, the aim of the present study was to analyze morphological, structural, chemical, and biological aspects of a set of medieval human bones, to provide an accurate reflection of the state of preservation of the bony components and to relate it with DNA presence."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17641642",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "Ancient DNA extraction from bones and teeth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21855309",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 224,
                    "text": "Despite the widespread use of bones in ancient DNA (aDNA) studies, relatively little concrete information exists in regard to how the DNA in mineralised collagen degrades, or where it survives in the material's architecture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27810583",
                    "endSection": "abstract",
                    "offsetInBeginSection": 673,
                    "offsetInEndSection": 785,
                    "text": "We managed to obtain nuclear DNA for successful STR typing from the left second molar and from the petrous bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26081994",
                    "endSection": "abstract",
                    "offsetInBeginSection": 79,
                    "offsetInEndSection": 270,
                    "text": "In the majority of ancient bones and teeth, endogenous DNA molecules represent a minor fraction of the whole DNA extract, rendering shot-gun sequencing inefficient for obtaining genomic data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28526291",
                    "endSection": "abstract",
                    "offsetInBeginSection": 605,
                    "offsetInEndSection": 708,
                    "text": "The petrous part yielded more endogenous ancient DNA molecules than the squamous part of the same bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26595274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 375,
                    "offsetInEndSection": 648,
                    "text": "The new samples include, to our knowledge, the first genome-wide ancient DNA from Anatolian Neolithic farmers, whose genetic material we obtained by extracting from petrous bones, and who we show were members of the population that was the source of Europe's first farmers."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26086078",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Optimal Ancient DNA Yields from the Inner Ear Part of the Human Petrous Bone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28129388",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Comparing Ancient DNA Preservation in Petrous Bone and Tooth Cementum."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28625158",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "A minimally-invasive method for sampling human petrous bones from the cranial base for ancient DNA analysis."
                }
            ]
        },
        {
            "body": "Is recursive splicing more common in short introns?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                "http://www.ncbi.nlm.nih.gov/pubmed/25970246",
                "http://www.ncbi.nlm.nih.gov/pubmed/11269499",
                "http://www.ncbi.nlm.nih.gov/pubmed/19924226",
                "http://www.ncbi.nlm.nih.gov/pubmed/16314266",
                "http://www.ncbi.nlm.nih.gov/pubmed/9111348",
                "http://www.ncbi.nlm.nih.gov/pubmed/17189193",
                "http://www.ncbi.nlm.nih.gov/pubmed/25800735"
            ],
            "id": "5abc974bfcf456587200001f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17189193",
                    "endSection": "abstract",
                    "offsetInBeginSection": 434,
                    "offsetInEndSection": 604,
                    "text": "Recursive splicing constructs, which uncouple U1 recruitment from transcription, suggest that cotranscriptional U1 recruitment contributes to optimal splicing efficiency."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16314266",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 182,
                    "text": "The analysis of lariats produced in vivo during pre-mRNA splicing is a powerful tool for elucidation of regulatory mechanisms and identification of natural recursive splicing events."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25800735",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "SplicePie: a novel analytical approach for the detection of alternative, non-sequential and recursive splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19924226",
                    "endSection": "abstract",
                    "offsetInBeginSection": 320,
                    "offsetInEndSection": 579,
                    "text": "In invertebrates, especially Drosophila, it has been shown that larger introns can be spliced efficiently through a process known as recursive splicing-a consecutive splicing from the 5'-end at a series of combined donor-acceptor splice sites called RP-sites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9111348",
                    "endSection": "abstract",
                    "offsetInBeginSection": 331,
                    "offsetInEndSection": 555,
                    "text": "To investigate if small introns contain special sequences that facilitate their recognition, the sequences and factors required for the splicing of a 59-nucleotide intron from the D. melanogaster mle gene have been examined."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11269499",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 79,
                    "text": "Uncoupling yeast intron recognition from transcription with recursive splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970246",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 310,
                    "text": "However, some long Drosophila melanogaster introns contain a cryptic site, known as a recursive splice site (RS-site), that enables a multi-step process of intron removal termed recursive splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25970244",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Recursive splicing is a process in which large introns are removed in multiple steps by re-splicing at ratchet points--5' splice sites recreated after splicing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15802507",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1254,
                    "offsetInEndSection": 1427,
                    "text": "Mutation of nonexonic site RP3 within Ultrabithorax also confirmed that recursive splicing is the predominant processing pathway even with a shortened version of the intron."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27965595",
                    "endSection": "abstract",
                    "offsetInBeginSection": 844,
                    "offsetInEndSection": 1029,
                    "text": "This process, called \"recursive splicing,\" often involves non-canonical splicing elements positioned deep within introns, and different mechanisms for its deployment have been proposed."
                }
            ]
        },
        {
            "body": "Is Lysyl oxidase crosslinking collagen?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                "http://www.ncbi.nlm.nih.gov/pubmed/26918",
                "http://www.ncbi.nlm.nih.gov/pubmed/12918034",
                "http://www.ncbi.nlm.nih.gov/pubmed/2890532",
                "http://www.ncbi.nlm.nih.gov/pubmed/906929",
                "http://www.ncbi.nlm.nih.gov/pubmed/9260463",
                "http://www.ncbi.nlm.nih.gov/pubmed/9402968",
                "http://www.ncbi.nlm.nih.gov/pubmed/9524359",
                "http://www.ncbi.nlm.nih.gov/pubmed/8096378"
            ],
            "id": "5ac07b67dd95b2cd42000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9524359",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Lysyl oxidase (LO) is a copper-dependent amine oxidase that plays a critical role in the biogenesis of connective tissue matrices by crosslinking the extracellular matrix proteins, collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9402968",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 176,
                    "text": "The lysyl oxidase-like (LOXL) gene is a new member of the lysyl oxidase family, a copper-dependent enzyme that is implicated in the crosslinking of collagen and elastin fibers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8096378",
                    "endSection": "abstract",
                    "offsetInBeginSection": 185,
                    "offsetInEndSection": 348,
                    "text": "A decrease in the functional activity of lysyl oxidase, a cuproenzyme, is thought in part to be responsible for the decreased crosslinking of collagen and elastin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26918",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "Lysyl oxidase catalyzes the crosslinking of collagen and elastin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2890532",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "The role of lysyl oxidase and collagen crosslinking during sea urchin development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/906929",
                    "endSection": "abstract",
                    "offsetInBeginSection": 175,
                    "offsetInEndSection": 395,
                    "text": "Lysyl oxidase controls one of the initial steps in the crosslinking of elastin and collagen, i.e., the conversion of peptidyl lysine or hydroxylysine residues to peptidyl alpha-aminoadipic-delta-semialdehyde derivatives."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9260463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 363,
                    "offsetInEndSection": 605,
                    "text": "Lysyl oxidase, which catalyzes the corresponding aldehyde formation from certain lysyl and hydroxylysyl residues in collagen and elastin in the first step of the linking reaction, is the only known enzyme required in the crosslinking process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12918034",
                    "endSection": "abstract",
                    "offsetInBeginSection": 105,
                    "offsetInEndSection": 361,
                    "text": "In this study, we utilized lysyl oxidase (LO) to enzymatically crosslink extracellular matrix (ECM) proteins, particularly collagen and elastin, to enhance the mechanical integrity of the ECM and thereby impart mechanical strength to the engineered tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4531019",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Lysyl oxidase catalyzes the formation of crosslinking aldehydes in collagen and elastin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2870873",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Skin lysyl oxidase activity is not rate limiting for collagen crosslinking in the glucocorticoid-treated rat."
                }
            ]
        },
        {
            "body": "Is sternotomy closure done using either a sternal ZipFix\u2122 implant  or conventional steel wire following cardiac surgery?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                "http://www.ncbi.nlm.nih.gov/pubmed/16967378",
                "http://www.ncbi.nlm.nih.gov/pubmed/20494064",
                "http://www.ncbi.nlm.nih.gov/pubmed/17244925",
                "http://www.ncbi.nlm.nih.gov/pubmed/15854093",
                "http://www.ncbi.nlm.nih.gov/pubmed/17073957",
                "http://www.ncbi.nlm.nih.gov/pubmed/27177262",
                "http://www.ncbi.nlm.nih.gov/pubmed/24771728",
                "http://www.ncbi.nlm.nih.gov/pubmed/23989817"
            ],
            "id": "5ab2cdc5fcf4565872000016",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27177262",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Titanium Plate Fixation versus Conventional Closure for Sternal Dehiscence after Cardiac Surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17073957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 410,
                    "offsetInEndSection": 672,
                    "text": "METHODS\nThree hundred sixty-six patients undergoing elective cardiac surgery with full median sternotomy and having body surface area (BSA) less than 1.5 m(2) were randomly assigned to receive PDS (n = 181) or stainless steel (SS, n = 185) sternal approximation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15854093",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "BACKGROUND\nSternal dehiscence is a rare, but serious complication after cardiac surgery procedures when performed through mid-line sternotomy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23989817",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "OBJECTIVE\nMediastinitis is a severe complication of cardiac surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24771728",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "INTRODUCTION\nMedian sternotomy is the preferred approach for open heart surgeries."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17244925",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 151,
                    "text": "Midline sternotomy is the most common incision for cardiac surgery, but problems of wound healing and sternal instability are still matters of concern."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20494064",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "PURPOSE\nMidline sternotomy remains the preferred technique for access in cardiac surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16967378",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "BACKGROUND\nSternal instability and mediastinitis are rare but serious complications following cardiac surgery with median sternotomy."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26290838",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "Multifilament Cable Wire versus Conventional Wire for Sternal Closure in Patients Undergoing Major Cardiac Surgery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23624983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "OBJECTIVES\nTo determine the difference in sternal infection and other infectious events between conventional wire and cable-tie-based closure techniques post-sternotomy in a collective of patients after cardiac surgery."
                }
            ]
        },
        {
            "body": "Is transcription of eRNA bidirectional?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                "http://www.ncbi.nlm.nih.gov/pubmed/25810254",
                "http://www.ncbi.nlm.nih.gov/pubmed/25588787",
                "http://www.ncbi.nlm.nih.gov/pubmed/25404134",
                "http://www.ncbi.nlm.nih.gov/pubmed/23636943",
                "http://www.ncbi.nlm.nih.gov/pubmed/28225006",
                "http://www.ncbi.nlm.nih.gov/pubmed/27932455",
                "http://www.ncbi.nlm.nih.gov/pubmed/23728303",
                "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                "http://www.ncbi.nlm.nih.gov/pubmed/25564661"
            ],
            "id": "5ac24f7595d0062724000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23993744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 322,
                    "text": "Here, by using genome-wide binding profiling, we show extensive occupancy of transcription factors of myogenesis (MyoD and Myogenin) at extragenic enhancer regions coinciding with RNA synthesis (i.e., eRNA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25564661",
                    "endSection": "abstract",
                    "offsetInBeginSection": 747,
                    "offsetInEndSection": 903,
                    "text": "Unexpectedly, genes repressed by TLR4 signaling are also associated with super enhancer domains and accompanied by massive repression of eRNA transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25404134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 817,
                    "offsetInEndSection": 967,
                    "text": "Conversely, knockdown of BACH1, a repressor of HO-1 transcription, further increased DEM-inducible eRNA E2-3 transcription as well as HO-1 expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1385,
                    "offsetInEndSection": 1586,
                    "text": "These studies provide evidence for a direct role of eRNAs in contributing to enhancer functions and suggest that Rev-Erbs act to suppress gene expression at a distance by repressing eRNA transcription."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25588787",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 110,
                    "text": "Chromatin looping and eRNA transcription precede the transcriptional activation of gene in the \u03b2-globin locus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28225006",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1199,
                    "offsetInEndSection": 1414,
                    "text": "Thus, our data support the view that eRNA dysregulation in HD striatum is a key mechanism leading to altered transcription of striatal neuron identity genes, through reduced recruitment of RNAPII at super-enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27932455",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1131,
                    "offsetInEndSection": 1362,
                    "text": "Lastly, basal eRNA transcription at enhancers, but not E2-induced transcription, is maintained upon depletion of MLL1 and ER\u03b1, suggesting some degree of chromatin accessibility prior to signal-dependent activation of transcription."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23636943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1035,
                    "offsetInEndSection": 1289,
                    "text": "We find that flavopiridol, a CDK9 inhibitor that blocks transcription elongation, inhibits eRNA production but does not affect other molecular indicators of enhancer activity, suggesting that eRNA production occurs after the assembly of active enhancers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25810254",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1569,
                    "offsetInEndSection": 1741,
                    "text": "Thus, the Cga eRNA mediates the physical interaction between these genomic regions and determines the chromatin structure of the proximal promoter to allow gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23728302",
                    "endSection": "abstract",
                    "offsetInBeginSection": 405,
                    "offsetInEndSection": 608,
                    "text": "Here we report that in human breast cancer cells 17\u03b2-oestradiol (E2)-bound oestrogen receptor \u03b1 (ER-\u03b1) causes a global increase in eRNA transcription on enhancers adjacent to E2-upregulated coding genes."
                }
            ]
        },
        {
            "body": "Is the protein pelota a ribosomal rescue factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                "http://www.ncbi.nlm.nih.gov/pubmed/28213379",
                "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                "http://www.ncbi.nlm.nih.gov/pubmed/28115162",
                "http://www.ncbi.nlm.nih.gov/pubmed/23031510",
                "http://www.ncbi.nlm.nih.gov/pubmed/25132172",
                "http://www.ncbi.nlm.nih.gov/pubmed/20876129",
                "http://www.ncbi.nlm.nih.gov/pubmed/22909071",
                "http://www.ncbi.nlm.nih.gov/pubmed/22358840"
            ],
            "id": "5ad35933133db5eb78000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22358840",
                    "endSection": "abstract",
                    "offsetInBeginSection": 430,
                    "offsetInEndSection": 604,
                    "text": "Here we present cryo-electron microscopy reconstructions of eukaryotic and archaeal ribosome recycling complexes containing ABCE1 and the termination factor paralogue Pelota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22909071",
                    "endSection": "abstract",
                    "offsetInBeginSection": 297,
                    "offsetInEndSection": 534,
                    "text": "A small protein, ArfA of 55 amino acids (formerly called YdhL), mediates binding of release factor 2 to the ribosomal A site lacking a complete mRNA codon and thereby triggers translational termination and rescue of the stalled ribosome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876129",
                    "endSection": "abstract",
                    "offsetInBeginSection": 183,
                    "offsetInEndSection": 334,
                    "text": "In eukaryotes, the protein complex of Pelota (yeast Dom34) and Hbs1 translational GTPase recognizes the stalled ribosome containing the defective mRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25132172",
                    "endSection": "abstract",
                    "offsetInBeginSection": 411,
                    "offsetInEndSection": 549,
                    "text": "We find that the primary role of the ribosome splitting factors Hbs1, Pelota, and ABCE1 is to permit Listerin access to the nascent chain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28213379",
                    "endSection": "abstract",
                    "offsetInBeginSection": 813,
                    "offsetInEndSection": 952,
                    "text": "Our data suggest that the decay of platelet mRNAs is slowed by the natural loss of the mRNA surveillance and ribosome rescue factor Pelota."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23031510",
                    "endSection": "abstract",
                    "offsetInBeginSection": 744,
                    "offsetInEndSection": 821,
                    "text": "In concert with eRF1 or Pelota, ABCE1 dissociates the ribosome into subunits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28115162",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 830,
                    "text": "In this work, we addressed the question of whether 5'-nonstop-mRNA fragments generated by siRNA cleavage or nonsense-mediated-mRNA decay (NMD) are degraded by the NSD pathway in Drosophila melanogaster cells by knocking down three NSD components, Pelota (a yeast Dom34 homolog), Hbs1 and ABCE1 (a ribosome-recycling factor)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25061210",
                    "endSection": "abstract",
                    "offsetInBeginSection": 308,
                    "offsetInEndSection": 571,
                    "text": "Here, we discover that loss of GTPBP2, a novel binding partner of the ribosome recycling protein Pelota, in mice with a mutation in a tRNA gene that is specifically expressed in the central nervous system causes ribosome stalling and widespread neurodegeneration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9584085",
                    "endSection": "abstract",
                    "offsetInBeginSection": 789,
                    "offsetInEndSection": 979,
                    "text": "Heterologous expression of pelota in dom34delata mutants restores wild-type growth and differentiation, suggesting conservation of function between the eukaryotic members of the gene family."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27493551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 271,
                    "offsetInEndSection": 398,
                    "text": "In eukaryotes, Pelota (Dom34 in yeast) and Hbs1 are responsible for solving general problems of ribosomal stall in translation."
                }
            ]
        },
        {
            "body": "Is CXCL7 a chemokine?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20022386",
                "http://www.ncbi.nlm.nih.gov/pubmed/28245630",
                "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                "http://www.ncbi.nlm.nih.gov/pubmed/20652876",
                "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                "http://www.ncbi.nlm.nih.gov/pubmed/12193731",
                "http://www.ncbi.nlm.nih.gov/pubmed/26283469",
                "http://www.ncbi.nlm.nih.gov/pubmed/28446981",
                "http://www.ncbi.nlm.nih.gov/pubmed/20652010",
                "http://www.ncbi.nlm.nih.gov/pubmed/27052313"
            ],
            "id": "5a9db99ffd02ddc336000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28446981",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1067,
                    "offsetInEndSection": 1227,
                    "text": "CXCL1, CXCL4, CXCL5, CXCL6, CXCL7, CXCL8, CXCL9, CXCL10, CXCL11 and CXCL12 levels were determined by ELISA, and chemokine concentration gradient was calculated."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20652010",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 317,
                    "text": "The chemokine CXCL7 binds heparin and the G-protein-linked receptor CXCR2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27052313",
                    "endSection": "abstract",
                    "offsetInBeginSection": 481,
                    "offsetInEndSection": 658,
                    "text": "Antibody arrays and ELISA assays confirmed that NK cells secrete RANTES (CCL5) and revealed that human NK cells secrete NAP-2 (CXCL7), a chemokine that can induce MSC migration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29038657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 148,
                    "offsetInEndSection": 313,
                    "text": "CXCL7 exerts its function by activating the CXC chemokine receptor 2 (CXCR2) receptor and binding sulfated glycosaminoglycans (GAGs) that regulate receptor activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26283469",
                    "endSection": "abstract",
                    "offsetInBeginSection": 722,
                    "offsetInEndSection": 848,
                    "text": "Plasma levels of CXCL4, CXCL4L1, CXCL7 and CCL5 as well as intracellular platelet CXCL4 and CXCL4L1 were measured using ELISA."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12193731",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 202,
                    "text": "Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28245630",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "CXCL7, a chemokine highly expressed in platelets, orchestrates neutrophil recruitment during thrombosis and related pathophysiological processes by interacting with CXCR2 receptor and sulfated glycosaminoglycans (GAG)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20022386",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "Many cells, including leucocytes and stromal cells, express CXCL7, a member of the CXC chemokine family, also known as platelet basic protein."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28368308",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 111,
                    "text": "Chemokine CXCL7 Heterodimers: Structural Insights, CXCR2 Receptor Function, and Glycosaminoglycan Interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20652876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 303,
                    "text": "The aim of our study was to analyse the effect of CXCL7, a chemokine that has the capacity to recruit MSCs, on the chondrogenic differentiation of MSCs."
                }
            ]
        },
        {
            "body": "The TRPM2 gene is associated with development of spontaneous thromboembolism?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18503142",
                "http://www.ncbi.nlm.nih.gov/pubmed/8800739",
                "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                "http://www.ncbi.nlm.nih.gov/pubmed/16352308",
                "http://www.ncbi.nlm.nih.gov/pubmed/17550854",
                "http://www.ncbi.nlm.nih.gov/pubmed/16252251",
                "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                "http://www.ncbi.nlm.nih.gov/pubmed/20515676",
                "http://www.ncbi.nlm.nih.gov/pubmed/8273075"
            ],
            "id": "5ab144fefcf4565872000012",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8273075",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 66,
                    "text": "[Etiology and pathogenesis of spontaneous venous thromboembolism]."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17550854",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 76,
                    "text": "Endothelial dysfunction in patients with spontaneous venous thromboembolism."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16352308",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "C-reactive protein 3' UTR +1444C>T polymorphism in patients with spontaneous venous thromboembolism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11380448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 351,
                    "text": "The G20210A mutation in the prothrombin gene is associated with an increased risk of a first venous thromboembolic episode; few data are available about the long-term risk for recurrent venous thromboembolism and it is not known whether or not carriers of the mutation should be recommended lifelong anticoagulant treatment after the first thrombosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20515676",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 148,
                    "text": "Gene variation of the transient receptor potential cation channel, subfamily M, member 2 (TRPM2) and type 2 diabetes mellitus: A case-control study."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16252251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1395,
                    "offsetInEndSection": 1553,
                    "text": "These findings suggest genetic variants of the TRPM2 gene increase risk for BD and support the notion that TRPM2 may be involved in the pathophysiology of BD."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8800739",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 506,
                    "text": "The temporal relationship between the conversion of atrial flutter to junctional bradycardia and two episodes of thromboembolism strongly suggest a role of the lack of atrial contraction during junctional rhythm for the development of spontaneous echocardiographic contrast and thromboembolism."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18503142",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 156,
                    "text": "Comparison of the plasminogen activator inhibitor-1 4G/5G gene polymorphism in females with venous thromboembolism during pregnancy or spontaneous abortion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27919223",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1131,
                    "offsetInEndSection": 1356,
                    "text": "CONCLUSIONS\nThis work demonstrates that SNPs in TRPM2 are associated with differences in gene expression, suggesting that modulation of expression of this innate immune gene contributes to susceptibility to R. equi pneumonia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24646197",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1279,
                    "offsetInEndSection": 1422,
                    "text": "Increased expression level of TRPM2 induced by oxidative stress might be involved in the ethiopathogenesis of HHcy related neurologic diseases."
                }
            ]
        },
        {
            "body": "Is a mutation of the  ZIKV's membrane protein prM responsible for the microcephaly in new-born infants?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                "http://www.ncbi.nlm.nih.gov/pubmed/28049830",
                "http://www.ncbi.nlm.nih.gov/pubmed/28239447",
                "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                "http://www.ncbi.nlm.nih.gov/pubmed/27355570",
                "http://www.ncbi.nlm.nih.gov/pubmed/28328129",
                "http://www.ncbi.nlm.nih.gov/pubmed/27228275",
                "http://www.ncbi.nlm.nih.gov/pubmed/27544075",
                "http://www.ncbi.nlm.nih.gov/pubmed/27876396",
                "http://www.ncbi.nlm.nih.gov/pubmed/28931684"
            ],
            "id": "5ac0aee419833b0d7b000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27876396",
                    "endSection": "abstract",
                    "offsetInBeginSection": 709,
                    "offsetInEndSection": 996,
                    "text": "Herein, we evaluated the most important human pathological, animal developmental, and neuro-cytotoxic findings released in 2016, and highlighted the original experimental evidence that strengthens the potential link between ZIKV and the high incidence of microcephaly in new-born babies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28931684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 276,
                    "text": "Zika virus (ZIKV), a mosquito-transmitted flavivirus, responsible for sporadic outbreaks of mild and febrile illness in Africa and Asia, re-emerged in the last decade causing serious human diseases including microcephaly, congenital malformations, and Guillain-Barr\u00e9 syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28328129",
                    "endSection": "abstract",
                    "offsetInBeginSection": 84,
                    "offsetInEndSection": 339,
                    "text": "In response, the Brazilian Society of Medical Genetics established a task force (SBGM-ZETF) to study the phenotype of infants born with microcephaly due to ZIKV congenital infection and delineate the phenotypic spectrum of this newly recognized teratogen."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27228275",
                    "endSection": "abstract",
                    "offsetInBeginSection": 138,
                    "offsetInEndSection": 321,
                    "text": "OBJECTIVE\nTo assess and identify possible risk factors for ophthalmoscopic findings in infants born with microcephaly and a presumed clinical diagnosis of ZIKV intrauterine infection."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27544075",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Estimating the Number of Pregnant Women Infected With Zika Virus and Expected Infants With Microcephaly Following the Zika Virus Outbreak in Puerto Rico, 2016."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28383800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "A recent outbreak of Zika virus (ZIKV) in Brazil is associated with microcephaly in infants born of infected mothers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27355570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 107,
                    "offsetInEndSection": 247,
                    "text": "ZIKV has been causally associated with fetal microcephaly, intrauterine growth restriction, and other birth defects in both humans and mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28239447",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Accumulating evidence implicates Zika virus (ZIKV) in pathogenesis of microcephaly in newborns and Guillain-Barr\u00e9 syndrome in adults."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28971967",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "A single mutation in the prM protein of Zika virus contributes to fetal microcephaly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28049830",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 74,
                    "text": "The Zika virus (ZIKV) causes microcephaly and the Guillain-Barr\u00e9 syndrome."
                }
            ]
        },
        {
            "body": "What is the aim of the PhenCode database?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                "http://www.ncbi.nlm.nih.gov/pubmed/22069583",
                "http://www.ncbi.nlm.nih.gov/pubmed/24228241",
                "http://www.ncbi.nlm.nih.gov/pubmed/8360667",
                "http://www.ncbi.nlm.nih.gov/pubmed/22026259",
                "http://www.ncbi.nlm.nih.gov/pubmed/27499284",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822120",
                "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                "http://www.ncbi.nlm.nih.gov/pubmed/22883936"
            ],
            "id": "5ad4f4f5133db5eb7800000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22026259",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "National Database of Genotypes--ethical and legal issues The aim of the project National Database of Genotypes is to outline structure and rules for the database operation collecting information about genotypes of individual persons."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822088",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1190,
                    "offsetInEndSection": 1342,
                    "text": "The database is valuable to assess the performance at a regional level and to compare Danish performance with international results at a national level."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8360667",
                    "endSection": "abstract",
                    "offsetInBeginSection": 416,
                    "offsetInEndSection": 559,
                    "text": "The aim of the Database is to provide the up-to-date clinical and pathological information relating to the material supplied by the Brain Bank."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27499284",
                    "endSection": "title",
                    "offsetInBeginSection": 83,
                    "offsetInEndSection": 164,
                    "text": "Aims and methods of the database analysis of the National Health Insurance Fund]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22069583",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 329,
                    "text": "The aim of this article is to present what type of information users can access from each database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22883936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 534,
                    "offsetInEndSection": 690,
                    "text": "AIMS\nThe aim of this study was to develop a database to support modeling of patent foramen ovale-attributable recurrence risk by combining extant data sets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24228241",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 376,
                    "text": "The secondary aim was to highlight the contribution each geographic area has to each database."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27822120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "AIM OF DATABASE\nThe aim of the National Database of Geriatrics is to monitor the quality of interdisciplinary diagnostics and treatment of patients admitted to a geriatric hospital unit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17326095",
                    "endSection": "abstract",
                    "offsetInBeginSection": 223,
                    "offsetInEndSection": 461,
                    "text": "Currently, it connects human phenotype and clinical data in various locus-specific databases (LSDBs) with data on genome sequences, evolutionary history, and function from the ENCODE project and other resources in the UCSC Genome Browser."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25385275",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 56,
                    "text": "VariSNP, a benchmark database for variations from dbSNP."
                }
            ]
        },
        {
            "body": "What is the basis of the Sp3 procedure used in proteomics?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                "http://www.ncbi.nlm.nih.gov/pubmed/27668303",
                "http://www.ncbi.nlm.nih.gov/pubmed/25538045",
                "http://www.ncbi.nlm.nih.gov/pubmed/27215607",
                "http://www.ncbi.nlm.nih.gov/pubmed/15362956",
                "http://www.ncbi.nlm.nih.gov/pubmed/15474306",
                "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                "http://www.ncbi.nlm.nih.gov/pubmed/22512350",
                "http://www.ncbi.nlm.nih.gov/pubmed/19950647"
            ],
            "id": "5ac28c0c95d006272400000a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22512350",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1319,
                    "offsetInEndSection": 1425,
                    "text": "We thus demonstrate that SNOSC is a widely applicable proteomic method for fast screening of SNO proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27215607",
                    "endSection": "abstract",
                    "offsetInBeginSection": 907,
                    "offsetInEndSection": 1046,
                    "text": "Exploiting SP3, a novel technology for proteomic sample preparation using magnetic beads, we scaled down proteome analysis to single cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16275928",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Molecular basis for keratoconus: lack of TrkA expression and its transcriptional repression by Sp3."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19950647",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1001,
                    "offsetInEndSection": 1225,
                    "text": "The analysis in terms of atomic vibrations confirms that the G and D peaks both come from sp2 C contribution, G peak is due to the stretching vibration of any pair of sp2 atoms and the T peak is due to the C-C sp3 vibration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15474306",
                    "endSection": "abstract",
                    "offsetInBeginSection": 662,
                    "offsetInEndSection": 925,
                    "text": "In this study, bacterial artificial chromosome (BAC) sequencing, reverse transcription-polymerase chain reaction (RT-PCR), genomic PCR, and database mining indicate that the Sp3 gene encompasses seven exons spanning more than 55 kb of genomic DNA on Chromosome 2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15362956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 775,
                    "offsetInEndSection": 1037,
                    "text": "Interestingly, Sp3 overexpression in HEK-293T cells (human embryonic kidney 293T cells) resulted in 3.3- and 4.0-fold increase in DNMT3A and DNMT3B mRNA expression levels respectively by quantitative reverse transcriptase-PCR, whereas Sp1 overexpression did not."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25538045",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1016,
                    "offsetInEndSection": 1298,
                    "text": "Through megakaryocyte transcriptomics and platelet proteomics, we identified several cytoskeleton-related proteins and downstream effector kinases, including Mylk, that were downregulated upon Sp1/Sp3 depletion, providing an explanation for the observed defects in megakaryopoiesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27668303",
                    "endSection": "abstract",
                    "offsetInBeginSection": 197,
                    "offsetInEndSection": 511,
                    "text": "In this study, we examined the effect of TFF2 on gastric cancer cell lines in\u00a0vitro and characterized the interaction between TFF2 and Sp3, including the mechanisms that mediate this interaction, using genomics and proteomics approaches, as well as genetics techniques, such as RNA interference and gene knockdown."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28948796",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "Evaluation of FASP, SP3, and iST Protocols for Proteomic Sample Preparation in the Low Microgram Range."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25358341",
                    "endSection": "abstract",
                    "offsetInBeginSection": 460,
                    "offsetInEndSection": 698,
                    "text": "SP3 provides a rapid and unbiased means of proteomic sample preparation in a single tube that facilitates ultrasensitive analysis by outperforming existing protocols in terms of efficiency, scalability, speed, throughput, and flexibility."
                }
            ]
        },
        {
            "body": "What is \"enhancer hijacking\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
                "http://www.ncbi.nlm.nih.gov/pubmed/27490482",
                "http://www.ncbi.nlm.nih.gov/pubmed/26065614",
                "http://www.ncbi.nlm.nih.gov/pubmed/28029156",
                "http://www.ncbi.nlm.nih.gov/pubmed/27856734",
                "http://www.ncbi.nlm.nih.gov/pubmed/28292442",
                "http://www.ncbi.nlm.nih.gov/pubmed/22516255",
                "http://www.ncbi.nlm.nih.gov/pubmed/21684744"
            ],
            "id": "5abc9157fcf456587200001e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28292442",
                    "endSection": "abstract",
                    "offsetInBeginSection": 447,
                    "offsetInEndSection": 622,
                    "text": "ETO2-GLIS2 directly binds DNA to control transcription of associated genes by upregulation of expression and interaction with the ETS-related ERG protein at enhancer elements."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21684744",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 116,
                    "text": "A transcription factor hijacking to regulate RAR\u03b1 by using a chimeric molecule of retinoic acid and a DNA alkylator."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28029156",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 55,
                    "text": "Copy number alterations unmasked as enhancer hijackers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26065614",
                    "endSection": "abstract",
                    "offsetInBeginSection": 209,
                    "offsetInEndSection": 526,
                    "text": "The so-called omics revolution, enabled by high-throughput sequencing, has empowered large consortia and independent groups alike to make major genetic discoveries, from dominant-negative histone mutations and hijacking of distal enhancer elements, to new oncogenic gene fusions and aberrantly active gene expression."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22516255",
                    "endSection": "abstract",
                    "offsetInBeginSection": 205,
                    "offsetInEndSection": 330,
                    "text": "provide new insights into how these factors are recruited by ETS-1 to the TCR\u03b1 enhancer and actively repress differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27490482",
                    "endSection": "abstract",
                    "offsetInBeginSection": 895,
                    "offsetInEndSection": 1003,
                    "text": "EBV therefore drives lymphomagenesis by hijacking long-range enhancer hubs and specific cellular co-factors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26229090",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1313,
                    "offsetInEndSection": 1504,
                    "text": "We identify novel mechanisms of enhancer-driven regulation of the oncogenes MYC and BCL6, and show that the BCL6 locus can serve as an enhancer donor in an \"enhancer hijacking\" translocation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27856734",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Control of Hoxd gene transcription in the mammary bud by hijacking a preexisting regulatory landscape."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25043047",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27869826",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 102,
                    "text": "Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking."
                }
            ]
        },
        {
            "body": "What disease is tinea ?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26885800",
                "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                "http://www.ncbi.nlm.nih.gov/pubmed/12748593",
                "http://www.ncbi.nlm.nih.gov/pubmed/10948816",
                "http://www.ncbi.nlm.nih.gov/pubmed/10354029",
                "http://www.ncbi.nlm.nih.gov/pubmed/26413063",
                "http://www.ncbi.nlm.nih.gov/pubmed/12040364",
                "http://www.ncbi.nlm.nih.gov/pubmed/10938522",
                "http://www.ncbi.nlm.nih.gov/pubmed/24739076",
                "http://www.ncbi.nlm.nih.gov/pubmed/15050029"
            ],
            "id": "5aa67b4fd6d6b54f7900000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10354029",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1187,
                    "offsetInEndSection": 1335,
                    "text": "These data confirm that tinea pedis, a potentially transmissible disease, is common in Australian schoolchildren, including those in primary school."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12748593",
                    "endSection": "abstract",
                    "offsetInBeginSection": 544,
                    "offsetInEndSection": 665,
                    "text": "Among superficial mycoses, tinea pedis is viewed as the pivotal disease because it is intractable and is the most common."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10948816",
                    "endSection": "abstract",
                    "offsetInBeginSection": 535,
                    "offsetInEndSection": 687,
                    "text": "Tinea pedis may be a risk factor for streptococcal infections such as erysipelas, mainly in tropical countries, where tinea pedis is a frequent disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12040364",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Tinea pedis responds well to topical antifungal therapy, however, relapse of the disease is not uncommon."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26885800",
                    "endSection": "abstract",
                    "offsetInBeginSection": 194,
                    "offsetInEndSection": 355,
                    "text": "Moccasin tinea pedis has not been recognized by governing bodies as a definable and treatable disease entity separate from interdigital tinea pedis at this time."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26413063",
                    "endSection": "abstract",
                    "offsetInBeginSection": 501,
                    "offsetInEndSection": 595,
                    "text": "Tinea capitis was the most common clinical disease followed by tinea pedis and tinea corporis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10938522",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Dermatophytosis of the external auditory meatus is believed to be a fairly rare disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15050029",
                    "endSection": "abstract",
                    "offsetInBeginSection": 311,
                    "offsetInEndSection": 424,
                    "text": "In other patients, tinea pedis may complicate allergy and asthma and may contribute to refractory atopic disease."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24739076",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 104,
                    "text": "Occult tinea pedis in an Israeli population and predisposing factors for the acquisition of the disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 198,
                    "text": "In preparing guidelines for dermatomycosis (tinea, trichophytia, dermatophytosis), we have primarily summarized the disease types and treatments as described in 4 textbooks used in Japan and abroad."
                }
            ]
        },
        {
            "body": "How are deletion breakpoints defined?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                "http://www.ncbi.nlm.nih.gov/pubmed/11001932",
                "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                "http://www.ncbi.nlm.nih.gov/pubmed/11336982",
                "http://www.ncbi.nlm.nih.gov/pubmed/8695862",
                "http://www.ncbi.nlm.nih.gov/pubmed/12297986",
                "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                "http://www.ncbi.nlm.nih.gov/pubmed/8875237",
                "http://www.ncbi.nlm.nih.gov/pubmed/16512914",
                "http://www.ncbi.nlm.nih.gov/pubmed/8364575"
            ],
            "id": "5abc9c1efcf4565872000020",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8364575",
                    "endSection": "abstract",
                    "offsetInBeginSection": 837,
                    "offsetInEndSection": 1008,
                    "text": "A probe from the proximal deletion breakpoint, PB11, lies within the currently defined minimum region of deletion overlap in PWS, which contains the SNRPN and D15S63 loci."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11336982",
                    "endSection": "abstract",
                    "offsetInBeginSection": 450,
                    "offsetInEndSection": 543,
                    "text": "The deletion breakpoint junctions have been defined for only three of the 34 macro-deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16293123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 282,
                    "offsetInEndSection": 499,
                    "text": "Subsequently, the deletion of exon 2 of the copper metabolism domain containing 1 (COMMD1) gene (formerly MURR1) was shown to be the major cause of copper toxicosis, although the deletion breakpoints were not defined."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8695862",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 348,
                    "text": "Conventional cytogenetic banding analysis and loss-of-heterozygosity (LOH) studies have detected several common regions of deletion ranging across the entire long arm (6q), with no defined recurrent breakpoint yet identified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16512914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1092,
                    "offsetInEndSection": 1257,
                    "text": "CONCLUSION\nThis Alu sequence like SSBR is commonly in the proximity of all known deletion breakpoints of 22q11 region and also in the low copy repeat regions (LCRs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12297986",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 495,
                    "text": "Deletion breakpoints, mechanisms, and lengths, as well as inventories of affected genes, have been elucidated for deletions of AZFa and of AZFc but not for deletions of AZFb or of AZFb plus AZFc."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8875237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 872,
                    "offsetInEndSection": 1135,
                    "text": "A degree of breakpoint clustering was found, but the identification of a number of deletion types, based on the position of proximal and distal breakpoints as defined by microsatellite analysis, strongly supports a leukaemogenic mechanism involving gene deletion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11001932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 372,
                    "text": "By sequence-tagged site (STS) content mapping, we roughly defined deletion breakpoints in two unrelated, azoospermic men with AZFa deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1741389",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1225,
                    "offsetInEndSection": 1465,
                    "text": "Therefore, the Fah gene maps within or proximal to the hsdr-1 locus, as defined by deletion breakpoints, and disruption of this gene may be partially or completely responsible for the phenotypes associated with the hsdr-1 deletion syndrome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1684331",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "The albino-deletion complex of the mouse: molecular mapping of deletion breakpoints that define regions necessary for development of the embryonic and extraembryonic ectoderm."
                }
            ]
        },
        {
            "body": "How is the nuclear localization of lncRNA mediated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                "http://www.ncbi.nlm.nih.gov/pubmed/27250657",
                "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                "http://www.ncbi.nlm.nih.gov/pubmed/22361292",
                "http://www.ncbi.nlm.nih.gov/pubmed/25690653",
                "http://www.ncbi.nlm.nih.gov/pubmed/25630241",
                "http://www.ncbi.nlm.nih.gov/pubmed/27821766",
                "http://www.ncbi.nlm.nih.gov/pubmed/23835137"
            ],
            "id": "5ab8fb5bfcf4565872000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27821766",
                    "endSection": "abstract",
                    "offsetInBeginSection": 423,
                    "offsetInEndSection": 599,
                    "text": "Importantly, we show that TP53TG1 binds to the multifaceted DNA/RNA binding protein YBX1 to prevent its nuclear localization and thus the YBX1-mediated activation of oncogenes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23835137",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1324,
                    "offsetInEndSection": 1463,
                    "text": "In addition, localization of NEAT1_2 lncRNA was identified in detail by electron microscopic analysis combined with ISH for NEAT1_2 lncRNA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25690653",
                    "endSection": "abstract",
                    "offsetInBeginSection": 570,
                    "offsetInEndSection": 789,
                    "text": "Subcellular localization analysis revealed that compared to mRNAs, lncRNAs more often have a specific subcellular localization with a markedly higher percentage of nuclear enrichment within the Myc-repressed lncRNA set."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27250657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 906,
                    "offsetInEndSection": 1204,
                    "text": "Further, lncRNA SPRY4-IT1 can directly increase the transcription, expression, and nuclear localization of Snail, one key transcription factor during the EMT processes of cancer cells, while siRNA-mediated specific knockdown of Snail can significantly attenuate SPRY4-IT1-induced EMT of ESCC cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22361292",
                    "endSection": "abstract",
                    "offsetInBeginSection": 751,
                    "offsetInEndSection": 1050,
                    "text": "Analysis of the lncRNAs and their comparison to protein-coding transcripts revealed sequence features including paucity of introns and low GC content in lncRNAs, which could explain several biological characteristics of these transcripts, such as their nuclear localization and low expression level."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24463464",
                    "endSection": "abstract",
                    "offsetInBeginSection": 129,
                    "offsetInEndSection": 279,
                    "text": "However, the molecular identities, functional roles and localization dynamics of lncRNAs that influence nuclear architecture remain poorly understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630241",
                    "endSection": "abstract",
                    "offsetInBeginSection": 96,
                    "offsetInEndSection": 255,
                    "text": "In contrast to extensive genomic annotation of lncRNA transcripts, far fewer have been characterized for subcellular localization and cell-to-cell variability."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26578588",
                    "endSection": "abstract",
                    "offsetInBeginSection": 788,
                    "offsetInEndSection": 1067,
                    "text": "To address whether localization of the lncRNA influences susceptibility to degradation by either ASOs or RNAi, nuclear lncRNAs (MALAT1 and NEAT1), cytoplasmic lncRNAs (DANCR and OIP5-AS1) and dual-localized lncRNAs (TUG1, CasC7 and HOTAIR) were compared for knockdown efficiency."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27198227",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "HuR and GRSF1 modulate the nuclear export and mitochondrial localization of the lncRNA RMRP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24732794",
                    "endSection": "abstract",
                    "offsetInBeginSection": 150,
                    "offsetInEndSection": 427,
                    "text": "As many lncRNAs regulate nuclear events and thus must localize to nuclei, we analyzed the sequence requirements for nuclear localization in an intergenic lncRNA named BORG (BMP2-OP1-responsive gene), which is both spliced and polyadenylated but is strictly localized in nuclei."
                }
            ]
        },
        {
            "body": "What is ATAC-seq?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                "http://www.ncbi.nlm.nih.gov/pubmed/28075484",
                "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                "http://www.ncbi.nlm.nih.gov/pubmed/28138849",
                "http://www.ncbi.nlm.nih.gov/pubmed/27903897",
                "http://www.ncbi.nlm.nih.gov/pubmed/27146274",
                "http://www.ncbi.nlm.nih.gov/pubmed/28723572"
            ],
            "id": "5abd31e0fcf456587200002c",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27832532",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "Assay for Transposase-Accessible Chromatin with High-Throughput Sequencing (ATAC-Seq) Protocol for Zebrafish Embryos."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28138849",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "Contiguity-Preserving Transposition Sequencing (CPT-Seq) for Genome-Wide Haplotyping, Assembly, and Single-Cell ATAC-Seq."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559105",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "ATAC-seq: A Method for Assaying Chromatin Accessibility Genome-Wide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27146274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "In recent years, the assay for transposase-accessible chromatin using sequencing (ATAC-Seq) has become a fundamental tool of epigenomic research."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28723572",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1090,
                    "offsetInEndSection": 1256,
                    "text": "Thus, FANS-assisted ATAC-seq using transgenic zebrafish embryos provides a robust approach for genome-wide identification of active tissue-specific enhancer elements."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28075484",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "Assay for Transposase-Accessible Chromatin Using Sequencing (ATAC-seq) Data Analysis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27903897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 405,
                    "offsetInEndSection": 555,
                    "text": "Assay for Transposase Accessible Chromatin sequencing (ATAC-seq) is a recently developed technique used to map open chromatin zones in animal genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29155775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 631,
                    "offsetInEndSection": 1000,
                    "text": "ATAC-seq is a robust and sensitive alternative to DNase I hypersensitivity analysis coupled with next-generation sequencing (DNase-seq) and formaldehyde-assisted isolation of regulatory elements (FAIRE-seq) for genome-wide analysis of chromatin accessibility and to the sequencing of micrococcal nuclease-sensitive sites (MNase-seq) to determine nucleosome positioning."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28550296",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "ATAC-seq is a high-throughput sequencing technique that identifies open chromatin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29181276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Assay for Transposase Accessible Chromatin (ATAC-seq) is an open chromatin profiling assay that is adapted to interrogate chromatin accessibility from small cell numbers."
                }
            ]
        },
        {
            "body": "What is the TALE-iD method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                "http://www.ncbi.nlm.nih.gov/pubmed/23840477",
                "http://www.ncbi.nlm.nih.gov/pubmed/26876161",
                "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                "http://www.ncbi.nlm.nih.gov/pubmed/23869221",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821439",
                "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                "http://www.ncbi.nlm.nih.gov/pubmed/26854857",
                "http://www.ncbi.nlm.nih.gov/pubmed/24976123"
            ],
            "id": "5a8d8f39fcd1d6a10c000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24228087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 920,
                    "offsetInEndSection": 1157,
                    "text": "The feature of both ease-of-operation and high efficiency of ULtiMATE system makes it not only an ideal method for biologic labs, but also an approach well suited for large-scale assembly of TALENs and any other TALE-based constructions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25475013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 450,
                    "offsetInEndSection": 590,
                    "text": "This platform is fully compatible with the Golden Gate TALEN and TAL Effector Kit 2.0, a widely used and efficient method for TALE assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24976123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1316,
                    "offsetInEndSection": 1535,
                    "text": "We thus contribute to an easier approach for effective TALENs synthesis, which may highly facilitate the wide application of TALEN technology in genome editing, especially for human cells that require precise targeting."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23869221",
                    "endSection": "abstract",
                    "offsetInBeginSection": 664,
                    "offsetInEndSection": 911,
                    "text": "In this work a program with improved EBE prediction performances was developed using an updated specificity matrix and a position weight correction function to account for the matching pattern observed in a validation set of TALE-DNA interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26876161",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 550,
                    "text": "Here, we describe an improved method for characterizing TALE genes by the use of PacBio sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26854857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 686,
                    "offsetInEndSection": 770,
                    "text": "For example, one commonly deployed method uses a multitube, 5-day assembly protocol."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821439",
                    "endSection": "abstract",
                    "offsetInBeginSection": 593,
                    "offsetInEndSection": 744,
                    "text": "This unit describes a detailed protocol for the recently described fast ligation-based automatable solid-phase high-throughput (FLASH) assembly method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23840477",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1564,
                    "offsetInEndSection": 1676,
                    "text": "This is a rapid and cost-efficient method using the most common enzymes and facilities with a high success rate."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24083015",
                    "endSection": "abstract",
                    "offsetInBeginSection": 775,
                    "offsetInEndSection": 881,
                    "text": "A randomized controlled is needed to determine the best surgical approach for the treatment of carbuncles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27940490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 539,
                    "offsetInEndSection": 671,
                    "text": "To address these concerns, we developed \"i3C\", a novel approach for capturing spatial interactions without a need for cross-linking."
                }
            ]
        },
        {
            "body": "What is Paget's Disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                "http://www.ncbi.nlm.nih.gov/pubmed/9169352",
                "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                "http://www.ncbi.nlm.nih.gov/pubmed/21352264",
                "http://www.ncbi.nlm.nih.gov/pubmed/24160789",
                "http://www.ncbi.nlm.nih.gov/pubmed/18469796",
                "http://www.ncbi.nlm.nih.gov/pubmed/15377360",
                "http://www.ncbi.nlm.nih.gov/pubmed/10560346",
                "http://www.ncbi.nlm.nih.gov/pubmed/8009241",
                "http://www.ncbi.nlm.nih.gov/pubmed/24299684"
            ],
            "id": "5aa67b6ad6d6b54f79000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10560346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 33,
                    "text": "Perianal Paget's disease is rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24299684",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "The most serious complication of Paget's disease is sarcomatous degeneration of pagetic bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8009241",
                    "endSection": "abstract",
                    "offsetInBeginSection": 55,
                    "offsetInEndSection": 141,
                    "text": "The most frequent cause of articular symptoms is OA, secondary to the Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15389972",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1342,
                    "text": "Therefore, the etiology of Paget's disease remains uncertain."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9169352",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 62,
                    "text": "Peyronie's disease is associated with Paget's disease of bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15377360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "Triple extramammary Paget's disease, which consists ordinarily of bilateral axillary and genital lesions, is uncommon."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21352264",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "Loss of Wnt-5\u03b1 is associated with an invasive phenotype of extramammary Paget's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24160789",
                    "endSection": "abstract",
                    "offsetInBeginSection": 210,
                    "offsetInEndSection": 358,
                    "text": "Our objective was to determine if Paget's disease identified with synchronous parenchymal DCIS has as favorable an outcome as Paget's disease alone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18469796",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 136,
                    "text": "Reduced E-cadherin expression correlates with disease progression in Paget's disease of the vulva but not Paget's disease of the breast."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3026195",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 41,
                    "text": "Mammary and extramammary Paget's disease."
                }
            ]
        },
        {
            "body": "What is the function of penicillinase, also known as beta lactamase?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3541135",
                "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                "http://www.ncbi.nlm.nih.gov/pubmed/2406875",
                "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                "http://www.ncbi.nlm.nih.gov/pubmed/9624479",
                "http://www.ncbi.nlm.nih.gov/pubmed/11399858",
                "http://www.ncbi.nlm.nih.gov/pubmed/9158769",
                "http://www.ncbi.nlm.nih.gov/pubmed/4985545",
                "http://www.ncbi.nlm.nih.gov/pubmed/12841932",
                "http://www.ncbi.nlm.nih.gov/pubmed/2203736"
            ],
            "id": "5aae651ffcf456587200000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2203736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 154,
                    "offsetInEndSection": 381,
                    "text": "BLIP was first detected by its ability to inhibit Bactopenase, a penicillinase derived from Bacillus cereus, but it has also been shown to inhibit the plasmid pUC- and chromosomally mediated beta-lactamases of Escherichia coli."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4985545",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1169,
                    "offsetInEndSection": 1406,
                    "text": "Such derepression also occurs in a strain of B. cereus very sensitive to penicillin and in which both uninduced as well as \"spore-peptide\"-induced beta-lactamase is a small fraction of that produced by the typical penicillinase producer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9158769",
                    "endSection": "abstract",
                    "offsetInBeginSection": 970,
                    "offsetInEndSection": 1302,
                    "text": "The more recent discovery of a PRP-hydrolyzing beta-lactamase (methicillinase) produced, in addition to the conventional penicillinase, by borderline S. aureus strains suggests that this second, more specific beta-lactamase is more likely to be responsible for the borderline phenotype than an increased amount of the penicillinase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12841932",
                    "endSection": "abstract",
                    "offsetInBeginSection": 941,
                    "offsetInEndSection": 1279,
                    "text": "In contrast to a 32.7% extracellular fraction of total beta-lactamase activity in a penicillinase-producing S. aureus, the fractions were 0.6%, 0.6% and 1.2% in a TEM-derived extended-spectrum beta-lactamase-producing E. coli, an inhibitor-resistant beta-lactamase-producing K. pneumoniae and an IMP-producing S. marcescens, respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11399858",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "BACKGROUND\nMechanisms of borderline resistance of Staphylococcus aureus to penicillinase-resistant penicillins (PRPs) may include hyperproduction of classical penicillinase and/or production of beta-lactamase hydrolyzing also PRPs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/806305",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 501,
                    "text": "In both cases, we have shown the simultaneous biosynthesis of two enzymes: an inducible and chromosome cephalosporinase frequently found in this germ, and a constitutive beta lactamase, with a penicillinase activity which has been identified with the extrachromosomic beta lactamase R-TEM."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9624479",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1595,
                    "offsetInEndSection": 1724,
                    "text": "We conclude that the major beta-lactamase of M. tuberculosis is a class A beta-lactamase with predominant penicillinase activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2406875",
                    "endSection": "abstract",
                    "offsetInBeginSection": 644,
                    "offsetInEndSection": 751,
                    "text": "The non-fragilis species of Bacteroides produce beta-lactamases that are mainly penicillinase in character."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3541135",
                    "endSection": "abstract",
                    "offsetInBeginSection": 769,
                    "offsetInEndSection": 862,
                    "text": "The nonfragilis Bacteroides species produce beta-lactamases mainly of the penicillinase type."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3877980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 219,
                    "offsetInEndSection": 303,
                    "text": "The most important factor in beta-lactam resistance is production of beta-lactamase."
                }
            ]
        },
        {
            "body": "The common house cat, Felis silvestris catus and the domestic dog, Canis familiaris both belong to what taxonomic order?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                "http://www.ncbi.nlm.nih.gov/pubmed/16772461",
                "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                "http://www.ncbi.nlm.nih.gov/pubmed/21846752",
                "http://www.ncbi.nlm.nih.gov/pubmed/15474307",
                "http://www.ncbi.nlm.nih.gov/pubmed/7777329",
                "http://www.ncbi.nlm.nih.gov/pubmed/12969463",
                "http://www.ncbi.nlm.nih.gov/pubmed/21658128",
                "http://www.ncbi.nlm.nih.gov/pubmed/25162450",
                "http://www.ncbi.nlm.nih.gov/pubmed/10640803"
            ],
            "id": "5ab1483bfcf4565872000014",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12969463",
                    "endSection": "abstract",
                    "offsetInBeginSection": 295,
                    "offsetInEndSection": 535,
                    "text": "Cats were identified as European wildcats (Felis silvestris silvestris), Sardinian wildcats (F. s. libyca) and domestic cats (F. s. catus), according to phenotypic traits, geographical locations and independently of any genetic information."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21658128",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 109,
                    "text": "Domestic dogs (Canis familiaris) and cats (Felis catus) are the most abundant mammalian carnivores worldwide."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10640803",
                    "endSection": "abstract",
                    "offsetInBeginSection": 521,
                    "offsetInEndSection": 683,
                    "text": "Application of the CFA 5 paint probe to metaphase spreads of the domestic cat (Felis catus, FCA) demonstrated hybridisation to cat chromosomes C1, D1, E1, and E2."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25162450",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "The genetic integrity of the ex situ population of the European wildcat (Felis silvestris silvestris) is seriously threatened by introgression from domestic cats (Felis silvestris catus)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7777329",
                    "endSection": "abstract",
                    "offsetInBeginSection": 325,
                    "offsetInEndSection": 515,
                    "text": "Rabies has been confirmed in this region among the above species as well as in a domestic cat (Felis catus) and a cow (Bos indicus) by fluorescent antibody tests (FAT) and/or histopathology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15474307",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 352,
                    "text": "The newly determined fPrnp sequence is similar to dog (Canis familiaris) and mink (Mustela putorius) Prnp, but differs significantly from both fPrnp sequences that were previously deposited in the GenBank."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21846752",
                    "endSection": "abstract",
                    "offsetInBeginSection": 36,
                    "offsetInEndSection": 160,
                    "text": "is a conservation concern largely due to introgressive hybridization with its congener F. s. catus, the common domestic cat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17727851",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 280,
                    "text": "The present study explored the feasibility of a hair cortisol assay in domestic cats (Felis silvestris catus) and dogs (Canis familiaris) as a valid and reliable alternative to existing non-invasive techniques for monitoring the hypothalamic-pituitary-adrenal (HPA) axis activity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16772461",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "The evolutionary basis for the feeding behavior of domestic dogs (Canis familiaris) and cats (Felis catus)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26154131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "The domestic cat (Felis silvestris catus) has shared an intertwined existence with humans for thousands of years, living on our city streets and in our homes."
                }
            ]
        },
        {
            "body": "What is caused by the ectopic expression of CTCF?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                "http://www.ncbi.nlm.nih.gov/pubmed/15941718",
                "http://www.ncbi.nlm.nih.gov/pubmed/14980504",
                "http://www.ncbi.nlm.nih.gov/pubmed/26268681",
                "http://www.ncbi.nlm.nih.gov/pubmed/22724006",
                "http://www.ncbi.nlm.nih.gov/pubmed/28161276"
            ],
            "id": "5abcf6b9fcf4565872000027",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28161276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 903,
                    "offsetInEndSection": 1056,
                    "text": "The role of GATA-1 in interaction between CTCF sites was revealed by its ectopic expression in 293 cells and by deletion of a GATA-1 site in the LCR HS2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26268681",
                    "endSection": "abstract",
                    "offsetInBeginSection": 834,
                    "offsetInEndSection": 1066,
                    "text": "Depletion of the BORIS gene leads to altered transcription of a large number of genes and the differentiation of K562 cells, while the ectopic expression of this CTCF paralog leads to specific changes in transcription in MCF7 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14980504",
                    "endSection": "abstract",
                    "offsetInBeginSection": 213,
                    "offsetInEndSection": 381,
                    "text": "Ectopic expression of CTCF results in severe cell growth inhibition at multiple points within the cell cycle, indicating that CTCF levels must be stringently monitored."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862757",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1014,
                    "offsetInEndSection": 1228,
                    "text": "Depletion of CTCF resulted in reduced motility and invasiveness in HCC cells that could be reversed by ectopic expression of FOXM1, suggesting that FOXM1 is one of the important downstream effectors of CTCF in HCC."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15941718",
                    "endSection": "abstract",
                    "offsetInBeginSection": 585,
                    "offsetInEndSection": 1087,
                    "text": "By using these model systems we demonstrated that: (i) ectopic expression of CTCF in K562 cells led to growth retardation and promotion of differentiation into the erythroid lineage; (ii) CTCF knock-down significantly inhibited differentiation of K562 cells into erythroid lineage; (iii) differentiation of K562 into the megakaryocytic lineage was not significantly affected; and (iv) down-regulation of MYC has been identified as one of the mechanisms by which CTCF promotes erythroid differentiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21465478",
                    "endSection": "abstract",
                    "offsetInBeginSection": 120,
                    "offsetInEndSection": 310,
                    "text": "Ectopic expression of CTCF in various normal and tumoral human cell lines inhibits cell division and clonogenicity, with the consequence to consider CTCF a potential tumor-suppressor factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22724006",
                    "endSection": "abstract",
                    "offsetInBeginSection": 382,
                    "offsetInEndSection": 467,
                    "text": "We here unravel the expression of CTCF and BORIS proteins throughout human epidermis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19369356",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1173,
                    "offsetInEndSection": 1405,
                    "text": "Ectopic expression of Rad21 repressed CTCF-regulated transcription of KSHV lytic genes, and a Rad21-CTCF chimeric protein converted CTCF into an efficient transcriptional repressor of KSHV genes normally activated in the G(2) phase."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26929370",
                    "endSection": "abstract",
                    "offsetInBeginSection": 898,
                    "offsetInEndSection": 1094,
                    "text": "CTCF is a zinc-finger protein that binds to an insulator region in genomic DNA and plays a fundamental role in controlling higher order chromatin structure and gene expression in vertebrate cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11507042",
                    "endSection": "abstract",
                    "offsetInBeginSection": 506,
                    "offsetInEndSection": 655,
                    "text": "Here we show that ectopic expression of CTCF in many cell types inhibits cell clonogenicity by causing profound growth retardation without apoptosis."
                }
            ]
        },
        {
            "body": "What is the dardarin protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                "http://www.ncbi.nlm.nih.gov/pubmed/16175160",
                "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                "http://www.ncbi.nlm.nih.gov/pubmed/15541308",
                "http://www.ncbi.nlm.nih.gov/pubmed/16280683",
                "http://www.ncbi.nlm.nih.gov/pubmed/18213618",
                "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                "http://www.ncbi.nlm.nih.gov/pubmed/18496192"
            ],
            "id": "5ac0fccf19833b0d7b000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16280683",
                    "endSection": "abstract",
                    "offsetInBeginSection": 971,
                    "offsetInEndSection": 1049,
                    "text": "The protein product was named dardarin and contains GTPase and kinase domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18496192",
                    "endSection": "abstract",
                    "offsetInBeginSection": 111,
                    "offsetInEndSection": 303,
                    "text": "The present study analyzes the postoperative outcome of deep brain subthalamic stimulation in patients carrying the R1441G mutation in the leucine-rich repeat kinase-2 (LRRK2) (dardarin) gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17622782",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "BACKGROUND\nRecently, mutations in LRRK2 encoding the protein dardarin have been linked to an autosomal dominant form of parkinsonism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16102903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "Mutations in the leucine-rich kinase 2 gene (LRRK 2) encoding dardarin, on chromosome 12, are a common cause of familial and sporadic Parkinson's disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16115731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 166,
                    "text": "Mutations in the leucine-rich repeat kinase 2 (LRRK 2), encoding dardarin protein, have been demonstrated to be linked to autosomal dominant Parkinson's disease (PD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18213618",
                    "endSection": "abstract",
                    "offsetInBeginSection": 831,
                    "offsetInEndSection": 1003,
                    "text": "These data and analysis of previously reported disease-segregating mutations shows that the majority of disease-causing mutations lie in the C-terminal half of the protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15541308",
                    "endSection": "abstract",
                    "offsetInBeginSection": 763,
                    "offsetInEndSection": 950,
                    "text": "Because of the tremor observed in PD and because a number of the families are of Basque descent, we have named this protein dardarin, derived from the Basque word dardara, meaning tremor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17394548",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Several mutations have been found in the leucine-rich repeat kinase 2 gene (LRRK2), encoding the protein dardarin, which are associated with autosomal dominant Parkinson disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16175160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 818,
                    "offsetInEndSection": 1189,
                    "text": "Last, mutations in 2 of these genes turned out to be frequent enough to have relevance in clinical practice: parkin mutations are common in early-onset familial and sporadic PD; moreover, emerging data delineate mutations in the LRRK2 gene (encoding the dardarin protein) as a frequent cause of the familial late onset PD forms, and even of few late-onset sporadic cases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16750377",
                    "endSection": "abstract",
                    "offsetInBeginSection": 858,
                    "offsetInEndSection": 1000,
                    "text": "We also show that dardarin protein is expressed within human midbrain neurons and that C-terminal epitopes are also found in some Lewy bodies."
                }
            ]
        },
        {
            "body": "In which syndrome is the RPS19 gene most frequently mutated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                "http://www.ncbi.nlm.nih.gov/pubmed/17053056",
                "http://www.ncbi.nlm.nih.gov/pubmed/18515656",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768533",
                "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                "http://www.ncbi.nlm.nih.gov/pubmed/17376718",
                "http://www.ncbi.nlm.nih.gov/pubmed/15523650",
                "http://www.ncbi.nlm.nih.gov/pubmed/21223253",
                "http://www.ncbi.nlm.nih.gov/pubmed/27732904",
                "http://www.ncbi.nlm.nih.gov/pubmed/21435505"
            ],
            "id": "5a896c26fcd1d6a10c000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17376718",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 233,
                    "text": "The gene encoding the small subunit ribosomal protein 19 (RPS19) is mutated in about 25% of cases of the bone marrow failure syndrome Diamond Blackfan Anemia (DBA), a childhood disease characterized by failure of red cell production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27732904",
                    "endSection": "abstract",
                    "offsetInBeginSection": 306,
                    "offsetInEndSection": 439,
                    "text": "We have identified a novel heterozygous frameshift mutation in RPS19 gene in a DBA child presenting with profound anemia after birth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768533",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 240,
                    "text": "BACKGROUND\nMutations in the ribosomal protein S19 gene (RPS19) have been found in 25% of patients with Diamond-Blackfan anemia, a rare syndrome of congenital bone marrow failure characterized by erythroblastopenia and various malformations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15523650",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 207,
                    "text": "Mutations in the ribosomal protein (RP)S19 gene have been found in about 25% of the cases of Diamond-Blackfan anemia (DBA), a rare congenital hypoplastic anemia that includes variable physical malformations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21435505",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 235,
                    "text": "Within the decade following the demonstration that mutations in the RPS19 gene can lead to Diamond-Blackfan anemia (DBA), this disease has become a paradigm for an emerging group of pathologies linked to defects in ribosome biogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17053056",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 140,
                    "text": "The gene encoding the ribosomal protein S19 (RPS19) is frequently mutated in Diamond-Blackfan anemia (DBA), a congenital erythroblastopenia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18515656",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 195,
                    "text": "Mutations in several ribosomal proteins (RPs) lead to Diamond-Blackfan anemia (DBA), a syndrome characterized by defective erythropoiesis, congenital anomalies, and increased frequency of cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21223253",
                    "endSection": "abstract",
                    "offsetInBeginSection": 998,
                    "offsetInEndSection": 1187,
                    "text": "In addition, knockdown of two other RP genes, rps3a and rpl36a, which result in severe morphological abnormalities but only mild erythroid defects, also elicited an activated Tp53 response."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24675553",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1357,
                    "offsetInEndSection": 1422,
                    "text": "Among these patients, RPS19 was the most frequently mutated gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23990987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 163,
                    "offsetInEndSection": 309,
                    "text": "It has been proven that defects of ribosomal proteins can lead to this disease and that RPS19 is the most frequently mutated gene in DBA patients."
                }
            ]
        },
        {
            "body": "What type of sequences do enhancers evolve from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                "http://www.ncbi.nlm.nih.gov/pubmed/6954502",
                "http://www.ncbi.nlm.nih.gov/pubmed/21151964",
                "http://www.ncbi.nlm.nih.gov/pubmed/22073317",
                "http://www.ncbi.nlm.nih.gov/pubmed/23895828",
                "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                "http://www.ncbi.nlm.nih.gov/pubmed/24218638"
            ],
            "id": "5ac37afc0340b9f058000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22073317",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 614,
                    "text": "In this study of the cis-regulatory elements of the pair rule segmentation gene fushi tarazu (ftz) I report the DNA sequences of ftz's zebra element (promoter) and a region containing the proximal enhancer from a total of 45 fly lines belonging to several populations of the species Drosophila melanogaster, D. simulans, D. sechellia, D. mauritiana, D. yakuba, D. teissieri, D. orena and D. erecta."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15014138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 877,
                    "offsetInEndSection": 1010,
                    "text": "The starting sequences considered are either real enhancers from the Drosophila melanogaster genome, or randomized versions of these."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23895828",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1345,
                    "offsetInEndSection": 1747,
                    "text": "Biological significance To our knowledge, this is the first report indicating that the peptide TNAENEFVTIKK, which is identical to Unknown protein 18 from P. menziesii (P85925), Unknown protein 1 (P86104) from V. rotundifolia and a part of the oxygen-evolving enhancer protein 1 (OEE1) from P. strobus (P84718), may originate from type II cytoskeletal keratin - a common contaminant in protein samples."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 595,
                    "text": "We found that the relative efficiency of the enhancers is approximately the same, irrespective of the type of promoter used, i.e., there was no strong preference for any given enhancer/promoter combination."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24218638",
                    "endSection": "abstract",
                    "offsetInBeginSection": 805,
                    "offsetInEndSection": 1052,
                    "text": "Because each mutation on the path from the D. yakuba/santomea ancestor to modern-day D. santomea contributes to the newly derived optic lobe enhancer activity, we sought here to use this system to study the path of evolution of enhancer sequences."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21151964",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 404,
                    "text": "Here, we examine the sequence, function, and genomic location of enhancers controlling tissue- and cell-type specific expression of the yellow gene in six Drosophila species."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6954502",
                    "endSection": "abstract",
                    "offsetInBeginSection": 824,
                    "offsetInEndSection": 1067,
                    "text": "Both base substitutions and expansions or deletions of tandemly repetitive elements are important in the evolution of this type of protein; functional constraints of the various protein domains dictate which class of mutations can be accepted."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25956793",
                    "endSection": "abstract",
                    "offsetInBeginSection": 848,
                    "offsetInEndSection": 1039,
                    "text": "We estimated the time necessary to evolve, from genomic background, enhancers capable of driving complex gene expression patterns similar to those involved in early development in Drosophila."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21593416",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1283,
                    "offsetInEndSection": 1474,
                    "text": "We suggest that the novel optic lobe enhancer evolved by exploiting the cryptic activity of extant regulatory sequences, and this may reflect a general mechanism whereby new enhancers evolve."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21798176",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1249,
                    "offsetInEndSection": 1408,
                    "text": "The results show that the repetitive sequences are rapidly evolving in the S. purpuratus genome and may serve as a renewable pool of transcriptional enhancers."
                }
            ]
        },
        {
            "body": "What nerve is involved in carpal tunnel syndrome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27894853",
                "http://www.ncbi.nlm.nih.gov/pubmed/19336461",
                "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                "http://www.ncbi.nlm.nih.gov/pubmed/25206437",
                "http://www.ncbi.nlm.nih.gov/pubmed/26014322",
                "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                "http://www.ncbi.nlm.nih.gov/pubmed/26589645",
                "http://www.ncbi.nlm.nih.gov/pubmed/28718333",
                "http://www.ncbi.nlm.nih.gov/pubmed/27456900",
                "http://www.ncbi.nlm.nih.gov/pubmed/21039008"
            ],
            "id": "5abcf010fcf4565872000023",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28718333",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 142,
                    "text": "BACKGROUND\nCompression of the median nerve at the wrist, or carpal tunnel syndrome, is the most commonly recognized nerve entrapment syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21039008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 77,
                    "offsetInEndSection": 275,
                    "text": "The purpose of this study is to determine whether high resolution ultrasonography can be an alternative diagnostic method to nerve conduction study in grading the severity of carpal tunnel syndrome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27456900",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "[Ultrasonography in evaluating the character of lesions of the median nerve in carpal tunnel syndrome]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26589645",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1571,
                    "offsetInEndSection": 1707,
                    "text": "CONCLUSIONS\nThe cross-sectional areas of the ulnar and median nerves at the wrist are increased in patients with carpal tunnel syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26014322",
                    "endSection": "abstract",
                    "offsetInBeginSection": 220,
                    "offsetInEndSection": 376,
                    "text": "METHODS\nWe performed median and ulnar nerve conduction studies with sonography in 109 hands of 60 patients with clinically suspected carpal tunnel syndrome."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25206437",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Axonal degeneration of the ulnar nerve secondary to carpal tunnel syndrome: fact or fiction?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25630774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "Carpal tunnel syndrome (CTS) is the most common median nerve neuropathy, accounting for 90% of all neuropathies."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7235907",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 55,
                    "text": "Carpal tunnel syndrome following automobile collisions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27894853",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2459,
                    "offsetInEndSection": 2667,
                    "text": "CONCLUSION\nIt is important to consider the diagnosis of double crush syndrome of the median nerve, as carpal tunnel syndrome combined with pronator syndrome may impede treatment of the carpal tunnel syndrome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19336461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 494,
                    "offsetInEndSection": 822,
                    "text": "The results showed that pressure pain threshold levels were significantly decreased bilaterally over the median, ulnar, and radial nerve trunks, the carpal tunnel, the C5-C6 zygapophyseal joint, and the tibialis anterior muscle in patients with unilateral carpal tunnel syndrome as compared to healthy controls (all, P < 0.001)."
                }
            ]
        },
        {
            "body": "What is the function of LOX proteins in the ECM?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                "http://www.ncbi.nlm.nih.gov/pubmed/19592613",
                "http://www.ncbi.nlm.nih.gov/pubmed/24348049",
                "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                "http://www.ncbi.nlm.nih.gov/pubmed/28273952",
                "http://www.ncbi.nlm.nih.gov/pubmed/26582054",
                "http://www.ncbi.nlm.nih.gov/pubmed/23970168",
                "http://www.ncbi.nlm.nih.gov/pubmed/18803461"
            ],
            "id": "5ad243e30340b9f058000016",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28273952",
                    "endSection": "abstract",
                    "offsetInBeginSection": 136,
                    "offsetInEndSection": 285,
                    "text": "Lysyl oxidase (LOX) and LOX-like (LOXL) proteins play crucial roles in ECM remodeling due to their collagen crosslinking and intracellular functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27899976",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1018,
                    "offsetInEndSection": 1109,
                    "text": "Therefore, LOX expression level in the ECM may function as an independent predictor of Pca."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23970168",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "Lysyl oxidase (LOX) is an extracellular matrix (ECM) remodeling enzyme, which is involved in the development and progression of many types of tumors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26582054",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "A hallmark of heart failure (HF) is adverse extracellular matrix (ECM) remodeling, which is regulated by the collagen cross-linking enzyme, lysyl oxidase (LOX)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18803461",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Differential expression of lysyl oxidases LOXL1 and LOX during growth and aging suggests specific roles in elastin and collagen fiber remodeling in rat aorta."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24348049",
                    "endSection": "abstract",
                    "offsetInBeginSection": 207,
                    "offsetInEndSection": 352,
                    "text": "The family of lysyl oxidase (LOX) enzymes cross-links collagens and elastin and, therefore, is a central player in ECM deposition and maturation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19592613",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1559,
                    "offsetInEndSection": 1750,
                    "text": "Our data signify that diet-induced MetS alters the remodeling enzymes, mainly LOX, thereby altering ECM structure by increasing the amount of cross-linking and inducing diastolic dysfunction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16085123",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "Lysyl oxidase (LOX) is a copper- and lysyl-tyrosyl cofactor containing amine oxidase that has been known to play a critical role in the catalysis of lysine-derived crosslinks in extracellular matrix (ECM) proteins in the dermis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26024311",
                    "endSection": "abstract",
                    "offsetInBeginSection": 111,
                    "offsetInEndSection": 311,
                    "text": "The best-studied role of LOX enzymes is the remodeling of the extracellular matrix (ECM) in animals by cross-linking collagens and elastin, although intracellular functions have been reported as well."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17931358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 404,
                    "offsetInEndSection": 645,
                    "text": "While the catalytic function of LOX is essential for cross-linking of ECM proteins, we also reported that LOX induced invasive and metastatic properties in breast tumour epithelial cells through hydrogen peroxide-mediated FAK/Src activation."
                }
            ]
        },
        {
            "body": "Please list 3 diseases treated with Valtrex(valacyclovir)",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19841603",
                "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                "http://www.ncbi.nlm.nih.gov/pubmed/27425241",
                "http://www.ncbi.nlm.nih.gov/pubmed/27464057",
                "http://www.ncbi.nlm.nih.gov/pubmed/9589847",
                "http://www.ncbi.nlm.nih.gov/pubmed/18675103",
                "http://www.ncbi.nlm.nih.gov/pubmed/15043175",
                "http://www.ncbi.nlm.nih.gov/pubmed/21404597",
                "http://www.ncbi.nlm.nih.gov/pubmed/25362676",
                "http://www.ncbi.nlm.nih.gov/pubmed/9514622"
            ],
            "id": "5abcf755fcf4565872000028",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18675103",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1094,
                    "offsetInEndSection": 1400,
                    "text": "On the basis of the neoadjuvant treatment results to reduce drop-out risk, we suggest avoiding the high priority for the HCC cohort, particularly within the first 6 months from entrance on the waiting list, because this approach can reduce the chances of patients with end-stage liver disease (ESLD) alone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9514622",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 123,
                    "text": "Blood Cells, Molecules, & Diseases is an electronically published journal with an average accept-to-publish time of 7 days."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9589847",
                    "endSection": "abstract",
                    "offsetInBeginSection": 998,
                    "offsetInEndSection": 1195,
                    "text": "Managing patients with asthma who have other diseases requires constant supervision of their medication usage and careful and cautious review of the entire list of medications at each presentation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25362676",
                    "endSection": "abstract",
                    "offsetInBeginSection": 458,
                    "offsetInEndSection": 818,
                    "text": "To describe the experience of a status 7 patient on the liver transplant waiting list from the perspectives of family members, 38 hours of bedside observation of participants, 9 semistructured interviews with 6 family members, and 9 semistructured interviews with 8 health care professionals from nursing, medicine, and other health care disciplines were done."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27464057",
                    "endSection": "abstract",
                    "offsetInBeginSection": 448,
                    "offsetInEndSection": 705,
                    "text": "If there are changes in your program or if you would like your program to be added to the list, please submit that information by December 1, 1990, to The Physician and Sportsmedicine, Editorial Dept, Fellowships List, 4530 W 77th St, Minneapolis, MN 55435."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27425241",
                    "endSection": "abstract",
                    "offsetInBeginSection": 484,
                    "offsetInEndSection": 734,
                    "text": "If there are changes in your program or if you would like your program to be included in next year's list, please submit that information by December 1, 1994, to The Physician and Sportsmedicine, Editorial Dept, 4530 W 77th St, Minneapolis, MN 55435."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043175",
                    "endSection": "abstract",
                    "offsetInBeginSection": 420,
                    "offsetInEndSection": 646,
                    "text": "METHODS\nWe conducted semistructured personal interviews with 16 adults from 4 urban family practices in the CaReNet practice-based research network who self-reported the presence of 2 or more common chronic medical conditions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19841603",
                    "endSection": "abstract",
                    "offsetInBeginSection": 805,
                    "offsetInEndSection": 997,
                    "text": "RESULTS\nThere was a 79% response rate to the overall questionnaire, and 91% of the respondents listed 1 or more consequences of their M\u00e9ni\u00e8re's disease, with a mean of 3.4 consequences listed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404597",
                    "endSection": "abstract",
                    "offsetInBeginSection": 463,
                    "offsetInEndSection": 649,
                    "text": "The atlas is divided into three sections, (1) Introduction, (2) Cardinal signs, and (3) Diagnosis and the clinical spectrum of leprosy, and they are all accompanied with relevant photos."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28089147",
                    "endSection": "abstract",
                    "offsetInBeginSection": 808,
                    "offsetInEndSection": 1009,
                    "text": "RESULTS\nPatient characteristics, prior diseases, clinical presentation, ejection fraction, procedural success and lost-for-follow-up did not differ between patients treated with the SeQuent Please and."
                }
            ]
        },
        {
            "body": "Which olfactory gene senses androsterone?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                "http://www.ncbi.nlm.nih.gov/pubmed/9566734",
                "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                "http://www.ncbi.nlm.nih.gov/pubmed/8921833",
                "http://www.ncbi.nlm.nih.gov/pubmed/3138978",
                "http://www.ncbi.nlm.nih.gov/pubmed/20440461",
                "http://www.ncbi.nlm.nih.gov/pubmed/8422755"
            ],
            "id": "5ace17c30340b9f058000009",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20440461",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1171,
                    "offsetInEndSection": 1465,
                    "text": "CONCLUSIONS\nThe effects induced by androsterone and hemisuccinate of androsterone on the perfusion pressure and resistance vascular probably involve the interaction of steroid-receptor androgenic and, indirectly, activation of the calcium channel to induce variations in the perfusion pressure."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8422755",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Regional assignment of rat androsterone UDP-glucuronosyltransferase gene (UGT2B2) to chromosome 14p21.2-p22."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8921833",
                    "endSection": "abstract",
                    "offsetInBeginSection": 200,
                    "offsetInEndSection": 565,
                    "text": "We have studied the effects of short-term (3 days) fasting and long-term (3 weeks) food restriction to one-third of normal intake (FR33) on hepatic UGT activities for thyroxine (T4), triiodothyronine (T3), bilirubin and androsterone in male and female Wistar rats with either a functional (high activity, HA) or a defective (low activity, LA) androsterone UGT gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3138978",
                    "endSection": "abstract",
                    "offsetInBeginSection": 161,
                    "offsetInEndSection": 401,
                    "text": "The F1 hybrids showed normal GT activities towards androsterone, bilirubin and 4-nitrophenol, demonstrating that Gunn and LA ('low activity') Wistar rats inherit a homozygous dominant trait for androsterone GT and bilirubin GT respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2881811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 364,
                    "offsetInEndSection": 536,
                    "text": "Northern blot analysis of total RNA from normal and androsterone glucuronidation deficient Wistar rats demonstrated that the mRNA encoding this protein was not synthesised."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16675527",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 85,
                    "text": "The nuclear hormone receptor farnesoid X receptor (FXR) is activated by androsterone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9566734",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 228,
                    "text": "Rat hydroxysteroid sulfotransferase (HS-SULT) cDNAs, ST-40 and ST-20 are 90% identical in amino acid sequences and show different substrate specificities toward dehydroepiandrosterone (DHEA), androsterone (AD) and cortisol (CS)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1737068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 892,
                    "offsetInEndSection": 1128,
                    "text": "Based on these lines of evidence, it is concluded that the large portion of androsterone UDPGT gene is deleted in LA Wistar rats, which results in the absence of androsterone UDPGT mRNA and consequently the corresponding enzyme protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8043710",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 230,
                    "text": "Olfactory sensitivity to two odorants, isoamyl acetate and androsterone, was assessed in 14 obsessive compulsive disorder (OCD) patients, nine major depressive disorder (MDD) patients, and 16 sex- and age-matched healthy controls."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23321429",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 236,
                    "text": "The present study examined differences in olfactory sensitivity between 16 naturally cycling (NC) women and 17 women taking monophasic oral contraceptives (OCs) to six odors: lemon, peppermint, rose, musk, androstenone and androsterone."
                }
            ]
        },
        {
            "body": "Where in the body would the navicular bone be found?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                "http://www.ncbi.nlm.nih.gov/pubmed/24719271",
                "http://www.ncbi.nlm.nih.gov/pubmed/2735530",
                "http://www.ncbi.nlm.nih.gov/pubmed/20525052",
                "http://www.ncbi.nlm.nih.gov/pubmed/9622323",
                "http://www.ncbi.nlm.nih.gov/pubmed/24788547",
                "http://www.ncbi.nlm.nih.gov/pubmed/23767287",
                "http://www.ncbi.nlm.nih.gov/pubmed/6667428",
                "http://www.ncbi.nlm.nih.gov/pubmed/10029187"
            ],
            "id": "5abd13e1fcf4565872000029",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10029187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 89,
                    "offsetInEndSection": 302,
                    "text": "The anatomical bases were established for the morphometry of the navicular bone and its variations according to the category of horse, after corrections were made for front or rear limb, sex, weight, size and age."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23767287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1572,
                    "offsetInEndSection": 1690,
                    "text": "Also, the height of the flexor surface of the navicular bone is strongly correlated with the breadth of the phalanges."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6667428",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 353,
                    "text": "Degenerative lesions in the fibrocartilaginous surface of the navicular bone and of the surface of the deep flexor tendons were age related changes not necessarily related to lameness."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24788547",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 377,
                    "text": "OBJECTIVE\nTo test the anecdotal observation that isolated navicular collapse is associated with diabetes mellitus, we quantified the size of the tarsal navicular bone in subjects with and without diabetes and tested for association of size with age, height, weight, body mass index (BMI), gender, smoking, bone mineral density (BMD), duration, and level of control of diabetes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20525052",
                    "endSection": "abstract",
                    "offsetInBeginSection": 962,
                    "offsetInEndSection": 1278,
                    "text": "RESULTS\nThere were significant correlations between the presence of a cystic structure in the distal third of the navicular bone, or a distal border fragment, or increased signal intensity in fat suppressed images at the insertion of the DSIL on the distal phalanx and the histological grade of the body of the DSIL."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9622323",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2558,
                    "offsetInEndSection": 2762,
                    "text": "The histological and histomorphometric changes in the navicular bone and palmar fibrocartilage were considered similar of those found in articular hyaline cartilage and subchondral bone in osteoarthritis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2735530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1729,
                    "offsetInEndSection": 1843,
                    "text": "Concurrent with weight bearing there was a dorsal palmar orientation of the bone trabeculae of the navicular bone."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24719271",
                    "endSection": "abstract",
                    "offsetInBeginSection": 985,
                    "offsetInEndSection": 1160,
                    "text": "For symptomatic pes planus, significant abduction was measured for the navicular relative to the talus and the talar head was plantar flexed relative to the body (p\u2009<\u20090.0083)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28099198",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Osteomyelitis of the accessory and body of the navicular bone: a case report."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2681808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 72,
                    "offsetInEndSection": 356,
                    "text": "Analysis based on these cases and on 36 patients suffering from identical fractures reported in the literature led to a new mechanical assumption: the axial compression on the foot, as a result of falling from height, causes impaction of the talus into the body of the navicular bone."
                }
            ]
        },
        {
            "body": "Name an lncRNA associated with dilated cardiomyopathy.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                "http://www.ncbi.nlm.nih.gov/pubmed/25119045",
                "http://www.ncbi.nlm.nih.gov/pubmed/26676325",
                "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                "http://www.ncbi.nlm.nih.gov/pubmed/17010801",
                "http://www.ncbi.nlm.nih.gov/pubmed/20392463"
            ],
            "id": "5ac716810340b9f058000003",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20392463",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Persistent plasminogen activator inhibitor 1 gene expression in cardiac transplant recipients with idiopathic dilated cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17010801",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 380,
                    "text": "Mutations in the gene encoding PLN have been associated with dilated cardiomyopathy characterized by early onset and the presence of lethal ventricular arrhythmias."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25834770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1089,
                    "offsetInEndSection": 1534,
                    "text": "This suggests additional genetic factors contribute to the dilated cardiomyopathy phenotype.This study represents a meta-analysis of available canine dilated cardiomyopathy genetic datasets with the goal of determining potential multigenic interactions relating the sex chromosome genotype (XX vs. XY) with known dilated cardiomyopathy associated loci on chromosome 5 and the PDK4 gene in the incidence and progression of dilated cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27317124",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1040,
                    "offsetInEndSection": 1180,
                    "text": "RESULTS\nFourteen lncRNAs were significantly modulated in non end-stage heart failure patients, identifying a heart failure lncRNA signature."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26141701",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 97,
                    "text": "Microarray profiling of long non-coding RNA (lncRNA) associated with hypertrophic cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25119045",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1662,
                    "offsetInEndSection": 1823,
                    "text": "Human MHRT also originates from MYH7 loci and is repressed in various types of myopathic hearts, suggesting a conserved lncRNA mechanism in human cardiomyopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28430627",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "In the previous study, we generated a rat model of dilated cardiomyopathy (DCM) induced by adriamycin and found that the expression of lncRNA H19 was significantly upregulated in myocardial tissue."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26676325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 895,
                    "offsetInEndSection": 1159,
                    "text": "Through pathway analysis of these 39 key lncRNAs, the novel function of an annotated lncRNAs\u2011H19 was predicted, which may regulate apoptosis signal\u2011regulating kinase, which is a protein that promotes pathological cardiac remodeling following myocardial infarction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28115490",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 302,
                    "text": "In the heart, lncRNAs have been implicated in the regulation of development, ischemic and dilated cardiomyopathy, and myocardial infarction."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26951817",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Myocardial Infarction-Associated Transcript, a Long Noncoding RNA, Is Overexpressed During Dilated Cardiomyopathy Due to Chronic Chagas Disease."
                }
            ]
        },
        {
            "body": "Which gene is responsible for red hair?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                "http://www.ncbi.nlm.nih.gov/pubmed/2363420",
                "http://www.ncbi.nlm.nih.gov/pubmed/19482440",
                "http://www.ncbi.nlm.nih.gov/pubmed/18484624",
                "http://www.ncbi.nlm.nih.gov/pubmed/19571053",
                "http://www.ncbi.nlm.nih.gov/pubmed/11672965",
                "http://www.ncbi.nlm.nih.gov/pubmed/23146638",
                "http://www.ncbi.nlm.nih.gov/pubmed/11549109"
            ],
            "id": "5ace19420340b9f05800000a",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11672965",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Sequence polymorphism in the human melanocortin 1 receptor gene as an indicator of the red hair phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11549109",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 182,
                    "text": "To determine whether the Agouti Signalling Protein (ASP) gene is associated with skin and hair coloration in humans, the complete coding region of ASP was screened for polymorphisms."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23146638",
                    "endSection": "abstract",
                    "offsetInBeginSection": 144,
                    "offsetInEndSection": 277,
                    "text": "The genetic basis for red hair involves specific mutations, red hair color (RHC) alleles, in the melanocortin-1 receptor (MC1R) gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19571053",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 91,
                    "text": "BACKGROUND\nRed hair color is caused by variants of the melanocortin-1 receptor (MC1R) gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19482440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 443,
                    "offsetInEndSection": 617,
                    "text": "A causal association between red hair and melanocortin-1 receptor has been shown, and is the only gene that is known to explain physiological variation in human pigmentation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2363420",
                    "endSection": "abstract",
                    "offsetInBeginSection": 598,
                    "offsetInEndSection": 864,
                    "text": "A possible explanation for the existence of these 2 different group of patients is that the locus of the gene responsible for the syndrome is closely linked to the locus for a gene responsible for hair color with linkage disequilibrium in Tunisian Jews (Sepharadim)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28024137",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 190,
                    "text": "A specific variant of MC1R gene (R allele) is responsible for the red hair."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18484624",
                    "endSection": "abstract",
                    "offsetInBeginSection": 162,
                    "offsetInEndSection": 296,
                    "text": "The MC1R gene has many polymorphisms, some of which have been linked to variation in pigmentation phenotypes within human populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9302268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 988,
                    "offsetInEndSection": 1141,
                    "text": "Rather, it is likely that additional modifier genes exist, making variance in the MSHR gene necessary but not always sufficient, for red hair production."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 775,
                    "text": "Sequence variation in the melanocortin-1 receptor (MC1R) gene is associated with red hair in the normal population, but red hair is unusual in OCA."
                }
            ]
        },
        {
            "body": "Which bacteria was EcoRI, restriction endonuclease isolated from?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                "http://www.ncbi.nlm.nih.gov/pubmed/10573394",
                "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                "http://www.ncbi.nlm.nih.gov/pubmed/2695392",
                "http://www.ncbi.nlm.nih.gov/pubmed/3025707",
                "http://www.ncbi.nlm.nih.gov/pubmed/8760442",
                "http://www.ncbi.nlm.nih.gov/pubmed/403933",
                "http://www.ncbi.nlm.nih.gov/pubmed/344144",
                "http://www.ncbi.nlm.nih.gov/pubmed/347245",
                "http://www.ncbi.nlm.nih.gov/pubmed/16887645"
            ],
            "id": "5abd5a62fcf4565872000031",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16887645",
                    "endSection": "abstract",
                    "offsetInBeginSection": 686,
                    "offsetInEndSection": 779,
                    "text": "The most discriminating restriction endonuclease enzymes for ribotyping were EcoRI and BamHI."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/403933",
                    "endSection": "abstract",
                    "offsetInBeginSection": 530,
                    "offsetInEndSection": 654,
                    "text": "A fragment pattern of the products of EcoRI restriction endonuclease digestion of Euglena chloroplast DNA is also described."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8760442",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1437,
                    "offsetInEndSection": 1603,
                    "text": "Each of these clones was analysed to map BamHI, EcoRI, Sa/l, Smal and Xhol restriction endonuclease sites to provide complete endonuclease maps for the entire genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025707",
                    "endSection": "abstract",
                    "offsetInBeginSection": 299,
                    "offsetInEndSection": 579,
                    "text": "The restriction analysis has revealed that plasmid pFT15/10-1 possesses a single specific cleavage site for restriction endonuclease EcoRI, two sites for restriction endonucleases BamHI, BgIII, HincII, HindIII, PstI, three sites for BglI and SalI, some for AluI, TagI, MvaI, CfrI."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/347245",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 164,
                    "text": "The DNA of an E. coli K12 strain harboring ten wildtype Mu prophages was restricted with endonuclease EcoRI, and the fragments ligated into the plasmid vector pMB9."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2695392",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "The RsrI endonuclease, a type-II restriction endonuclease (ENase) found in Rhodobacter sphaeroides, is an isoschizomer of the EcoRI ENase."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/344144",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 187,
                    "text": "DNA cleavage of lambda and phi 80 transducing phages carrying the argA, argECBH, argF and argI operons of Escherichia coli K-12 with the restriction endonucleases EcoRI, SmaI and HindIII."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3025706",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "The restriction endonuclease EcoRI dependent recombination of compatible plasmids has been studied in RecA cells of Escherichia coli."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10573394",
                    "endSection": "abstract",
                    "offsetInBeginSection": 259,
                    "offsetInEndSection": 473,
                    "text": "The isolates were initially classified according to their restriction endonuclease profiles using HindIII and EcoRI restriction endonucleases and further characterised by rRNA gene restriction patterns (ribotypes)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/349563",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "An endonuclease having EcoRI specificity is produced by bacteria containing the ColE1 plasmid."
                }
            ]
        },
        {
            "body": "Which is the main reason for the increase in the incidence of cryptococcal disease?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                "http://www.ncbi.nlm.nih.gov/pubmed/19127040",
                "http://www.ncbi.nlm.nih.gov/pubmed/21982529",
                "http://www.ncbi.nlm.nih.gov/pubmed/16011530",
                "http://www.ncbi.nlm.nih.gov/pubmed/21905781",
                "http://www.ncbi.nlm.nih.gov/pubmed/28483415",
                "http://www.ncbi.nlm.nih.gov/pubmed/11428412",
                "http://www.ncbi.nlm.nih.gov/pubmed/17290547",
                "http://www.ncbi.nlm.nih.gov/pubmed/19245939"
            ],
            "id": "5ace37d50340b9f058000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19245939",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 445,
                    "text": "The increasing incidence of cryptococcal infection as a result of the AIDS epidemic, the recent emergence of a hypervirulent cryptococcal strain in Canada and the fact that mortality from cryptococcal disease remains high have stimulated intensive research into this organism."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28483415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 316,
                    "text": "Global burden estimates are crucial to guide prevention strategies and to determine treatment needs, and we aimed to provide an updated estimate of global incidence of HIV-associated cryptococcal disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21905781",
                    "endSection": "abstract",
                    "offsetInBeginSection": 534,
                    "offsetInEndSection": 821,
                    "text": "A newly developed point-of-care assay for cryptococcal antigen, as well as growing evidence supporting the utility and cost-effectiveness of screening, are further reasons to consider broad implementation of cryptococcal screening in countries with a high burden of cryptococcal disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11428412",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 219,
                    "text": "Pulmonary cryptococcal infections occur in both immunocompetent and immunocompromised individuals, with a reported increased incidence of diffuse pulmonary disease in acquired immune deficiency syndrome (AIDS) patients."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17290547",
                    "endSection": "abstract",
                    "offsetInBeginSection": 519,
                    "offsetInEndSection": 650,
                    "text": "Thorough examination including thoracoscopy and histological analysis of the mediastinal lymph nodes revealed cryptococcal disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16011530",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "Despite advances in the treatment of HIV disease, the incidence and mortality of invasive cryptococcal disease remain significant."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21982529",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 188,
                    "text": "BACKGROUND\nCryptococcal disease remains an important cause of morbidity and mortality in HIV-infected individuals in sub-Saharan Africa, despite the introduction of antiretroviral therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19127040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1874,
                    "offsetInEndSection": 1980,
                    "text": "Acute and/or subacute presentation of cryptococcal meningitis is not uncommon in HIV-infected individuals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19009138",
                    "endSection": "abstract",
                    "offsetInBeginSection": 496,
                    "offsetInEndSection": 633,
                    "text": "AIDS is the main predisposing condition for cryptococcal meningitis, and thus the profile of most patients mirrors that of HIV infection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16034947",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3331,
                    "offsetInEndSection": 3522,
                    "text": "AUTHORS' CONCLUSIONS\nAntifungal primary prophylaxis with either itraconazole or fluconazole is effective in reducing the incidence of cryptococcal disease in adults with advanced HIV disease."
                }
            ]
        },
        {
            "body": "Which genes are responsible for the high-altitude adaptation of Tibetans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                "http://www.ncbi.nlm.nih.gov/pubmed/24513612",
                "http://www.ncbi.nlm.nih.gov/pubmed/21030426",
                "http://www.ncbi.nlm.nih.gov/pubmed/26294746",
                "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                "http://www.ncbi.nlm.nih.gov/pubmed/23666208"
            ],
            "id": "5ace20fa0340b9f05800000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23666208",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "Tibetans are well adapted to high-altitude hypoxic conditions, and in recent genome-wide scans, many candidate genes have been reported involved in the physiological response to hypoxic conditions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22503288",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 86,
                    "text": "Recent studies have identified genes involved in high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26294746",
                    "endSection": "abstract",
                    "offsetInBeginSection": 750,
                    "offsetInEndSection": 1047,
                    "text": "Here, in this minireview, we discuss the progress made since the discovery of the genes involved in Tibetans' adaptation to high altitude with a particular emphasis on describing the series of studies that led us to conclude that archaic human DNA likely contributed to this impressive adaptation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24513612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 177,
                    "offsetInEndSection": 325,
                    "text": "Studies of Tibetans revealed candidates for high-altitude adaptations in the EGLN1 and EPAS1 genes, associated with lower haemoglobin concentration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 149,
                    "text": "The genetic adaptation of Tibetans to high altitude hypoxia likely involves a group of genes in the hypoxic pathway, as suggested by earlier studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21030426",
                    "endSection": "abstract",
                    "offsetInBeginSection": 891,
                    "offsetInEndSection": 1123,
                    "text": "For these two genes, Tibetans show unusually high divergence from the non-Tibetan lowlanders (Han Chinese and Japanese) and possess high frequencies of many linked sequence variations as reflected by the Tibetan-specific haplotypes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26053282",
                    "endSection": "abstract",
                    "offsetInBeginSection": 383,
                    "offsetInEndSection": 469,
                    "text": "Recent studies have identified genes involved in high-altitude adaptation in Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28585439",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 383,
                    "text": "Here we report on a hypoxia gene ( GCH1, GTP-cyclohydrolase I), involved in maintaining nitric oxide synthetase (NOS) function and normal blood pressure, that harbors many potentially adaptive variants in Tibetans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25501874",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 99,
                    "text": "Two functional loci in the promoter of EPAS1 gene involved in high-altitude adaptation of Tibetans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20838600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1617,
                    "offsetInEndSection": 1857,
                    "text": "Our results indicate that several key HIF-regulatory and targeted genes are responsible for adaptation to high altitude in Andeans and Tibetans, and several different chromosomal regions are implicated in the putative response to selection."
                }
            ]
        },
        {
            "body": "Which is the main protein in brown adipose tissue (BAT) active in thermogenesis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                "http://www.ncbi.nlm.nih.gov/pubmed/27498420",
                "http://www.ncbi.nlm.nih.gov/pubmed/1763812",
                "http://www.ncbi.nlm.nih.gov/pubmed/21373720",
                "http://www.ncbi.nlm.nih.gov/pubmed/29224101",
                "http://www.ncbi.nlm.nih.gov/pubmed/19906816",
                "http://www.ncbi.nlm.nih.gov/pubmed/23603815",
                "http://www.ncbi.nlm.nih.gov/pubmed/22535970",
                "http://www.ncbi.nlm.nih.gov/pubmed/27339605",
                "http://www.ncbi.nlm.nih.gov/pubmed/23037904"
            ],
            "id": "5a8980d2fcd1d6a10c00000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23603815",
                    "endSection": "abstract",
                    "offsetInBeginSection": 123,
                    "offsetInEndSection": 334,
                    "text": "Central to these pathologies is the fat depot: white adipose tissue (WAT) stores excess calories, and brown adipose tissue (BAT) consumes fuel for thermogenesis using tissue-specific uncoupling protein 1 (UCP1)."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19906816",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Expression of uncoupling protein 1 in mouse brown adipose tissue is thyroid hormone receptor-beta isoform specific and required for adaptive thermogenesis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23037904",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 70,
                    "text": "Brown adipose tissue and the regulation of nonshivering thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27339605",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1246,
                    "offsetInEndSection": 1454,
                    "text": "Inhibition of autophagy in brown adipocytes leads to an increase in UCP1 protein and uncoupled respiration, suggesting a repressing role for autophagy in relation to the activity of BAT thermogenic machinery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22535970",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "CONTEXT\nStimulation of thermogenesis in brown adipose tissue (BAT) is a potential target to treat obesity."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29224101",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 59,
                    "text": "Estradiol Regulation of Brown Adipose Tissue Thermogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21373720",
                    "endSection": "abstract",
                    "offsetInBeginSection": 191,
                    "offsetInEndSection": 275,
                    "text": "Brown adipose tissue (BAT) is responsible for cold-induced thermogenesis in rodents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1763812",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "Brown adipose tissue (BAT) is the main effector of nonshivering thermogenesis and diet-induced thermogenesis in mammals."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27498420",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "Brown adipose tissue (BAT) has been also considered as the main thermogenic organ responsible of maintenance body temperature through heat production."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24809334",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 73,
                    "text": "Negative regulators of brown adipose tissue (BAT)-mediated thermogenesis."
                }
            ]
        },
        {
            "body": "Which method is Proseek based on?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                "http://www.ncbi.nlm.nih.gov/pubmed/29026368",
                "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                "http://www.ncbi.nlm.nih.gov/pubmed/26204497",
                "http://www.ncbi.nlm.nih.gov/pubmed/28437237"
            ],
            "id": "5a9e202bde7cb99d40000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29392211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 366,
                    "offsetInEndSection": 542,
                    "text": "To simultaneously measure 92 inflammatory biomarkers, we used the proximity extension assay with the Proseek Multiplex Inflammation I panel (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27710869",
                    "endSection": "abstract",
                    "offsetInBeginSection": 498,
                    "offsetInEndSection": 588,
                    "text": "Samples were analyzed by Mesoscale Discovery, Myriad RBM MAP technology and Olink Proseek."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26204497",
                    "endSection": "abstract",
                    "offsetInBeginSection": 440,
                    "offsetInEndSection": 634,
                    "text": "Levels of 82 proteins were assessed in plasma by a proximity extension assay (Proseek Multiplex CVD, Olink Bioscience, Uppsala, Sweden) and related to carotid measures in a regression framework."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27383427",
                    "endSection": "abstract",
                    "offsetInBeginSection": 767,
                    "offsetInEndSection": 929,
                    "text": "In addition to conventional laboratory tests, 92 inflammatory proteins were analysed with a multiplex system (Proseek Multiplex Inflammation I, Olink Bioscience)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28437237",
                    "endSection": "abstract",
                    "offsetInBeginSection": 750,
                    "offsetInEndSection": 962,
                    "text": "Blood samples were obtained at baseline (0 hour), 6, 24, and 96 hours post PCI, and stored at -80\u00b0C until they were analyzed by PROSEEK Multiplex CVD and PROSEEK Multiplex INF (Olink Bioscience, Uppsala, Sweden)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28083617",
                    "endSection": "abstract",
                    "offsetInBeginSection": 543,
                    "offsetInEndSection": 828,
                    "text": "Serum concentrations of 92 inflammation-associated proteins were measured in samples obtained from 80 aHSCT patients 14\u00a0days after transplantation and from 23 healthy control subjects by a novel sensitive proximity extension assay technology using Proseek Multiplex Inflammation I kit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28936257",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 654,
                    "text": "Among 92 proteins in the Proseek Multiplex Oncology Iv2 panel, 87 were above the limit of detection (LOD) in liquid plasma and 56 among 92 above LOD in plasma applied to FTA cards."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29026368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 416,
                    "offsetInEndSection": 653,
                    "text": "METHODS\nWe used proximity extension immunoassay (PEA, Proseek Multiplex, Olink) to assess the serum levels of ninety-two inflammation-related proteins in Czech patients with SLE (n\u00a0=\u00a075) and age-matched healthy control subjects (n\u00a0=\u00a023)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25987887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1281,
                    "offsetInEndSection": 1489,
                    "text": "RESULTS\nSimilar quantitative expression patterns for 13 plasma antigens common to both platforms endorsed the potential efficacy of Proseek as an immune-based multiplex assay for proteomic biomarker research."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19040730",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "ProSeeK: a web server for MLPA probe design."
                }
            ]
        },
        {
            "body": "With which personality traits has the human monoamine oxidase A (MAOA) gene been associated?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                "http://www.ncbi.nlm.nih.gov/pubmed/25606465",
                "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                "http://www.ncbi.nlm.nih.gov/pubmed/19194374",
                "http://www.ncbi.nlm.nih.gov/pubmed/16360899",
                "http://www.ncbi.nlm.nih.gov/pubmed/17920180",
                "http://www.ncbi.nlm.nih.gov/pubmed/29075213"
            ],
            "id": "5a99566e1d1251d03b00000f",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29075213",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Monoamine Oxidase A (MAOA) Gene and Personality Traits from Late Adolescence through Early Adulthood: A Latent Variable Investigation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16360899",
                    "endSection": "abstract",
                    "offsetInBeginSection": 306,
                    "offsetInEndSection": 608,
                    "text": "In the present study, we investigated the association between personality traits and systematic combination of functional polymorphisms in three genes that regulate the metabolism of catecholamines, namely, tyrosine hydroxylase (TH), monoamine oxidase A (MAOA), and catechol-O-methyltransferase (COMT)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16436187",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 377,
                    "text": "By conferring allele-specific transcriptional activity on the monoamine oxidase A (MAOA) gene in humans, length variation of a repetitive sequence [(variable number of tandem repeat (VNTR)] in the MAOA promoter influences a constellation of personality traits related to aggressive and antisocial behavior and increases the risk of neurodevelopmental and psychiatric disorders."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19194374",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "Association studies suggest that the low activity variant of the monoamine oxidase A (MAOA)-uVNTR polymorphism confers risk for emotional disturbances associated with antisocial traits, particularly in males."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18845200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 187,
                    "offsetInEndSection": 457,
                    "text": "In the present study, we investigated the relationships between a polymorphism involving a variable number of tandem repeats in the promoter of the monoamine oxidase A (MAOA-VNTR) gene and personality traits, as assessed by the Temperament and Character Inventory (TCI)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17920180",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 373,
                    "text": "In the present study, we investigated the variable number of tandem repeats (VNTR) polymorphism of the norepinephrine transporter (NET) and monoamine oxidase A (MAOA), which are major components of the adrenergic system, to elucidate their relationship with personality."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15870836",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 179,
                    "text": "Genetic variants of the monoamine oxidase A (MAOA) have been associated with aggression-, anxiety-, and addiction-related behavior in several nonclinical and clinical populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25606465",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 206,
                    "text": "Androgen receptor gene (AR), monoamine oxidase A gene (MAOA) and monoamine oxidase B gene (MAOB) have been found to have associations with behavioral traits, such as aggressiveness, and disorders in humans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19657584",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 222,
                    "text": "Monoamine oxidase A and B (MAOA and MAOB) appear to be involved in the pathogenesis of Major Depression, and vulnerability of Major Depression is associated with personality traits relating to positive and negative affect."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12566936",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 132,
                    "text": "Monoamine oxidase type A (MAOA) has been implicated to be part of mechanisms underlying human temperament and psychiatric disorders."
                }
            ]
        },
        {
            "body": "What is the function of HDAC  proteins?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                "http://www.ncbi.nlm.nih.gov/pubmed/27345839",
                "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                "http://www.ncbi.nlm.nih.gov/pubmed/20072728",
                "http://www.ncbi.nlm.nih.gov/pubmed/17767915",
                "http://www.ncbi.nlm.nih.gov/pubmed/10220385",
                "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                "http://www.ncbi.nlm.nih.gov/pubmed/22621256",
                "http://www.ncbi.nlm.nih.gov/pubmed/26645980",
                "http://www.ncbi.nlm.nih.gov/pubmed/24483782"
            ],
            "id": "5aafc37afcf4565872000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483782",
                    "endSection": "abstract",
                    "offsetInBeginSection": 207,
                    "offsetInEndSection": 549,
                    "text": "RECENT ADVANCES\nBesides the classical function of HDACs as HDAC enzymes controlling the transcription, it is becoming increasingly evident that these proteins are involved in the regulation of several other cellular processes by their ability to deacetylate hundreds of proteins with different functions in both the cytoplasm and the nucleus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17694083",
                    "endSection": "abstract",
                    "offsetInBeginSection": 559,
                    "offsetInEndSection": 803,
                    "text": "This review provides a comprehensive examination of the transcriptional and post-translational mechanisms by which HDACs alter the expression and function of cancer-associated proteins and examines the general impact of HDAC activity in cancer."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17767915",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 154,
                    "text": "The function of eukaryotic histone deacetylase (HDAC) has been extensively studied for its critical role in transcriptional regulation and carcinogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10220385",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1482,
                    "offsetInEndSection": 1615,
                    "text": "This finding suggests that the human class II HDAC enzymes may function in cellular processes distinct from those of HDAC1 and HDAC2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20072728",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 168,
                    "text": "Histone deacetylases (HDACs) are a family of proteins that play an important role in regulating transcription as well as the function of a variety of cellular proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26645980",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1097,
                    "offsetInEndSection": 1243,
                    "text": "The cytosolic actions of HDACs result in changed protein function through post-translational modifications and/or modulation of their degradation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22621256",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1206,
                    "offsetInEndSection": 1391,
                    "text": "Evaluation of the effects of HDAC inhibitors on PA stem cell function and epithelial to mesenchymal transformation is also an evolving area that holds future potential for these agents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27345839",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 406,
                    "text": "Although the functions of HDAC proteins are becoming apparent both biochemically and clinically, how this class of proteins is regulated remains poorly understood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23088873",
                    "endSection": "abstract",
                    "offsetInBeginSection": 436,
                    "offsetInEndSection": 667,
                    "text": "Treatment with HDAC inhibitors results in the hyperacetylation of chaperones including heat shock protein (hsp)90, hsp70, hsp40, and the ER-resident hsp70 homolog, glucose-regulated protein 78 (GRP78), which affects their function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17227860",
                    "endSection": "abstract",
                    "offsetInBeginSection": 133,
                    "offsetInEndSection": 303,
                    "text": "Efforts to understand how associated proteins modulate the function of HDACs would benefit from new technologies that evaluate HDAC activity in native biological systems."
                }
            ]
        },
        {
            "body": "What is the H4S47C cleavage mapping method used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                "http://www.ncbi.nlm.nih.gov/pubmed/26275423",
                "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                "http://www.ncbi.nlm.nih.gov/pubmed/10079758",
                "http://www.ncbi.nlm.nih.gov/pubmed/8054978",
                "http://www.ncbi.nlm.nih.gov/pubmed/8502555",
                "http://www.ncbi.nlm.nih.gov/pubmed/24698368",
                "http://www.ncbi.nlm.nih.gov/pubmed/24590784",
                "http://www.ncbi.nlm.nih.gov/pubmed/17033956"
            ],
            "id": "5a885add61bb38fb24000017",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24698368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 122,
                    "offsetInEndSection": 256,
                    "text": "In this study, we developed a fast and reliable method for mapping the recognition and cleavage site of the restriction endonucleases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8502555",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1260,
                    "offsetInEndSection": 1452,
                    "text": "The approach of using the lambda-terminase cleavage reaction is a simple one-step procedure with a high specificity which is particularly suitable for mapping very large genomes of eucaryotes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17033956",
                    "endSection": "abstract",
                    "offsetInBeginSection": 581,
                    "offsetInEndSection": 813,
                    "text": "A novel method, extension ligation-mediated polymerase chain reaction (ELMPCR), was used here for mapping topoisomerase-mediated DNA strand breaks and apoptotic DNA cleavage across a translocation-prone region of MLL in human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10079758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 181,
                    "text": "A method for mass spectrometric peptide mapping was developed, based on hydrolysis of a solid protein by acid vapor followed by mass spectrometric analysis of the cleavage products."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24590784",
                    "endSection": "abstract",
                    "offsetInBeginSection": 89,
                    "offsetInEndSection": 276,
                    "text": "While RNA-seq reads cover most regions of an mRNA sequence, they are often depleted in the 3' end region, making them less amenable for mapping the cleavage and polyadenylation site (pA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8054978",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 163,
                    "text": "RecA-assisted restriction endonuclease (RARE) cleavage is a method to perform sequence-specific cleavage of genomic DNA, and is useful in physical mapping studies."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2413446",
                    "endSection": "abstract",
                    "offsetInBeginSection": 616,
                    "offsetInEndSection": 766,
                    "text": "The peptide antibody method used, called cleavage mapping, should be a convenient technique for mapping residues and ligand binding sites in proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26275423",
                    "endSection": "abstract",
                    "offsetInBeginSection": 164,
                    "offsetInEndSection": 327,
                    "text": "To map fission yeast centromeres, we applied H4S47C-anchored cleavage mapping and native and cross-linked chromatin immunoprecipitation with paired-end sequencing."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24737863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 170,
                    "offsetInEndSection": 332,
                    "text": "To resolve this controversy, we have applied H4S47C-anchored cleavage mapping, which reveals the precise position of histone H4 in every nucleosome in the genome."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25491770",
                    "endSection": "abstract",
                    "offsetInBeginSection": 113,
                    "offsetInEndSection": 349,
                    "text": "To identify nucleosomes with alternative structures genome-wide, we used H4S47C-anchored cleavage mapping, which revealed that 5% of budding yeast (Saccharomyces cerevisiae) nucleosome positions have asymmetric histone-DNA interactions."
                }
            ]
        },
        {
            "body": "Which human gene encode for DNA polymerase \u03b8?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                "http://www.ncbi.nlm.nih.gov/pubmed/28695890",
                "http://www.ncbi.nlm.nih.gov/pubmed/28570559",
                "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                "http://www.ncbi.nlm.nih.gov/pubmed/27264557",
                "http://www.ncbi.nlm.nih.gov/pubmed/25775267",
                "http://www.ncbi.nlm.nih.gov/pubmed/24375106",
                "http://www.ncbi.nlm.nih.gov/pubmed/26514729",
                "http://www.ncbi.nlm.nih.gov/pubmed/22135286",
                "http://www.ncbi.nlm.nih.gov/pubmed/25643323"
            ],
            "id": "5aacd487fcf4565872000007",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22135286",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Promiscuous DNA synthesis by human DNA polymerase \u03b8."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25643323",
                    "endSection": "abstract",
                    "offsetInBeginSection": 264,
                    "offsetInEndSection": 504,
                    "text": "We demonstrate that purified human DNA polymerase \u03b8 (Pol\u03b8) performs MMEJ of DNA containing 3' single-strand DNA overhangs with \u22652 bp of homology, including DNA modeled after telomeres, and show that MMEJ is dependent on Pol\u03b8 in human cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26514729",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "DNA polymerase theta (Pol \u03b8) is an error-prone A-family polymerase that is highly conserved among multicellular eukaryotes and plays multiple roles in DNA repair and the regulation of genome integrity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25775267",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "DNA polymerase \u03b8 protects against genomic instability via an alternative end-joining repair pathway for DNA double-strand breaks."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24375106",
                    "endSection": "abstract",
                    "offsetInBeginSection": 131,
                    "offsetInEndSection": 195,
                    "text": "It encodes the \u03b8 subunit of the DNA polymerase III core complex."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27657134",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "The gene encoding DNA polymerase \u03b8 (Pol\u03b8) was discovered over ten years ago as having a role in suppressing genome instability in mammalian cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28570559",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "DNA polymerase \u03bd (pol \u03bd), encoded by the POLN gene, is an A-family DNA polymerase in vertebrates and some other animal lineages."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27264557",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "DNA polymerase theta (pol \u03b8) is encoded in the genomes of many eukaryotes, though not in fungi."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28695890",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 633,
                    "text": "Here we show that DNA polymerase \u03b8, despite its minor role in chromosomal DNA repair, substantially contributes to random integration, and that cells lacking both DNA polymerase \u03b8 and DNA ligase IV, which is essential for non-homologous end joining (NHEJ), exhibit 100% efficiency of spontaneous gene targeting by virtue of undetectable levels of random integration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28668117",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "DNA polymerase theta (pol \u03b8) is an evolutionarily conserved protein encoded by the POLQ gene in mammalian genomes."
                }
            ]
        },
        {
            "body": "In what percentage of skeletal muscle fibers is dystrophin expression restored after PPMO- mediated exon skipping?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                "http://www.ncbi.nlm.nih.gov/pubmed/19844193",
                "http://www.ncbi.nlm.nih.gov/pubmed/20170628",
                "http://www.ncbi.nlm.nih.gov/pubmed/20924363",
                "http://www.ncbi.nlm.nih.gov/pubmed/8213828",
                "http://www.ncbi.nlm.nih.gov/pubmed/19277018",
                "http://www.ncbi.nlm.nih.gov/pubmed/18806224",
                "http://www.ncbi.nlm.nih.gov/pubmed/19796077",
                "http://www.ncbi.nlm.nih.gov/pubmed/18384691"
            ],
            "id": "5ac0a82d19833b0d7b000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18384691",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 278,
                    "text": "BACKGROUND\nExon skipping oligonucleotides (ESOs) of 2'O-Methyl (2'OMe) and morpholino chemistry have been shown to restore dystrophin expression in muscle fibers from the mdx mouse, and are currently being tested in phase I clinical trials for Duchenne Muscular Dystrophy (DMD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8213828",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 231,
                    "text": "Although many Duchenne muscular dystrophy patients have a deletion in the dystrophin gene which disrupts the translational reading frame, they express dystrophin in a small proportion of skeletal muscle fibers (\"revertant fibers\")."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19277018",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 247,
                    "text": "Reading frame restoration of the dystrophin transcript can be achieved by AON-mediated exon skipping in the dystrophic mdx mouse model."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20924363",
                    "endSection": "abstract",
                    "offsetInBeginSection": 505,
                    "offsetInEndSection": 757,
                    "text": "To achieve a significant variation in dystrophin expression, we locally administered into tibialis anterior muscles various doses of a phosphorodiamidate morpholino oligomer (PMO) designed to skip the mutated exon 23 from the mRNA of murine dystrophin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18806224",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 171,
                    "text": "Antisense oligonucleotide-mediated exon skipping is able to correct out-of-frame mutations in Duchenne muscular dystrophy and restore truncated yet functional dystrophins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19844193",
                    "endSection": "abstract",
                    "offsetInBeginSection": 820,
                    "offsetInEndSection": 1094,
                    "text": "injections of a PPMO targeted to exon 23 of dystrophin pre-mRNA in dKO mice induce a near-normal level of dystrophin expression in all muscles examined, except for the cardiac muscle, resulting in a considerable improvement of their muscle function and dystrophic pathology."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19796077",
                    "endSection": "abstract",
                    "offsetInBeginSection": 307,
                    "offsetInEndSection": 504,
                    "text": "A peptide-morpholino conjugate (PPMO) restored dystrophin in mdx mice to > 80% and 50% of normal levels in skeletal and cardiac muscles, respectively, after a single intravenous 30-mg/kg injection."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20170628",
                    "endSection": "abstract",
                    "offsetInBeginSection": 342,
                    "offsetInEndSection": 548,
                    "text": "The studies have shown that PMOs can diffuse into leaky muscle cells, modify splicing of DMD transcripts, induce expression of partially functional dystrophin, and improve function of some skeletal muscles."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24942628",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 122,
                    "text": "Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28373570",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1423,
                    "offsetInEndSection": 1591,
                    "text": "The present study reports the rescue of dystrophin expression and recovery of the conduction system in the heart of dystrophic dogs by PPMO-mediated multiexon skipping."
                }
            ]
        },
        {
            "body": "Which miRNA is associated with the circular RNA ciRS-7?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                "http://www.ncbi.nlm.nih.gov/pubmed/27929395",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                "http://www.ncbi.nlm.nih.gov/pubmed/28174233",
                "http://www.ncbi.nlm.nih.gov/pubmed/27614453",
                "http://www.ncbi.nlm.nih.gov/pubmed/28296235",
                "http://www.ncbi.nlm.nih.gov/pubmed/27796758",
                "http://www.ncbi.nlm.nih.gov/pubmed/26211738",
                "http://www.ncbi.nlm.nih.gov/pubmed/26649774"
            ],
            "id": "5ac725250340b9f058000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26211738",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 281,
                    "text": "Among the identified thousands of circular RNAs (circRNA) in humans and animals, Cdr1as (also known as CiRS-7) was recently demonstrated to act as a powerful miR-7 sponge/inhibitor in developing midbrain of zebrafish, suggesting a novel mechanism for regulating microRNA functions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26649774",
                    "endSection": "abstract",
                    "offsetInBeginSection": 305,
                    "offsetInEndSection": 515,
                    "text": "Recent studies have mainly been devoted to the function of the circular RNA sponge for miR-7 (ciRS-7) and sex-determining region Y (SRY) by targeting microRNA-7 (miR-7) and microRNA-138 (miR-138), respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27796758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 503,
                    "offsetInEndSection": 774,
                    "text": "The best known ones so far include a particular type of circRNA namely \"circular RNA sponge for miR-7\" (ciRS-7 and CDR1as) which is the inhibitor of miR-7 microRNA-known to regulate various diseases like, cancer, neurodegenerative diseases, diabetes, and atherosclerosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28296235",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 88,
                    "text": "The circular RNA ciRS-7 promotes APP and BACE1 degradation in an NF-\u03baB-dependent manner."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27614453",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28174233",
                    "endSection": "abstract",
                    "offsetInBeginSection": 77,
                    "offsetInEndSection": 161,
                    "text": "Recently, a novel circular RNA, ciRS-7, was proposed to be a potential miR-7 sponge."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873049",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 65,
                    "text": "The emerging landscape of circular RNA ciRS-7 in cancer (Review)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24014594",
                    "endSection": "abstract",
                    "offsetInBeginSection": 300,
                    "offsetInEndSection": 484,
                    "text": "Particularly, the recently identified circular RNA, ciRS-7, which acts as a designated miR-7 inhibitor/sponge, has conceptually changed the mechanistic understanding of miRNA networks."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27929395",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 158,
                    "text": "Deficiency in the Ubiquitin Conjugating Enzyme UBE2A in Alzheimer's Disease (AD) is Linked to Deficits in a Natural Circular miRNA-7 Sponge (circRNA; ciRS-7)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23446346",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 578,
                    "text": "Here we show that this circRNA acts as a miR-7 sponge; we term this circular transcript ciRS-7 (circular RNA sponge for miR-7)."
                }
            ]
        },
        {
            "body": "Which are the two main bacterial phyla in human gut?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                "http://www.ncbi.nlm.nih.gov/pubmed/24324923",
                "http://www.ncbi.nlm.nih.gov/pubmed/25601048",
                "http://www.ncbi.nlm.nih.gov/pubmed/26061054",
                "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                "http://www.ncbi.nlm.nih.gov/pubmed/23690942",
                "http://www.ncbi.nlm.nih.gov/pubmed/25873372",
                "http://www.ncbi.nlm.nih.gov/pubmed/19710708",
                "http://www.ncbi.nlm.nih.gov/pubmed/27900395"
            ],
            "id": "5abd2ce0fcf456587200002a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27900395",
                    "endSection": "abstract",
                    "offsetInBeginSection": 147,
                    "offsetInEndSection": 304,
                    "text": "Out of thousands of bacterial species-level phylotypes inhabiting the human gut, the majority belong to two dominant phyla, the Bacteroidetes and Firmicutes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25873372",
                    "endSection": "abstract",
                    "offsetInBeginSection": 961,
                    "offsetInEndSection": 1208,
                    "text": "Analyses of sequenced bacterial genomes revealed that the cut cluster is present in many human gut bacteria, is predictive of choline utilization in sequenced isolates, and is widely but discontinuously distributed across multiple bacterial phyla."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26061054",
                    "endSection": "abstract",
                    "offsetInBeginSection": 237,
                    "offsetInEndSection": 393,
                    "text": "Recent evidence suggests that obesity is influenced by specific bacterial phyla present in the human gut that have increased energy harvesting capabilities."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23690942",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1034,
                    "offsetInEndSection": 1383,
                    "text": "The HuGChip development and validation showed that it is not only able to assess the known human gut microbiota but could also detect unknown species with the explorative probes to reveal the large number of bacterial sequences not yet described in the human gut microbiota, overcoming the main inconvenience encountered when developing microarrays."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23982459",
                    "endSection": "abstract",
                    "offsetInBeginSection": 334,
                    "offsetInEndSection": 577,
                    "text": "Here we reconstructed GEMs for three key species, (Bacteroides thetaiotamicron, Eubacterium rectale and Methanobrevibacter smithii) as relevant representatives of three main phyla in the human gut (Bacteroidetes, Firmicutes and Euryarchaeota)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19710708",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 553,
                    "text": "Principal component analysis of infant microbiota 16S rRNA gene microarray data showed that the main directions of variation were defined by three phylum-specific probes targeting Bacteroides, Proteobacteria and Firmicutes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24324923",
                    "endSection": "abstract",
                    "offsetInBeginSection": 2026,
                    "offsetInEndSection": 2239,
                    "text": "The presence of some bacterial phyla on gut tract suggests that cockroaches could be an interesting model to study the organization of gut bacterial communities during digestion of different lignocellulosic diets."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27638955",
                    "endSection": "abstract",
                    "offsetInBeginSection": 459,
                    "offsetInEndSection": 845,
                    "text": "As results, 132 bacterial genera and some unidentified operational taxonomic units within 29 phyla in the gut bacteria were detected, with Spirochaetes (11-55%), Firmicutes (7-18%), Bacteroidetes (7-31%), and Proteobacteria (8-14%) as the main phyla, and Treponema, TG5, Dysgonomonas, Tannerella, za29, Lactococcus, Pseudomonas, and SJA-88 as the common genera in all the four termites."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25601048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1010,
                    "offsetInEndSection": 1229,
                    "text": "In terms of microbial community structure, the analysis showed that the communities from the two environments were quite different from each other with only 7\u00a0% of species-level taxa shared between bee gut and beebread."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19321416",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla."
                }
            ]
        },
        {
            "body": "What are 7 symptoms of yellow fever?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                "http://www.ncbi.nlm.nih.gov/pubmed/12410495",
                "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                "http://www.ncbi.nlm.nih.gov/pubmed/8599063",
                "http://www.ncbi.nlm.nih.gov/pubmed/6268925",
                "http://www.ncbi.nlm.nih.gov/pubmed/27087559",
                "http://www.ncbi.nlm.nih.gov/pubmed/20300380",
                "http://www.ncbi.nlm.nih.gov/pubmed/18261201"
            ],
            "id": "5aac5469fcf4565872000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18261201",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 103,
                    "text": "BACKGROUND\nCameroon is one of 12 African countries that bear most of the global burden of yellow fever."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6268925",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1315,
                    "offsetInEndSection": 1431,
                    "text": "5 - Authors discussed some specific difficulties of yellow fever retrospective diagnosis in flavivirus endemic area."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20300380",
                    "endSection": "abstract",
                    "offsetInBeginSection": 226,
                    "offsetInEndSection": 307,
                    "text": "Clinical symptoms and signs observed among yellow fever cases are also described."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27087559",
                    "endSection": "abstract",
                    "offsetInBeginSection": 637,
                    "offsetInEndSection": 828,
                    "text": "Clinicians should alert to the possibility of YEL-AVD in vaccinees presenting with compatible symptoms after yellow fever vaccination, particularly in people at higher risk of adverse events."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11000957",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "Yellow fever is an arthropod-borne disease with symptoms ranging from mild fever to acute hepatonephritis, hemorrhages and shock often fatal."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19869938",
                    "endSection": "abstract",
                    "offsetInBeginSection": 895,
                    "offsetInEndSection": 1083,
                    "text": "If the brain was mildly injured at the time of the intraperitoneal injection, the symptoms of yellow fever encephalitis appeared 6 days later, but the virus was then absent from the blood."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19868337",
                    "endSection": "abstract",
                    "offsetInBeginSection": 220,
                    "offsetInEndSection": 730,
                    "text": "Of 74 guinea pigs inoculated with specimens of blood from 27 cases of yellow fever, 8, representing 6 cases, came down with the symptoms; namely, a marked rise of temperature after a period of incubation averaging 3 to 6 days, with simultaneous suffusion of the capillaries, particularly of the conjunctivaes and soles, then preliminary hyperleucocytosis followed by progressive leucopenia, the early appearance of albumin and casts in the urine, which gradually diminishes in volume as the disease progresses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8599063",
                    "endSection": "abstract",
                    "offsetInBeginSection": 114,
                    "offsetInEndSection": 257,
                    "text": "The patient suffered from fever, chills, sweating, headaches, backaches, myalgia, epigastric pains, nausea, vomiting, diarrhea and prostration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29546100",
                    "endSection": "abstract",
                    "offsetInBeginSection": 169,
                    "offsetInEndSection": 495,
                    "text": "According to operational case definition, suspected yellow fever cases are included in case spread sheet with variables like age, sex, locality, occupation, status of vaccination, onset of symptoms, presenting symptoms, date of blood sampling and confirmation of diagnosis either by laboratory results or epidemiological link."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12410495",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 141,
                    "text": "A 47-year-old Belgian woman acquired yellow fever during a 1-week vacation in The Gambia; she had never been vaccinated against yellow fever."
                }
            ]
        },
        {
            "body": "Which test is used for the definition of colour-blindness?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                "http://www.ncbi.nlm.nih.gov/pubmed/310055",
                "http://www.ncbi.nlm.nih.gov/pubmed/16431664",
                "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                "http://www.ncbi.nlm.nih.gov/pubmed/9893853",
                "http://www.ncbi.nlm.nih.gov/pubmed/1495767",
                "http://www.ncbi.nlm.nih.gov/pubmed/4049749",
                "http://www.ncbi.nlm.nih.gov/pubmed/19493108",
                "http://www.ncbi.nlm.nih.gov/pubmed/28274040"
            ],
            "id": "5ad6e431133db5eb7800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4049749",
                    "endSection": "abstract",
                    "offsetInBeginSection": 145,
                    "offsetInEndSection": 243,
                    "text": "This could explain the widespread occurrence of colour-blindness among movement-detecting systems."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/306798",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "The incidence of colour-blindness among the tribal populations of Andhra Pradesh."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1495767",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 663,
                    "text": "In his first pedigree Horner demonstrates that colour-blindness is transmitted from the grandfather to the grandson."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19493108",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "Individuals with red-green colour-blindness (CB) commonly experience great difficulty differentiating between certain histological stain pairs, notably haematoxylin-eosin (H&E)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9893853",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 211,
                    "text": "Alleles causing colour-blindness are present in humans at non-negligible levels, and it is not yet understood how colour-blindness is maintained, since colour-vision probably provides a selective advantage, e.g."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16431664",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 49,
                    "text": "Colour-blindness and sensitivity to PTC in Hadza."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/314267",
                    "endSection": "abstract",
                    "offsetInBeginSection": 748,
                    "offsetInEndSection": 1082,
                    "text": "The association of colour-blindness with higher socio-economic status is expected given the history of European conquest in the New World, and suggests that the major cause of varying rates of the defect in Latin American populations is socio-economic heterogeneity and by inference different degrees of European-Amerindian admixture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28274040",
                    "endSection": "abstract",
                    "offsetInBeginSection": 733,
                    "offsetInEndSection": 827,
                    "text": "Then, the Ishihara's colour charts were used to test the operators for colour vision handicap."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/310055",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1024,
                    "offsetInEndSection": 1179,
                    "text": "With coloured stimuli, the difference between normal and red-green colour-blindness is more clear-cut, and red-blind can be discriminated from green-blind."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25452008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 965,
                    "offsetInEndSection": 1096,
                    "text": "To test for colour-blindness, we used a cognitive approach involving a harbour seal trained to use a concept of same and different."
                }
            ]
        },
        {
            "body": "Of what origin is the MCF-7 cell line?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                "http://www.ncbi.nlm.nih.gov/pubmed/15183541",
                "http://www.ncbi.nlm.nih.gov/pubmed/7604203",
                "http://www.ncbi.nlm.nih.gov/pubmed/25321415",
                "http://www.ncbi.nlm.nih.gov/pubmed/19942292",
                "http://www.ncbi.nlm.nih.gov/pubmed/849449",
                "http://www.ncbi.nlm.nih.gov/pubmed/10514287",
                "http://www.ncbi.nlm.nih.gov/pubmed/26422101",
                "http://www.ncbi.nlm.nih.gov/pubmed/10961387"
            ],
            "id": "5ac08fe7d0c506ce46000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10961387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 452,
                    "text": "Genistein, a prominent isoflavone in soy products, produced dose- and time-dependent in vitro growth inhibition at high concentrations (at least 185 microM) with an IC50 of 7.0-274.2 microM after 72 h incubation in four breast cancer cell lines (DD-762, Sm-MT, MCF-7 and MDA-MB-231) and one breast epithelial cell line (HBL- 100) of human and animal origin; it stimulated estrogen-receptor-positive MCF-7 cells at low concentrations (3.7 nM-37 microM)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26422101",
                    "endSection": "abstract",
                    "offsetInBeginSection": 275,
                    "offsetInEndSection": 437,
                    "text": "MATERIALS AND METHODS\n5 breast cell lines of different origin - MCF-10 A, MCF-7, including doxorubicin/cisplatin resistant ones, T47D, MDA-MB-231, and MDA-MB-468."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/849449",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 120,
                    "text": "In a mammary gland cell line (MCF-7) of human origin, insulin stimulated the rates of RNA, DNA and protein biosynthesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10514287",
                    "endSection": "abstract",
                    "offsetInBeginSection": 575,
                    "offsetInEndSection": 693,
                    "text": "Cell lines from the same tissue origin, MDA-MB-435 (breast), CAKI-1 (renal), and A498 (renal), were insensitive to 1a."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19942292",
                    "endSection": "abstract",
                    "offsetInBeginSection": 637,
                    "offsetInEndSection": 781,
                    "text": "The cytotoxic effects of the compounds against cells of neoplastic origin (MOLT-4, MCF-7) and cells of benign origin (Chang Liver) were studied."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25321415",
                    "endSection": "abstract",
                    "offsetInBeginSection": 820,
                    "offsetInEndSection": 1039,
                    "text": "A significant number of unique chromosomal translocations were observed between the BG-1 NIEHS and MCF-7 cells, suggesting that acquired genotypic differences resulted in the formation of two lines from a common origin."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7604203",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Progesterone receptor heterogeneity in MCF-7 cell subclones is related to clonal origin and kinetics data."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15183541",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 128,
                    "text": "The adriamycin resistant breast cancer cell line (MCF-7/ADR) is a subject of ongoing debate concerning its origin and or source."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/176383",
                    "endSection": "abstract",
                    "offsetInBeginSection": 201,
                    "offsetInEndSection": 314,
                    "text": "To further characterize the tumor origin of the MCF-7 line, cells were grown on collagen-coated cellulos sponges."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21116879",
                    "endSection": "abstract",
                    "offsetInBeginSection": 556,
                    "offsetInEndSection": 838,
                    "text": "Since the MCF-7/ADR' cell line was definitely derived from parental MCF-7 cells, we were able to directly compare these cell lines together with MCF-7/ADR using immunocytochemical, morphological, and consecutive DNA fingerprinting analyses to determine the true origin of MCF-7/ADR."
                }
            ]
        },
        {
            "body": "Is lumican a secreted protein?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                "http://www.ncbi.nlm.nih.gov/pubmed/17050378",
                "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                "http://www.ncbi.nlm.nih.gov/pubmed/20138170",
                "http://www.ncbi.nlm.nih.gov/pubmed/23480731",
                "http://www.ncbi.nlm.nih.gov/pubmed/12381269",
                "http://www.ncbi.nlm.nih.gov/pubmed/21421073",
                "http://www.ncbi.nlm.nih.gov/pubmed/15966909",
                "http://www.ncbi.nlm.nih.gov/pubmed/11259366"
            ],
            "id": "5ad255210340b9f058000018",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15966909",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 218,
                    "text": "BACKGROUND\nSmall leucine-rich proteoglycans (SLRPs) decorin, biglycan, fibromodulin and lumican are secreted extracellular matrix molecules that associate with fibrillar collagens and regulate collagen fibrillogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11259366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 167,
                    "text": "Small leucine-rich proteoglycans (SLRPs), for example, decorin, biglycan, fibromodulin, and lumican, are extracellular matrix organizers and binding partners of TGF-b."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21421073",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1211,
                    "offsetInEndSection": 1518,
                    "text": "In conclusion, this study demonstrates a novel out-in signaling circuit in human osteosarcoma cells: secreted to extracellular matrix lumican is an endogenous inhibitor of TGF-\u03b22 activity, resulting in downstream effector modulation including pSmad 2, integrin \u03b21 and pFAK to regulate osteosarcoma adhesion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12381269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1722,
                    "offsetInEndSection": 1853,
                    "text": "The results indicate that the cysteine-rich domain of lumican is important in collagen fibrillogenesis and stromal matrix assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20138170",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 180,
                    "text": "Lumican is a member of a small leucine-rich proteoglycan (SLRP) family and it regulates the assembly and diameter of collagen fibers in the extracellular matrix of various tissues."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23480731",
                    "endSection": "abstract",
                    "offsetInBeginSection": 129,
                    "offsetInEndSection": 238,
                    "text": "Lumican is an ECM-localized proteoglycan associated with inflammatory conditions and known to bind collagens."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27126993",
                    "endSection": "abstract",
                    "offsetInBeginSection": 374,
                    "offsetInEndSection": 449,
                    "text": "Lumican is a secreted proteoglycan that regulates collagen fibril assembly."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17050378",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 160,
                    "text": "Lumican, a small leucine-rich proteoglycan substituted with keratan sulfate chains is expressed and secreted by human melanoma cells and not normal melanocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15466200",
                    "endSection": "abstract",
                    "offsetInBeginSection": 217,
                    "offsetInEndSection": 409,
                    "text": "Coexpression of MT1-MMP with lumican in HEK293T cells reduced the concentration of lumican secreted into culture medium, and this reduction was abolished by addition of the MMP inhibitor BB94."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22266188",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 364,
                    "text": "Lumican-transfected PANC-1 cells secreted a 70-kDa lumican protein and had an active ERK pathway."
                }
            ]
        },
        {
            "body": "Cytochrome p450 CYP3A is induced by rifampicin  and compounds used to treat what virus?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18799805",
                "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                "http://www.ncbi.nlm.nih.gov/pubmed/10620362",
                "http://www.ncbi.nlm.nih.gov/pubmed/23974699",
                "http://www.ncbi.nlm.nih.gov/pubmed/27490210",
                "http://www.ncbi.nlm.nih.gov/pubmed/26910068",
                "http://www.ncbi.nlm.nih.gov/pubmed/11336977",
                "http://www.ncbi.nlm.nih.gov/pubmed/7614688"
            ],
            "id": "5ab2cc66fcf4565872000015",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7614688",
                    "endSection": "abstract",
                    "offsetInBeginSection": 946,
                    "offsetInEndSection": 1099,
                    "text": "Treatment of cynomolgus monkeys with rifampicin induced hepatic cytochromes P450 related to human CYP3A4 and CYP2C9/10 without inducing CYP1A1 or CYP1A2."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11336977",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Induction of intestinal cytochrome P450 (CYP3A) by rifampicin in beagle dogs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26910068",
                    "endSection": "abstract",
                    "offsetInBeginSection": 352,
                    "offsetInEndSection": 660,
                    "text": "In this investigation, we tested the hypothesis that induction of cytochrome P450 (Cyp)3a11 gene by paclitaxel is downregulated by the inflammatory mediator, lipopolysaccharide (LPS), and that the pro-inflammatory cytokine, tumor necrosis factor (TNF)-\u03b1, attenuates human CYP3A4 gene induction by rifampicin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27490210",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 341,
                    "text": "In this study with crucian carp (Carassius auratus gibelio), the effect on enrofloxacin (EF) and its metabolite ciprofloxacin (CF) and on the activity of cytochrome P450 1A (CYP1A) and cytochrome P450 3A (CYP3A) was estimated following the oral administration of rifampicin (RIF) (12mg/kg) and \u03b2-naphthoflavone (BNF) (12mg/kg), respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9413920",
                    "endSection": "abstract",
                    "offsetInBeginSection": 3,
                    "offsetInEndSection": 158,
                    "text": "The effect of rifampicin on cytochrome P450 isoforms in the CYP1A and CYP3A subfamilies has been studied in 72-h cultured precision-cut human liver slices."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23974699",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 138,
                    "text": "Chronological effects of rifampicin discontinuation on cytochrome P450 activity in healthy Japanese volunteers, using the cocktail method."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23071008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 224,
                    "text": "Induction of the cytochrome P450 (CYP) family of enzymes by coadministered compounds can result in drug-drug interactions, as in the case of the coadministration of rifampicin with many CYP3A substrates, including midazolam."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10620362",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1320,
                    "offsetInEndSection": 1572,
                    "text": "Finally, in both chicken embryo liver and chicken hepatoma cells (LMH), CYP3A37 mRNA was increased after treatment with typical CYP3A inducers, such as metyrapone, phenobarbital, dexamethasone, and pregnenolone 16alpha-carbonitrile, but not rifampicin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15726657",
                    "endSection": "abstract",
                    "offsetInBeginSection": 312,
                    "offsetInEndSection": 489,
                    "text": "Therefore, we compared the induction potential of UDCA with that of the prototypical inducer rifampicin in a human model study with the CYP3A substrates budesonide and cortisol."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799805",
                    "endSection": "abstract",
                    "offsetInBeginSection": 687,
                    "offsetInEndSection": 857,
                    "text": "In TgCYP3A4/hPXR mice, CYP3A4 was strongly induced by rifampicin, a human-specific PXR ligand, but not by pregnenolone 16alpha-carbonitrile, a rodent-specific PXR ligand."
                }
            ]
        },
        {
            "body": "Which human chromosome is the product of fusion?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                "http://www.ncbi.nlm.nih.gov/pubmed/7284984",
                "http://www.ncbi.nlm.nih.gov/pubmed/9310467",
                "http://www.ncbi.nlm.nih.gov/pubmed/3289649",
                "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                "http://www.ncbi.nlm.nih.gov/pubmed/12676087",
                "http://www.ncbi.nlm.nih.gov/pubmed/10470089",
                "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                "http://www.ncbi.nlm.nih.gov/pubmed/15815621"
            ],
            "id": "5ace238e0340b9f05800000d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19332641",
                    "endSection": "abstract",
                    "offsetInBeginSection": 415,
                    "offsetInEndSection": 644,
                    "text": "The recombinant chromosome that harbors the beta/delta fusion gene in elephants is structurally similar to the \"anti-Lepore\" duplication mutant of humans (the reciprocal exchange product of the hemoglobin Lepore deletion mutant)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15815621",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 144,
                    "text": "Human chromosome 2 is unique to the human lineage in being the product of a head-to-head fusion of two intermediate-sized ancestral chromosomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12676087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 77,
                    "text": "Telomeres protect the eukaryotic chromosome ends from degradation and fusion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10470089",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1095,
                    "offsetInEndSection": 1296,
                    "text": "This association between a single viral gene and a specific human fusion transcript indicates a direct link between viral genes and chromosome translocations, one of the hallmarks of many human tumors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3289649",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 265,
                    "text": "The ABL proto-oncogene on the Philadelphia chromosome is 'activated' by its translocation in a manner similar to its activation by the murine Abelson leukemia virus--with the formation of a fusion protein with a new N-terminus and enhanced tyrosine kinase activity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7786792",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "We have recently identified a common ALL patient which harboured a chromosomal fusion between the TEL gene on chromosome 12 and the ABL gene on chromosome 9."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7284984",
                    "endSection": "abstract",
                    "offsetInBeginSection": 205,
                    "offsetInEndSection": 372,
                    "text": "We hypothesize that the near tetraploid chromosome number present in the tumor cells in both patients may be the product of fusion of two near diploid malignant cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9310467",
                    "endSection": "abstract",
                    "offsetInBeginSection": 424,
                    "offsetInEndSection": 660,
                    "text": "We have used here homologous recombination in ES cells to create an in-frame fusion of BCR-ABL(p190) that mimics the consequences of the human chromosomal translocation by fusion of BCR-ABL coding sequences into the bcr endogenous gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3325883",
                    "endSection": "abstract",
                    "offsetInBeginSection": 372,
                    "offsetInEndSection": 592,
                    "text": "The results also demonstrate that the product of the activated met gene is a fusion protein and that the amino terminal end of this fusion protein, which is encoded by human chromosome 1, exhibits homology to laminin B1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27423248",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Human chromosome 2 is a product of a telomere fusion of two ancestral chromosomes and loss/degeneration of one of the two original centromeres."
                }
            ]
        },
        {
            "body": "Where is the EpCam protein mainly located?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                "http://www.ncbi.nlm.nih.gov/pubmed/16054130",
                "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                "http://www.ncbi.nlm.nih.gov/pubmed/19276185",
                "http://www.ncbi.nlm.nih.gov/pubmed/25893293",
                "http://www.ncbi.nlm.nih.gov/pubmed/15555457",
                "http://www.ncbi.nlm.nih.gov/pubmed/20593890",
                "http://www.ncbi.nlm.nih.gov/pubmed/27431859",
                "http://www.ncbi.nlm.nih.gov/pubmed/22388758"
            ],
            "id": "5ac09a7b19833b0d7b000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22388758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 559,
                    "offsetInEndSection": 912,
                    "text": "To test this hypothesis and to evaluate whether lack of EPCAM expression can already be detected in Lynch syndrome-associated adenomas, we analyzed four carcinomas and two adenomas from EPCAM germline deletion carriers for EPCAM protein expression and allelic deletion status of the EPCAM gene region by multiplex ligation-dependent probe amplification."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27431859",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "The epithelial cell adhesion molecule (EpCAM) is a type I glycoprotein located on the surface of epithelial cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25893293",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20593890",
                    "endSection": "abstract",
                    "offsetInBeginSection": 532,
                    "offsetInEndSection": 786,
                    "text": "Reporter plasmids encoding the green fluorescent protein under control of different EpCAM promoter fragments were treated with the TFO-C141S conjugate to determine the specificity of targeted DNA methylation in the context of a functional EpCAM promoter."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19276185",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 756,
                    "text": "A chimeric EpCAM molecule with an exchange of the cytoplasmic and transmembrane domains and an EpCAM molecule with point mutations in an AxxxG motif in the transmembrane region do not associate with claudin-7."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15555457",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 112,
                    "text": "[Construction and expression of human EpCAM eukaryotic expression vectors and identification of their products]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26054340",
                    "endSection": "abstract",
                    "offsetInBeginSection": 112,
                    "offsetInEndSection": 235,
                    "text": "Basolaterally located cld7 is enriched in glycolipid-enriched membrane domains (GEM), where it associates with EpCAM (EpC)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23026194",
                    "endSection": "abstract",
                    "offsetInBeginSection": 478,
                    "offsetInEndSection": 563,
                    "text": "EPCAM protein, expressed in epithelial tissues, is encoded by the EPCAM/TACSTD1 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16054130",
                    "endSection": "abstract",
                    "offsetInBeginSection": 466,
                    "offsetInEndSection": 597,
                    "text": "This 20 kDa protein, which co-precipitated with EpCAM in BSp73ASML lysates, was identified as the tight junction protein claudin-7."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21115857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1381,
                    "offsetInEndSection": 1519,
                    "text": "CONCLUSION\nThese results indicate that loss of EPCAM protein expression is frequent in tumors from patients with EPCAM germline deletions."
                }
            ]
        },
        {
            "body": "What is the drug target for Eliquis (Apixaban)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                "http://www.ncbi.nlm.nih.gov/pubmed/24672216",
                "http://www.ncbi.nlm.nih.gov/pubmed/23305476",
                "http://www.ncbi.nlm.nih.gov/pubmed/26298448",
                "http://www.ncbi.nlm.nih.gov/pubmed/25195485",
                "http://www.ncbi.nlm.nih.gov/pubmed/27984753",
                "http://www.ncbi.nlm.nih.gov/pubmed/26095540"
            ],
            "id": "5abbe429fcf456587200001c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26095540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 216,
                    "offsetInEndSection": 482,
                    "text": "They include the oral direct thrombin inhibitor dabigatran etexilate (Pradaxa, Boehringer Ingelheim) and the oral direct FXa inhibitors rivaroxaban (Xarelto, Bayer HealthCare), apixaban (Eliquis, Bristol-Myers Squibb), and edoxaban (Lixiana/Savaysa, Daiichi-Sankyo)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25195485",
                    "endSection": "abstract",
                    "offsetInBeginSection": 364,
                    "offsetInEndSection": 690,
                    "text": "These new oral anticoagulants fall into two different categories: a direct thrombin inhibitor dabigatran etexilate (Pradaxa Boehringer-Ingelheim, Bracknell, Berkshire) and activated Factor X inhibitors rivaroxaban (Xarelto Bayer HealthCare, Newbury, Berkshire) and apixaban (Eliquis Bristol-Myers Squibb, Uxbridge, Middlesex)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28008269",
                    "endSection": "abstract",
                    "offsetInBeginSection": 692,
                    "offsetInEndSection": 814,
                    "text": "The drugs were dabigatran etexilate mesylate (Pradaxa), rivaroxaban (Xarelto), apixaban (Eliquis), and edoxaban (Savaysa)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24672216",
                    "endSection": "abstract",
                    "offsetInBeginSection": 681,
                    "offsetInEndSection": 760,
                    "text": "Rivaroxaban (Xarelto) was non-inferior to warfarin for stroke prevention in AF."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26298448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 581,
                    "offsetInEndSection": 749,
                    "text": "Cases were initially identified by a search of the poison centers' databases for case mentions involving a human exposure to Xarelto, rivaroxaban, Eliquis, or apixaban."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23305476",
                    "endSection": "abstract",
                    "offsetInBeginSection": 480,
                    "offsetInEndSection": 613,
                    "text": "The search was performed up to 31 December 2011 with the terms rivaroxaban OR Xarelto, apixaban OR Eliquis and dabigatran OR Pradaxa."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27984753",
                    "endSection": "abstract",
                    "offsetInBeginSection": 927,
                    "offsetInEndSection": 1099,
                    "text": "The proposed spectrofluorimetric methods were successfully applied for the determination of apixaban in Eliquis tablets and tirofiban HCl in Aggrastat intravenous infusion."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23821689",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 201,
                    "text": "The new oral anticoagulants dabigatran etexilate (Pradaxa), rivaroxaban (Xarelto), and apixaban (Eliquis) have predictable pharmacokinetic and pharmacodynamic profiles and are alternatives to warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23649961",
                    "endSection": "abstract",
                    "offsetInBeginSection": 245,
                    "offsetInEndSection": 458,
                    "text": "The new oral anticoagulants (NOAC) include dabigatran etexilate (Pradaxa\u00ae), a direct thrombin inhibitor, and rivaroxaban (Xarelto\u00ae), Apixaban (Eliquis) and Edoxaban (Lixiana\u00ae), which are direct anti-Xa inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24624626",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 332,
                    "text": "The new direct oral anticoagulants directly targeting thrombin (factor IIa) or factor-Xa, are currently used for the treatment of deep venous thrombosis and pulmonary embolism (rivaroxaban, Xarelto) or for the prevention of systemic embolism in non-valvular atrial fibrillation (rivaroxaban; dabigatran, Pradaxa; Apixaban, Eliquis)."
                }
            ]
        },
        {
            "body": "What in vivo tau tracers are being used?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                "http://www.ncbi.nlm.nih.gov/pubmed/24833492",
                "http://www.ncbi.nlm.nih.gov/pubmed/28587897",
                "http://www.ncbi.nlm.nih.gov/pubmed/26802556",
                "http://www.ncbi.nlm.nih.gov/pubmed/27683159",
                "http://www.ncbi.nlm.nih.gov/pubmed/28750496",
                "http://www.ncbi.nlm.nih.gov/pubmed/22683529",
                "http://www.ncbi.nlm.nih.gov/pubmed/29564387",
                "http://www.ncbi.nlm.nih.gov/pubmed/26697966"
            ],
            "id": "5a7d5580faa1ab7d2e00001a",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26697966",
                    "endSection": "abstract",
                    "offsetInBeginSection": 256,
                    "offsetInEndSection": 343,
                    "text": "In the past decade, we developed 2-arylquinoline (2-AQ) derivatives as PET tau tracers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29564387",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1493,
                    "offsetInEndSection": 1718,
                    "text": "Development of tau tracers comprises in-depth characterisation of existing radiotracers, clinical validation, a better understanding of uptake patterns, test-retest/dosimetry data, and neuropathological correlations with PET."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22683529",
                    "endSection": "abstract",
                    "offsetInBeginSection": 231,
                    "offsetInEndSection": 477,
                    "text": "While there are a number of amyloid-\u03b2 positron emission tomography (PET) tracers currently in different stages of clinical development and commercialization, there have been very few reports on imaging agents selectively targeting tau aggregates."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25239654",
                    "endSection": "abstract",
                    "offsetInBeginSection": 348,
                    "offsetInEndSection": 496,
                    "text": "Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27683159",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 258,
                    "text": "BACKGROUND\nThe recent development of tau-specific positron emission tomography (PET) tracers has allowed in vivo quantification of regional tau deposition and offers the opportunity to monitor the progression of tau pathology along with cognitive impairment."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28750496",
                    "endSection": "abstract",
                    "offsetInBeginSection": 283,
                    "offsetInEndSection": 384,
                    "text": "The particularities of tau present some unique challenges for the development of tau imaging tracers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26802556",
                    "endSection": "abstract",
                    "offsetInBeginSection": 646,
                    "offsetInEndSection": 802,
                    "text": "Recently, several tau PET tracers have been successfully developed and demonstrated as having high binding affinity and selectivity to tau protein deposits."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28587897",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 191,
                    "text": "The recent development of tau-specific positron emission tomography (PET) tracers enables in vivo quantification of regional tau pathology, one of the key lesions in Alzheimer's disease (AD)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24833492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 526,
                    "offsetInEndSection": 658,
                    "text": "Selective PET radiotracers for amyloid-\u03b2 are already available, and potential tau tracers are emerging as new-generation biomarkers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28219440",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1079,
                    "offsetInEndSection": 1261,
                    "text": "Extensive work remains in order to fully characterize the binding properties of the tau PET tracers, and to assess their usefulness as an early biomarker of the underlying pathology."
                }
            ]
        },
        {
            "body": "What is the Formalin test used for?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                "http://www.ncbi.nlm.nih.gov/pubmed/19762763",
                "http://www.ncbi.nlm.nih.gov/pubmed/20832171",
                "http://www.ncbi.nlm.nih.gov/pubmed/16492837",
                "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                "http://www.ncbi.nlm.nih.gov/pubmed/15105218",
                "http://www.ncbi.nlm.nih.gov/pubmed/18799335"
            ],
            "id": "5abbfd97fcf456587200001d",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9431444",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "The formalin test for nociception, predominantly used with rodents, is characterized by continuous pain due to tissue injury induced by formalin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18799335",
                    "endSection": "abstract",
                    "offsetInBeginSection": 224,
                    "offsetInEndSection": 446,
                    "text": "Log-probit analysis was used to evaluate dose-response effects and calculate the ED(50) values for gabapentin, tiagabine, and their combination at the fixed-ratio of 1:1 in the phases I and II of the formalin test in mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1484716",
                    "endSection": "abstract",
                    "offsetInBeginSection": 110,
                    "offsetInEndSection": 318,
                    "text": "The formalin test, which is based on these observations, is now widely used as a model of pain produced by tissue injury, but the neural mechanisms of pain and analgesia in this test have not been identified."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16492837",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1092,
                    "offsetInEndSection": 1321,
                    "text": "This is a demonstration of USV during the formalin test, allowing the inclusion of an additional nonreflex behavioral measure to help characterize more clinically relevant integrated behavioral patterns in this rat model of pain."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15105218",
                    "endSection": "abstract",
                    "offsetInBeginSection": 549,
                    "offsetInEndSection": 681,
                    "text": "Intrathecal gabapentin produced a suppression of the phase 2 flinching response, but not the phase 1 response, in the formalin test."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20832171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 197,
                    "text": "Although the formalin test is a widely used model of persistent pain, the primary afferent fiber types that underlie the cellular and behavioral responses to formalin injection are largely unknown."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17166125",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1480,
                    "offsetInEndSection": 1725,
                    "text": "In the present acute test conditions, there is a correlation in the pharmacological activity in rats and gerbils for the tested compounds a correlation between the second phase of the formalin test and the cold allodynia in CCI animals is found."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19762763",
                    "endSection": "abstract",
                    "offsetInBeginSection": 208,
                    "offsetInEndSection": 300,
                    "text": "We investigated, in a formalin test, whether pERK of the dorsal horn is affected by licking."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19168051",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 135,
                    "text": "The formalin test is used as a primary behavioural screen for assaying the antinociceptive activity of compounds in laboratory rodents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2247320",
                    "endSection": "abstract",
                    "offsetInBeginSection": 451,
                    "offsetInEndSection": 600,
                    "text": "The ability of the test to show the antinociceptive effect of morphine and acetylsalicylic acid was similar for high and low formalin concentrations."
                }
            ]
        },
        {
            "body": "What drug treatment can cause a spinal epidural hematoma?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                "http://www.ncbi.nlm.nih.gov/pubmed/21082060",
                "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                "http://www.ncbi.nlm.nih.gov/pubmed/8447556",
                "http://www.ncbi.nlm.nih.gov/pubmed/27495842",
                "http://www.ncbi.nlm.nih.gov/pubmed/19830087",
                "http://www.ncbi.nlm.nih.gov/pubmed/28357164",
                "http://www.ncbi.nlm.nih.gov/pubmed/25230268",
                "http://www.ncbi.nlm.nih.gov/pubmed/19462797",
                "http://www.ncbi.nlm.nih.gov/pubmed/21799620"
            ],
            "id": "5ab90a79fcf456587200001b",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21799620",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Drug interaction as cause of spontaneously resolving epidural spinal hematoma on warfarin therapy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25230268",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 198,
                    "text": "OBJECTIVE\nThe aim of this study was to assess the clinical presentation, causes or risk factors, treatment and outcomes of symptomatic acute postoperative cervical spinal epidural hematoma (APCSEH)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19462797",
                    "endSection": "abstract",
                    "offsetInBeginSection": 808,
                    "offsetInEndSection": 1010,
                    "text": "Especially, epidural hematoma and epidural abcess have possibility to cause nerve defect symptoms such as motor paralysis and sensory disturbance if appropriate treatment was not started in early stage."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28357164",
                    "endSection": "abstract",
                    "offsetInBeginSection": 856,
                    "offsetInEndSection": 1005,
                    "text": "Anticoagulant therapy is an important predisposing risk factor for spinal epidural hematomas and likely also predispose to spinal subdural hematomas."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19830087",
                    "endSection": "abstract",
                    "offsetInBeginSection": 792,
                    "offsetInEndSection": 887,
                    "text": "The incidence of epidural hematoma after spinal surgery is rare, but very serious complication."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27495842",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Full-Endoscopic Transforaminal Approach for Removal of a Spontaneous Spinal Epidural Hematoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21082060",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1079,
                    "offsetInEndSection": 1161,
                    "text": "Surgical treatment is an effective option to resolve the spinal epidural hematoma."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8447556",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "PURPOSE\nAlthough intracranial hemorrhage remains a leading cause of death in hemophilia, spinal epidural hematoma is seen rarely."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15043358",
                    "endSection": "abstract",
                    "offsetInBeginSection": 291,
                    "offsetInEndSection": 511,
                    "text": "Spontaneous spinal epidural hematoma should be suspected in any patient receiving anticoagulant agents who complains of local or referred spinal pain associated with limb weakness, sensory deficits, or urinary retention."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11707724",
                    "endSection": "abstract",
                    "offsetInBeginSection": 187,
                    "offsetInEndSection": 276,
                    "text": "SUMMARY OF BACKGROUND DATA\nThe treatment of spinal epidural hematoma is usually surgical."
                }
            ]
        },
        {
            "body": "List diseases caused by protein glutamine expanded repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                "http://www.ncbi.nlm.nih.gov/pubmed/7604023",
                "http://www.ncbi.nlm.nih.gov/pubmed/9536080",
                "http://www.ncbi.nlm.nih.gov/pubmed/21610160",
                "http://www.ncbi.nlm.nih.gov/pubmed/9536081",
                "http://www.ncbi.nlm.nih.gov/pubmed/19692580",
                "http://www.ncbi.nlm.nih.gov/pubmed/11448943",
                "http://www.ncbi.nlm.nih.gov/pubmed/15639784",
                "http://www.ncbi.nlm.nih.gov/pubmed/9143016"
            ],
            "id": "5ac2776195d0062724000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11448943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 281,
                    "offsetInEndSection": 454,
                    "text": "Members of this latter group, also known as triplet repeat diseases, are caused by the expansion of unstable CAG repeats coding for glutamine within the respective proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21610160",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Expanded glutamine repeats of the ataxin-2 (ATXN2) protein cause spinocerebellar ataxia type 2 (SCA2), a rare neurodegenerative disorder."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15639784",
                    "endSection": "abstract",
                    "offsetInBeginSection": 782,
                    "offsetInEndSection": 1206,
                    "text": "The size of the polyglutamine bearing protein also inversely influences the binding of 1C2 antibody (an antibody that selectively recognizes polyglutamine expansion) to the polyglutamine protein and determines the minimum length of glutamine expansion to be recognized by 1C2 antibody, which suggests that the critical pathological range of glutamine repeats could also be dependent on the size of the corresponding protein."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9143016",
                    "endSection": "abstract",
                    "offsetInBeginSection": 118,
                    "offsetInEndSection": 321,
                    "text": "The mutant gene is translated into protein whose electrophoretic mobility correlates to the number of expanded CAG trinucleotide repeats, indicating that the protein carries an expanded glutamine repeat."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7604023",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 106,
                    "text": "Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19692580",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1437,
                    "offsetInEndSection": 1747,
                    "text": "Our studies demonstrate the occurrence of hormone-dependent alterations in RNA splicing in Kennedy disease models, and they indicate that these changes are mediated by both the cell-autonomous effects of the expanded glutamine AR protein and by alterations in skeletal muscle that are secondary to denervation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8202492",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "Four inherited neurodegenerative diseases are linked to abnormally expanded repeats of glutamine residues in the affected proteins."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536081",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 133,
                    "text": "Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9536080",
                    "endSection": "abstract",
                    "offsetInBeginSection": 547,
                    "offsetInEndSection": 834,
                    "text": "By expressing a series of huntingtin constructs encoding various glutamine repeats (23-150 units) in cultured cells we observed N-terminal fragments of huntingtin (amino acids 1-67 and 1-212), but not full-length huntingtins, with glutamine repeats >/=66 units formed protein aggregates."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9932422",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 114,
                    "text": "Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions."
                }
            ]
        },
        {
            "body": "What is the nucleotide composition of the Lamin Associated Domains (LADs)?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                "http://www.ncbi.nlm.nih.gov/pubmed/23934658",
                "http://www.ncbi.nlm.nih.gov/pubmed/28424353",
                "http://www.ncbi.nlm.nih.gov/pubmed/26798136",
                "http://www.ncbi.nlm.nih.gov/pubmed/25559185",
                "http://www.ncbi.nlm.nih.gov/pubmed/23964094",
                "http://www.ncbi.nlm.nih.gov/pubmed/22726435",
                "http://www.ncbi.nlm.nih.gov/pubmed/26883443",
                "http://www.ncbi.nlm.nih.gov/pubmed/25784758"
            ],
            "id": "5a86e6fafaa1ab7d2e000036",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23964094",
                    "endSection": "abstract",
                    "offsetInBeginSection": 455,
                    "offsetInEndSection": 669,
                    "text": "Genome-wide mapping reveals that LMNB1 is depleted during senescence, preferentially from the central regions of lamina-associated domains (LADs), which are enriched for Lys9 trimethylation on histone H3 (H3K9me3)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25784758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 179,
                    "text": "In mammals, the nuclear lamina interacts with hundreds of large genomic regions, termed lamina-associated domains (LADs) that are generally in a transcriptionally repressed state."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28424353",
                    "endSection": "abstract",
                    "offsetInBeginSection": 474,
                    "offsetInEndSection": 697,
                    "text": "To address this, we mapped LADs using Lamin B1-DamID during Jurkat T-cell activation, finding significant genome reorganization at the nuclear periphery dominated by release of loci frequently important for T-cell function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22726435",
                    "endSection": "abstract",
                    "offsetInBeginSection": 218,
                    "offsetInEndSection": 450,
                    "text": "Using genomic repositioning assays, we show that LADs, spanning the developmentally regulated IgH and Cyp3a loci contain discrete DNA regions that associate chromatin with the nuclear lamina and repress gene activity in fibroblasts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26798136",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Lamins are components of the peripheral nuclear lamina and interact with heterochromatic genomic regions, termed lamina-associated domains (LADs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26883443",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1596,
                    "offsetInEndSection": 1767,
                    "text": "We suggest that in somatic cells lamin B1 meshwork growth is coordinated with replication of LADs, and lamin A meshwork assembly seems to be chromatin-independent process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23934658",
                    "endSection": "abstract",
                    "offsetInBeginSection": 602,
                    "offsetInEndSection": 855,
                    "text": "Mesas form at lamin B1-associated domains (LADs) in replicative senescence and oncogene-induced senescence and overlap DNA hypomethylation regions in cancer, suggesting that pre-malignant senescent chromatin changes foreshadow epigenetic cancer changes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25559185",
                    "endSection": "abstract",
                    "offsetInBeginSection": 313,
                    "offsetInEndSection": 518,
                    "text": "We use our tagged chromosomal insertion site system to identify small sequences from borders of fibroblast-specific variable LADs that are sufficient to target these ectopic sites to the nuclear periphery."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26359231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 856,
                    "offsetInEndSection": 1006,
                    "text": "De novo formation of adipogenic lamin A/C LADs occurs nonrandomly on GADs, which consist of megabase-size intergenic and repressive chromatin domains."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25602132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1298,
                    "offsetInEndSection": 1540,
                    "text": "Comparison of published LMNB1 DamID LADs with LMNB1 and LMNA LiDs identified here by ChIP-seq further shows that LMNA can associate with 'open' chromatin domains displaying euchromatin characteristics, and which are not associated with LMNB1."
                }
            ]
        },
        {
            "body": "What is the clathrin triskelia structure?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/7738035",
                "http://www.ncbi.nlm.nih.gov/pubmed/7674375",
                "http://www.ncbi.nlm.nih.gov/pubmed/19925798",
                "http://www.ncbi.nlm.nih.gov/pubmed/1587861",
                "http://www.ncbi.nlm.nih.gov/pubmed/18502808",
                "http://www.ncbi.nlm.nih.gov/pubmed/2868889",
                "http://www.ncbi.nlm.nih.gov/pubmed/23270814",
                "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                "http://www.ncbi.nlm.nih.gov/pubmed/27410749",
                "http://www.ncbi.nlm.nih.gov/pubmed/2571614"
            ],
            "id": "5ad4dd93133db5eb78000008",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27410749",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 115,
                    "text": "The assembly of clathrin triskelia into polyhedral cages during endocytosis is regulated by adaptor proteins (APs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2868889",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 255,
                    "text": "It is shown that in immunological, structural and functional terms the uncoating protein, which catalyses ATP-dependent dissociation of clathrin triskelia from clathrin-coated vesicles is intimately related to two major stress proteins of mammalian cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2571614",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 145,
                    "text": "Trimeric binding of the 70-kD uncoating ATPase to the vertices of clathrin triskelia: a candidate intermediate in the vesicle uncoating reaction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23270814",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 253,
                    "text": "Atomic force microscopy (AFM), single molecule force spectroscopy (SMFS), and single particle force spectroscopy (SPFS) are used to characterize intermolecular interactions and domain structures of clathrin triskelia and clathrin-coated vesicles (CCVs)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19925798",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 107,
                    "text": "Atomic force microscopy (AFM) is used to characterize the structure and interactions of clathrin triskelia."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18502808",
                    "endSection": "abstract",
                    "offsetInBeginSection": 314,
                    "offsetInEndSection": 591,
                    "text": "Recent static light scattering and dynamic light scattering studies of triskelia in solution showed that an individual triskelion has an intrinsic pucker similar to, but differing from, that inferred from a high resolution cryoEM structure of a triskelion in a clathrin basket."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7674375",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1186,
                    "offsetInEndSection": 1377,
                    "text": "We find that the bacterially expressed 33 kD NH2-terminus of F1-20/AP-3 binds to clathrin triskelia, fails to bind to preassembled clathrin cages, and is not sufficient for clathrin assembly."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1587861",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 118,
                    "text": "AP-2 and AP-3 are cellular proteins that drive the in vitro polymerization of clathrin triskelia into cage structures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22563470",
                    "endSection": "abstract",
                    "offsetInBeginSection": 657,
                    "offsetInEndSection": 784,
                    "text": "Clathrin triskelia and cages were characterized by size, structure, protein concentration, and chelate and gadolinium contents."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7738035",
                    "endSection": "abstract",
                    "offsetInBeginSection": 228,
                    "offsetInEndSection": 419,
                    "text": "The 58-kDa C-terminal region of AP-3 is able to bind to clathrin triskelia and assemble them into a homogeneous population of clathrin cages and will also bind to preassembled clathrin cages."
                }
            ]
        },
        {
            "body": "What is myelin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/6191815",
                "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                "http://www.ncbi.nlm.nih.gov/pubmed/4141622",
                "http://www.ncbi.nlm.nih.gov/pubmed/22102008",
                "http://www.ncbi.nlm.nih.gov/pubmed/6203931",
                "http://www.ncbi.nlm.nih.gov/pubmed/21401967",
                "http://www.ncbi.nlm.nih.gov/pubmed/24684721",
                "http://www.ncbi.nlm.nih.gov/pubmed/12605409",
                "http://www.ncbi.nlm.nih.gov/pubmed/27417284",
                "http://www.ncbi.nlm.nih.gov/pubmed/20487834"
            ],
            "id": "5abcf108fcf4565872000025",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12605409",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 155,
                    "text": "Proteolipid protein (PLP) is the primary protein component of CNS myelin, yet myelin from the PLP(null) mouse has only minor ultrastructural abnormalities."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27417284",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Novel molecular insights into the critical role of sulfatide in myelin maintenance/function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20487834",
                    "endSection": "abstract",
                    "offsetInBeginSection": 637,
                    "offsetInEndSection": 761,
                    "text": "In experimental demyelination and multiple sclerosis, the major glycoprotein is the first myelin constituent to be affected."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24684721",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "BACKGROUND\nThe pathological hallmark of multiple sclerosis (MS) is myelin phagocytosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21401967",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1859,
                    "offsetInEndSection": 1963,
                    "text": "Thus, myelin CD47 produces SIRP\u03b1-dependent down-regulation of CD47+/+ myelin phagocytosis in phagocytes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22102008",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Performing 2-DE of lipid-rich multilamellar membranes like myelin is a cumbersome task."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4141622",
                    "endSection": "title",
                    "offsetInBeginSection": 29,
                    "offsetInEndSection": 83,
                    "text": "Evidence for a precursor role of a myelin subfraction."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6203931",
                    "endSection": "abstract",
                    "offsetInBeginSection": 961,
                    "offsetInEndSection": 1123,
                    "text": "A few myelin basic protein or myelin-associated glycoprotein-containing oligodendrocytes were seen in lesion areas and remyelination by oligodendrocytes was rare."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6191815",
                    "endSection": "abstract",
                    "offsetInBeginSection": 323,
                    "offsetInEndSection": 383,
                    "text": "Myelin basic protein (MBP) was nearly missing in mld myelin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28377211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 454,
                    "offsetInEndSection": 649,
                    "text": "To investigate what MWF measures in the presence of debris, we compared MWF to transmission electron microscopy (TEM) derived myelin fraction that measures the amount of compact appearing myelin."
                }
            ]
        },
        {
            "body": "Is Brucella abortus the organism that causes brucillosis known to cause spontaneous abortions in humans?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                "http://www.ncbi.nlm.nih.gov/pubmed/23942901",
                "http://www.ncbi.nlm.nih.gov/pubmed/17296251",
                "http://www.ncbi.nlm.nih.gov/pubmed/16739129",
                "http://www.ncbi.nlm.nih.gov/pubmed/4882024",
                "http://www.ncbi.nlm.nih.gov/pubmed/23837364",
                "http://www.ncbi.nlm.nih.gov/pubmed/4295848",
                "http://www.ncbi.nlm.nih.gov/pubmed/20117540",
                "http://www.ncbi.nlm.nih.gov/pubmed/18501554",
                "http://www.ncbi.nlm.nih.gov/pubmed/24994009"
            ],
            "id": "5aa6800ad6d6b54f79000011",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24994009",
                    "endSection": "abstract",
                    "offsetInBeginSection": 94,
                    "offsetInEndSection": 215,
                    "text": "However, the current Brucella abortus vaccines (S19 and RB51) are deficient; they can cause abortion in pregnant animals."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18501554",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 113,
                    "text": "Expression of heme oxygenase-1 is associated with abortion caused by Brucella abortus infection in pregnant mice."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4295848",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 240,
                    "text": "The use of whole-cell antigens in agglutination and agglutinin-absorption tests showed that the organism causing abortion in dogs is similar to rough Brucella abortus, B. melitensis, and B. ovis, but different from smooth Brucella cultures."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20117540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 143,
                    "text": "Infection of cattle caused by Brucella abortus (ie, bovine brucellosis) has been of political importance in the United States for many decades."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23837364",
                    "endSection": "abstract",
                    "offsetInBeginSection": 91,
                    "offsetInEndSection": 342,
                    "text": "Brucella melitensis, B. abortus and B. suis, which are transmitted between animals both vertically and horizontally, cause abortion and infertility in their primary natural hosts - goats and sheep (B. melitensis), cows (B. abortus) and sows (B. suis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/4882024",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 258,
                    "text": "The bacterium that causes canine abortion has polynucleotide sequences similar, in deoxyribonucleic acid (DNA)-DNA homology studies, to those of Brucella suis and, by inference from previous data, those of B. abortus and B. melitensis as well as B. neotomae."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16739129",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 125,
                    "text": "Brucella abortus is the etiologic agent of bovine brucellosis and causes a chronic disease in humans known as undulant fever."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17296251",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 177,
                    "text": "Brucella abortus, a facultative intracellular pathogen, is of tremendous zoonotic importance because of its ability to induce spontaneous abortion in cattle and other livestock."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23942901",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 95,
                    "text": "Abortion and premature birth in cattle following vaccination with Brucella abortus strain RB51."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25566611",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1590,
                    "offsetInEndSection": 1720,
                    "text": "In conclusion, Brucella abortus cannot cause spontaneous abortion by altering the mouse cytokine profile towards Th1 in pregnancy."
                }
            ]
        },
        {
            "body": "What percentage of Homo sapiens DNA is of Neanderthal origin?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                "http://www.ncbi.nlm.nih.gov/pubmed/21445243",
                "http://www.ncbi.nlm.nih.gov/pubmed/21078988",
                "http://www.ncbi.nlm.nih.gov/pubmed/14745010",
                "http://www.ncbi.nlm.nih.gov/pubmed/12802332"
            ],
            "id": "5ace1a590340b9f05800000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12802332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 157,
                    "text": "The origin of anatomically modern Homo sapiens and the fate of Neanderthals have been fundamental questions in human evolutionary studies for over a century."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14745010",
                    "endSection": "abstract",
                    "offsetInBeginSection": 240,
                    "offsetInEndSection": 424,
                    "text": "Adherents to the regional continuity model consider Neanderthals a subspecies or population of Homo sapiens, which contributed significantly to the evolution of early modern Europeans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21445243",
                    "endSection": "abstract",
                    "offsetInBeginSection": 975,
                    "offsetInEndSection": 1315,
                    "text": "Based on comparisons with modern hunter-gatherer populations with known diets, Neanderthals as well as early Homo sapiens show high dietary variability in Mediterranean evergreen habitats but a more restricted diet in upper latitude steppe/coniferous forest environments, suggesting a significant consumption of high protein meat resources."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21404232",
                    "endSection": "abstract",
                    "offsetInBeginSection": 243,
                    "offsetInEndSection": 499,
                    "text": "However, while anatomical differences between Neanderthal suprainiac fossa and the depression in the inion region of the occipital bone of fossil and recent Homo sapiens have been discussed in detail, the etiology of these structures has not been resolved."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18768141",
                    "endSection": "abstract",
                    "offsetInBeginSection": 813,
                    "offsetInEndSection": 997,
                    "text": "We show that the power to reject ancient admixture increases as the ratio, at the time of putative admixture, of the population size of Homo sapiens over that of Neanderthal decreases."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21078988",
                    "endSection": "abstract",
                    "offsetInBeginSection": 534,
                    "offsetInEndSection": 672,
                    "text": "Dental development in later Homo species has been intensely debated, most notably the issue of whether Neanderthals and H. sapiens differ."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27429943",
                    "endSection": "abstract",
                    "offsetInBeginSection": 289,
                    "offsetInEndSection": 524,
                    "text": "The availability of edible insects in East Asia aided the spread of the unaggressive, highly cooperative Neanderthals, who interbred with H. sapiens in Asia, resulting in a higher admixture of Neanderthal DNA in East Asian populations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10788336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 146,
                    "offsetInEndSection": 565,
                    "text": "When hybridized with genomic DNA of either human or Neanderthal origin, DNA extracted from two Neanderthal finds-the Os parietale, from Warendorf-Neuwarendorf, Germany, and a clavicula, from Krapina, Croatia-was shown to yield hybridization signals that differ by at least a factor of two compared to the signals obtained with the use of fossil DNA of an early Homo sapiens from the Vogelherd cave (Stetten I), Germany."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17110569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 381,
                    "offsetInEndSection": 674,
                    "text": "Several lines of evidence indicate that the 65,250 base pairs of hominid sequence so far identified in the library are of Neanderthal origin, the strongest being the ascertainment of sequence identities between Neanderthal and chimpanzee at sites where the human genomic sequence is different."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17146600",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 246,
                    "text": "The retrieval of Neanderthal (Homo neanderthalsensis) mitochondrial DNA is thought to be among the most significant ancient DNA contributions to date, allowing conflicting hypotheses on modern human (Homo sapiens) evolution to be tested directly."
                }
            ]
        },
        {
            "body": "What is Dupuytren's contracture?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                "http://www.ncbi.nlm.nih.gov/pubmed/18453667",
                "http://www.ncbi.nlm.nih.gov/pubmed/21935843",
                "http://www.ncbi.nlm.nih.gov/pubmed/1960490",
                "http://www.ncbi.nlm.nih.gov/pubmed/22872850",
                "http://www.ncbi.nlm.nih.gov/pubmed/10409813",
                "http://www.ncbi.nlm.nih.gov/pubmed/3437199",
                "http://www.ncbi.nlm.nih.gov/pubmed/6380478",
                "http://www.ncbi.nlm.nih.gov/pubmed/24024053"
            ],
            "id": "5abcf66afcf4565872000026",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3437199",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 49,
                    "text": "Conservative surgery for Dupuytren's contracture."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18453667",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 48,
                    "text": "Needle aponeurotomy for Dupuytren's contracture."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6380478",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 46,
                    "text": "'Firebreak' grafts in Dupuytren's contracture."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24024053",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 72,
                    "text": "Dupuytren's Contracture Cosegregation with Limb-Girdle Muscle Dystrophy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22872850",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1374,
                    "offsetInEndSection": 1503,
                    "text": "Therefore, segmental fasciectomies with multiple transverse incisions can be a good treatment option for Dupuytren's contracture."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21935843",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "[Collagenase Clostridum histolyticum in the management of Dupuytren's contracture]."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1960490",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 48,
                    "text": "The collagen changes of Dupuytren's contracture."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/3336640",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 49,
                    "text": "Rheumatoid arthritis and Dupuytren's contracture."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10409813",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "Comparison of palmar aponeuroses from individuals with diabetes mellitus and Dupuytren's contracture."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21992150",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 129,
                    "text": "BACKGROUND\nDupuytren's contracture is a condition of the palmar fascia involving contractures of the fascia and skin in the hand."
                }
            ]
        },
        {
            "body": "What phenotype is associated with the V60L mutation in the human MC1R gene?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                "http://www.ncbi.nlm.nih.gov/pubmed/25794181",
                "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                "http://www.ncbi.nlm.nih.gov/pubmed/16567973",
                "http://www.ncbi.nlm.nih.gov/pubmed/26103569",
                "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                "http://www.ncbi.nlm.nih.gov/pubmed/12851336"
            ],
            "id": "5ace2d600340b9f05800000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12851336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 280,
                    "text": "The characterization of the melanocortin 1 receptor (MC1R) expressed on human melanocytes and the findings that certain mutations in the POMC gene or the MC1R gene result in red hair phenotype underscore the significance of melanocortins and MC1R in regulating human pigmentation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12876664",
                    "endSection": "abstract",
                    "offsetInBeginSection": 841,
                    "offsetInEndSection": 1114,
                    "text": "Mutations in the P gene were responsible for classic phenotype of oculocutaneous albinism type 2 (OCA2) in all eight, and mutations in the MC1R gene were responsible for the red (rather than yellow/blond) hair in the six of eight who continued to have red hair after birth."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11030758",
                    "endSection": "abstract",
                    "offsetInBeginSection": 319,
                    "offsetInEndSection": 633,
                    "text": "We have investigated 174 individuals from 11 large kindreds with a preponderance of red hair and an additional 99 unrelated redheads, for MC1R variants and have confirmed that red hair is usually inherited as a recessive characteristic with the R151C, R160W, D294H, R142H, 86insA and 537insC alleles at this locus."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17616515",
                    "endSection": "abstract",
                    "offsetInBeginSection": 218,
                    "offsetInEndSection": 424,
                    "text": "We have performed a systematic functional analysis of nine common MC1R variants and correlated these results with the strength of the genetic association of each variant allele with pigmentation phenotypes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16567973",
                    "endSection": "abstract",
                    "offsetInBeginSection": 990,
                    "offsetInEndSection": 1244,
                    "text": "Carriers of high-penetrance 'R' MC1R alleles, that define MC1R variants strongly associated with the red hair colour phenotype, showed a statistically significant increase in melanoma risk [odds ratio (OR), 2.55; 95% confidence interval (CI), 1.19-5.55]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26103569",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1316,
                    "offsetInEndSection": 1470,
                    "text": "CONCLUSIONS\nOur pooled-analysis highlighted a role of MC1R variants in NMSC development and suggested an effect modification by red hair colour phenotype."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15972726",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1408,
                    "offsetInEndSection": 1659,
                    "text": "These results indicate that reduced receptor coupling activity may not be the only contributing factor to the genetic association between the MC1R variants and the RHC phenotype, with MC1R polymorphisms now linked to a change in receptor localization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25794181",
                    "endSection": "abstract",
                    "offsetInBeginSection": 732,
                    "offsetInEndSection": 1244,
                    "text": "The R variants D84E, R142H, R151C, I155T, R160W and D294H were classified as damaging by the majority of the tools while the r variants V60L, V92M and R163Q have been predicted as neutral in most of the programs The combination of the prediction tools results in 14 nsSNPs indicated as the most damaging mutations in MC1R (L48P, R67W, H70Y, P72L, S83P, R151H, S172I, L206P, T242I, G255R, P256S, C273Y, C289R and R306H); C273Y showed to be highly damaging in SIFT, Polyphen-2, MutPred, PANTHER and PROVEAN scores."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24045876",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 137,
                    "text": "Simultaneous purifying selection on the ancestral MC1R allele and positive selection on the melanoma-risk allele V60L in south Europeans."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20876876",
                    "endSection": "abstract",
                    "offsetInBeginSection": 700,
                    "offsetInEndSection": 1019,
                    "text": "In this family-based study, we assessed the associations of the four most frequent MC1R variants (V60L, V92M, R151C, and R160W) and the number of variants (1, \u22652 variants), alone or jointly with the host phenotypes (hair color, propensity to sunburn, and number of nevi), with melanoma risk in CDKN2A mutation carriers."
                }
            ]
        },
        {
            "body": "List proteins with HEAT repeats",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                "http://www.ncbi.nlm.nih.gov/pubmed/11491282",
                "http://www.ncbi.nlm.nih.gov/pubmed/27802131",
                "http://www.ncbi.nlm.nih.gov/pubmed/20887736",
                "http://www.ncbi.nlm.nih.gov/pubmed/20060908",
                "http://www.ncbi.nlm.nih.gov/pubmed/23895768",
                "http://www.ncbi.nlm.nih.gov/pubmed/25435324"
            ],
            "id": "5abd44b1fcf4565872000030",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25435324",
                    "endSection": "abstract",
                    "offsetInBeginSection": 385,
                    "offsetInEndSection": 632,
                    "text": "An in vitro transport assay and FRAP analyses demonstrated that not only karyopherin \u03b2 family proteins but also other proteins with HEAT repeats could pass through the NPC by themselves, and serve as transport mediators for their binding partners."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20060908",
                    "endSection": "abstract",
                    "offsetInBeginSection": 149,
                    "offsetInEndSection": 383,
                    "text": "This strategy uses multiple HHpred alignments against proteins of known 3D structure to enable protein repeats referenced from the 3D structure to be traced back to the query protein sequence by using user-directed repeat assignments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20887736",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 314,
                    "text": "HEAT repeat proteins, although very common, have not been used as a scaffold for artificial proteins, probably because they are made of long and irregular repeats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14970380",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 90,
                    "text": "The Noc proteins involved in ribosome synthesis and export contain divergent HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27802131",
                    "endSection": "abstract",
                    "offsetInBeginSection": 393,
                    "offsetInEndSection": 723,
                    "text": "In this Opinion article, we will focus on HEAT repeats, flexible arrays of amphiphilic helices found in many eukaryotic proteins, such as karyopherins and condensins, and discuss how these uniquely designed helical repeats might underlie dynamic protein-protein interactions and support cellular functions in crowded environments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23895768",
                    "endSection": "abstract",
                    "offsetInBeginSection": 514,
                    "offsetInEndSection": 709,
                    "text": "A structure-based sequence alignment of the \u03b1-helical repeats identified a conserved pattern of hydrophobic or aliphatic residues reminiscent of the consensus sequence of eukaryotic HEAT repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11042144",
                    "endSection": "abstract",
                    "offsetInBeginSection": 155,
                    "offsetInEndSection": 438,
                    "text": "Using sensitive sequence analysis techniques we detected HEAT repeats in various chromosome-associated proteins, including four families of proteins associated with condensins and cohesins, which are nuclear complexes that contain structural maintenance of chromosome (SMC) proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11491282",
                    "endSection": "abstract",
                    "offsetInBeginSection": 724,
                    "offsetInEndSection": 976,
                    "text": "Inspection of these profiles indicated that the individual repeat motifs of all four classes share a common set of seven highly conserved hydrophobic residues, which in proteins of known three-dimensional structure are buried within or between repeats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24053231",
                    "endSection": "abstract",
                    "offsetInBeginSection": 230,
                    "offsetInEndSection": 462,
                    "text": "In order to investigate the origin of the stability of these proteins, we dissect the subdomain architecture of the giant repeat protein PR65/A, which comprises 15 \u03b1-helical HEAT repeats, using a series of truncations and deletions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19777061",
                    "endSection": "abstract",
                    "offsetInBeginSection": 332,
                    "offsetInEndSection": 552,
                    "text": "However, methods using single sequence queries do not have the sensitivity required to deal with more divergent repeats and, when applied to proteins with known structures, in some cases failed to detect a single repeat."
                }
            ]
        },
        {
            "body": "What is the aim of  perfoming a \"cycloheximide chase assay\"?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                "http://www.ncbi.nlm.nih.gov/pubmed/19151744",
                "http://www.ncbi.nlm.nih.gov/pubmed/16081639",
                "http://www.ncbi.nlm.nih.gov/pubmed/26599052",
                "http://www.ncbi.nlm.nih.gov/pubmed/28880013",
                "http://www.ncbi.nlm.nih.gov/pubmed/16925598",
                "http://www.ncbi.nlm.nih.gov/pubmed/27987332",
                "http://www.ncbi.nlm.nih.gov/pubmed/9143349"
            ],
            "id": "5ac08478d0c506ce46000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28880013",
                    "endSection": "abstract",
                    "offsetInBeginSection": 718,
                    "offsetInEndSection": 1192,
                    "text": "After blocking transcription and translation processes with actinomycin D and cycloheximide, respectively, osimertinib continued to reduce the expression of PD-L1, demonstrating that osimertinib might degrade PD-L1 at the post-translational level, which was confirmed by a cycloheximide chase assay, revealing that osimertinib (125 nmol/L) decreased the half-life of PD-L1 from approximately 17.8 h and 13.8 h to 8.6 h and 4.6 h, respectively, in NCI-H1975 and HCC827 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16925598",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1244,
                    "offsetInEndSection": 1361,
                    "text": "Finally, we show that Renilla luciferase may serve as a reporter of protein stability in a cycloheximide chase assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9143349",
                    "endSection": "abstract",
                    "offsetInBeginSection": 223,
                    "offsetInEndSection": 460,
                    "text": "Two methods were used to study the CYP2E1 turnover; after addition of cycloheximide, the half-life of the CYP2E1 in the intact cells was about 6 h as detected by PNP catalytic activity assay and immunoblot analysis of apoprotein content."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27987332",
                    "endSection": "abstract",
                    "offsetInBeginSection": 298,
                    "offsetInEndSection": 434,
                    "text": "To this end, we investigated the effects of the inhibition of Cullin E3 ligases, by using inhibitors and knockdown techniques in HUVECs."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26599052",
                    "endSection": "abstract",
                    "offsetInBeginSection": 480,
                    "offsetInEndSection": 784,
                    "text": "In this study, we found that cycloheximide treatment induced mild activation of a ZVAD-sensitive protease in Drosophila Kc cells, resulting in cleavage of tau at its C-terminus; this cleavage could generate misleading tau protein degradation pattern results depending on the antibodies used in the assay."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16081639",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1391,
                    "offsetInEndSection": 1656,
                    "text": "To address these potential mechanisms, metabolic pulse-chase labeling experiments and experiments in which the fate of previously synthesized GHR was followed by anti-GHR immunoblotting after cycloheximide treatment (cycloheximide chase experiments) were performed."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29122887",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 245,
                    "text": "Although it is widely appreciated that the use of global translation inhibitors, such as cycloheximide, in protein degradation assays may result in artefacts, these inhibitors continue to be employed, owing to the absence of robust alternatives."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151744",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1649,
                    "offsetInEndSection": 1802,
                    "text": "Furthermore, the cycloheximide chase assay indicated that the degradation of Bcl-2 protein was extended in the BAG-1 p50 and p46 transfected MCF-7 cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27167179",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1023,
                    "offsetInEndSection": 1172,
                    "text": "The cycloheximide chase procedure permits visualization of the degradation kinetics of the steady state population of a variety of cellular proteins."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/29082276",
                    "endSection": "abstract",
                    "offsetInBeginSection": 328,
                    "offsetInEndSection": 452,
                    "text": "Here we present a full cycloheximide chase assay in our laboratory using a lung adenocarcinoma cell line, CL1-5, as a model."
                }
            ]
        },
        {
            "body": "What is an exosome?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26725667",
                "http://www.ncbi.nlm.nih.gov/pubmed/23376832",
                "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                "http://www.ncbi.nlm.nih.gov/pubmed/27348448",
                "http://www.ncbi.nlm.nih.gov/pubmed/27756426",
                "http://www.ncbi.nlm.nih.gov/pubmed/24462375",
                "http://www.ncbi.nlm.nih.gov/pubmed/28862274",
                "http://www.ncbi.nlm.nih.gov/pubmed/26601950",
                "http://www.ncbi.nlm.nih.gov/pubmed/23254476",
                "http://www.ncbi.nlm.nih.gov/pubmed/28679592"
            ],
            "id": "5ac0a36f19833b0d7b000002",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27756426",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 187,
                    "text": "Exosome is an important part of TME."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28679592",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1051,
                    "offsetInEndSection": 1147,
                    "text": "It is concluded that hypoxia stimulates exosome production and secretion in renal tubular cells."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26601950",
                    "endSection": "abstract",
                    "offsetInBeginSection": 173,
                    "offsetInEndSection": 326,
                    "text": "Heparan sulfates on target cell surfaces can act as receptors for exosome uptake, but the ligand for heparan sulfate on exosomes has not been identified."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23254476",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Dynamics of exosome internalization and trafficking."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24462375",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28862274",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 415,
                    "text": "The exosome-specific dual-patterned immunofiltration (ExoDIF) device is composed of two distinct immuno-patterned layers, and is capable of enhancing the chance of binding between the antibody and exosomes by generating mechanical whirling, thus achieving high-throughput exosome isolation with high specificity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27348448",
                    "endSection": "abstract",
                    "offsetInBeginSection": 182,
                    "offsetInEndSection": 394,
                    "text": "Alternatively, when exosome source cells are unavailable for customized exosome production, exosomes derived from a variety of biological origins can be modified post isolation which is the focus of this article."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24333249",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1304,
                    "offsetInEndSection": 1475,
                    "text": "This provides a simple, label-free means of enriching exogenously modified exosomes and introduces the potential for MRI-driven theranostic exosome investigations in vivo."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23376832",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1608,
                    "offsetInEndSection": 1716,
                    "text": "In conclusion, exosomal protein content is influenced by the cell source and stimulus for exosome formation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26725667",
                    "endSection": "abstract",
                    "offsetInBeginSection": 689,
                    "offsetInEndSection": 841,
                    "text": "We selected lactadherin as an exosome tropic protein and developed it as a fusion protein with Gaussia luciferase to label exosomes for in vivo imaging."
                }
            ]
        },
        {
            "body": "Are human enhancers or promoters evolving faster?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                "http://www.ncbi.nlm.nih.gov/pubmed/21457775",
                "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                "http://www.ncbi.nlm.nih.gov/pubmed/12610136",
                "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                "http://www.ncbi.nlm.nih.gov/pubmed/8508026",
                "http://www.ncbi.nlm.nih.gov/pubmed/28116828",
                "http://www.ncbi.nlm.nih.gov/pubmed/8417365",
                "http://www.ncbi.nlm.nih.gov/pubmed/24429298"
            ],
            "id": "5ac3699f0340b9f058000001",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24429298",
                    "endSection": "abstract",
                    "offsetInBeginSection": 697,
                    "offsetInEndSection": 990,
                    "text": "Relative to evolutionarily young lincRNAs, mammalian-expressed lincRNAs show higher primary sequence conservation in their promoters and exons, increased proximity to protein-coding genes enriched for tissue-specific functions, fewer repeat elements, and more frequent single-exon transcripts."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28116828",
                    "endSection": "abstract",
                    "offsetInBeginSection": 265,
                    "offsetInEndSection": 460,
                    "text": "The main hypothesis of this manuscript is that, developmental enhancers evolved from unicellular inducible promoters that diversified the expression of regulatory genes during metazoan evolution."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/1668145",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 186,
                    "text": "The promoters and enhancers of cell type-specific genes are often conserved in evolution, and hence one might expect that a given enhancer has evolved to work best with its own promoter."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8508026",
                    "endSection": "abstract",
                    "offsetInBeginSection": 193,
                    "offsetInEndSection": 325,
                    "text": "Unlike enhancers of other muscle genes, the TnC enhancer and basal promoter are muscle cell-specific only when linked to each other."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21457775",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 208,
                    "text": "Equimolecular presence of ribosomal proteins (RPs) in the cell is needed for ribosome assembly and is achieved by synchronized expression of ribosomal protein genes (RPGs) with promoters of similar strengths."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8417365",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 150,
                    "text": "The human aldolase A gene is transcribed from three different promoters, pN, pM, and pH, all of which are clustered within a small 1.6-kbp DNA domain."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18367463",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 52,
                    "text": "Fast evolution of core promoters in primate genomes."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12610136",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1266,
                    "offsetInEndSection": 1433,
                    "text": "Proximal and distal chimeras of the human and murine enhancers also replicated less efficiently at a low MOI and expressed lower levels of GFP from the UL127 promoter."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8931987",
                    "endSection": "abstract",
                    "offsetInBeginSection": 115,
                    "offsetInEndSection": 302,
                    "text": "In transgenic mice, the upstream pN and the downstream pH promoters are ubiquitous, whereas the pM promoter, located between pN and pH, is activated specifically in fast skeletal muscles."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21282711",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1215,
                    "offsetInEndSection": 1328,
                    "text": "Promoters were primarily evolving under purifying selection but with certain categories of genes evolving faster."
                }
            ]
        },
        {
            "body": "What are the 3 antidotes for anticoagulant (anti-blood clotting) drugs, including factor Xa inhibitors, as of November 2017.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                "http://www.ncbi.nlm.nih.gov/pubmed/12516682",
                "http://www.ncbi.nlm.nih.gov/pubmed/25485923",
                "http://www.ncbi.nlm.nih.gov/pubmed/25523529",
                "http://www.ncbi.nlm.nih.gov/pubmed/28314985",
                "http://www.ncbi.nlm.nih.gov/pubmed/23790307",
                "http://www.ncbi.nlm.nih.gov/pubmed/21254900",
                "http://www.ncbi.nlm.nih.gov/pubmed/12557411",
                "http://www.ncbi.nlm.nih.gov/pubmed/23455714",
                "http://www.ncbi.nlm.nih.gov/pubmed/19351313"
            ],
            "id": "5ac0f7b919833b0d7b000006",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12557411",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1075,
                    "offsetInEndSection": 1529,
                    "text": "For example, protamine sulfate reverses only about 60% of the anti-factor Xa activity of low-molecular-weight heparin, has negligible effects on danaparoid (a mixture of anticoagulant glycosaminoglycans used to treat heparin-induced thrombocytopenia) and fondaparinux (a novel synthetic antithrombin-binding pentasaccharide with exclusive anti-factor Xa activity approved in the United States for antithrombotic prophylaxis following orthopedic surgery)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23455714",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 161,
                    "text": "Inhibitors of coagulation factor Xa (fXa) have emerged as a new class of antithrombotics but lack effective antidotes for patients experiencing serious bleeding."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21254900",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 235,
                    "text": "Abstract The limits of traditional anticoagulants, such as heparin and warfarin, have prompted the search for new agents for prophylaxis and treatment of arterial and venous thromboembolism, including factor Xa and thrombin inhibitors."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28314985",
                    "endSection": "abstract",
                    "offsetInBeginSection": 718,
                    "offsetInEndSection": 977,
                    "text": "The European Heart Rhythm Association recommends 48-h period of stoppage preoperatively for factor Xa inhibitors and at least 3 or 4\u00a0days for dabigatran, while the French Study Group on Thrombosis and Haemostasis recommends 5-day discontinuation for all NOAC."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25523529",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1005,
                    "offsetInEndSection": 1296,
                    "text": "Of the traditional clotting assays, a sensitive and calibrated prothrombin time may be useful for detecting the presence or absence of clinically relevant factor Xa inhibitor concentrations (rivaroxaban or apixaban), but specific anti-factor Xa assays can measure drug levels quantitatively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23790307",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 131,
                    "text": "New oral anticoagulants which specifically inhibit factor Xa (FXa) or thrombin (FIIa) do not require routine laboratory monitoring."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19351313",
                    "endSection": "abstract",
                    "offsetInBeginSection": 439,
                    "offsetInEndSection": 569,
                    "text": "Rivaroxaban, which inhibits activated factor X (Xa), is currently in clinical trials and is the most advanced factor Xa inhibitor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25485923",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 326,
                    "text": "The direct thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban and apixaban are US Food and Drug Administration (FDA)-approved target-specific oral anticoagulants (TSOACs) that have emerged onto the market for use in some indications similar to those for warfarin; in addition, edoxaban is seeking FDA approval."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12516682",
                    "endSection": "abstract",
                    "offsetInBeginSection": 744,
                    "offsetInEndSection": 1159,
                    "text": "To test the feasibility of using the prothrombin time (PT), International Normalized Ratio (INR), activated partial thromboplastin time (aPTT), Heptest, thrombin time, RVVT, ECT, and a modified anti-Xa amidolytic assay, to monitor a synthetic factor Xa inhibitor, normal human pool plasma samples were spiked with a synthetic factor Xa inhibitor in the concentration range of 0 to 1 microg/mL and 0 to 25 microg/mL."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26378211",
                    "endSection": "abstract",
                    "offsetInBeginSection": 381,
                    "offsetInEndSection": 623,
                    "text": "Inhibition of clotting factor Xa has been evaluated as a potential target for anticoagulation therapy with the hypothesis that using target-specific therapy will alleviate some of the dosing variability observed with the vitamin K antagonist."
                }
            ]
        },
        {
            "body": "Which genes are associated with Epidermolysis Bullosa Simplex?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                "http://www.ncbi.nlm.nih.gov/pubmed/28425111",
                "http://www.ncbi.nlm.nih.gov/pubmed/14675180",
                "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                "http://www.ncbi.nlm.nih.gov/pubmed/25454730",
                "http://www.ncbi.nlm.nih.gov/pubmed/19797037",
                "http://www.ncbi.nlm.nih.gov/pubmed/11851893",
                "http://www.ncbi.nlm.nih.gov/pubmed/21674528",
                "http://www.ncbi.nlm.nih.gov/pubmed/9804357"
            ],
            "id": "5ace34eb0340b9f058000010",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 159,
                    "offsetInEndSection": 315,
                    "text": "Here, we report a patient with mutations in the gene for BP180/collagen XVII, COL17A1, but predominant phenotypic features of epidermolysis bullosa simplex."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19797037",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 200,
                    "text": "Epidermolysis bullosa simplex is an autosomal dominant inherited skin blistering disorder caused by mutations in the genes KRT5 or KRT14 coding for the basal epidermal keratins 5 and 14, respectively."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21674528",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "Epidermolysis bullosa associated with muscular dystrophy is a rare, autosomal recessive form of epidermolysis bullosa simplex caused by mutations in the plectin gene, PLEC1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9804357",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 215,
                    "text": "We report novel keratin 5 and 14 gene mutations in four unrelated German families with the localized subtype of the dominantly inherited blistering disease epidermolysis bullosa simplex Weber-Cockayne (MIM# 131800)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7537032",
                    "endSection": "abstract",
                    "offsetInBeginSection": 267,
                    "offsetInEndSection": 392,
                    "text": "The simplex forms of epidermolysis bullosa are caused by mutations in the genes for the basal epidermal keratins, K5 and K14."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28425111",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 465,
                    "text": "We present the first report of a nails-only phenotype in two patients with epidermolysis bullosa simplex (EBS) and a heterozygous pGlu170Lys mutation and the second reported case of EBS associated with a homozygous p.Glu170Lys mutation in the KRT5 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25454730",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 94,
                    "text": "Plectin mutations have been reported in epidermolysis bullosa simplex with muscular dystrophy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/14675180",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 438,
                    "text": "Genetic mutations in plectin, a cytoskeleton linker protein expressed in a large variety of tissues including skin, muscle, and nerves, cause epidermolysis bullosa simplex with muscular dystrophy, a recessive inherited disease characterized by blistering of the skin and late onset of muscular dystrophy, and Ogna epidermolysis bullosa simplex, a rare dominant inherited form of epidermolysis bullosa simplex with no muscular involvement."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11851880",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 117,
                    "text": "A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9406827",
                    "endSection": "abstract",
                    "offsetInBeginSection": 361,
                    "offsetInEndSection": 569,
                    "text": "The keratin 5 and keratin 14 genes encode proteins that form the primary structural components of the basal epidermal keratinocytes, mutations in either of these genes can cause epidermolysis bullosa simplex."
                }
            ]
        },
        {
            "body": "What biologic process in the body is associated with Mast cells?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                "http://www.ncbi.nlm.nih.gov/pubmed/10359893",
                "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                "http://www.ncbi.nlm.nih.gov/pubmed/24903914",
                "http://www.ncbi.nlm.nih.gov/pubmed/22906983",
                "http://www.ncbi.nlm.nih.gov/pubmed/12217409",
                "http://www.ncbi.nlm.nih.gov/pubmed/6178551",
                "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                "http://www.ncbi.nlm.nih.gov/pubmed/8353280"
            ],
            "id": "5aac543bfcf4565872000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8353280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1037,
                    "offsetInEndSection": 1475,
                    "text": "The prolonged biologic half-life of IL-3 was reproducibly associated with a threefold to fivefold increase in splenic mast-cell precursors over levels observed in mice treated with IL-3 alone; increases in the numbers of mature mucosal-type mast cells in the spleen, but not in the jejunum or lung; increases in IL-3-dependent colony-forming unit-cell in the spleen; and an apparent redistribution of mast cells away from the bone marrow."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12217409",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 98,
                    "text": "Heterotypic adhesion-induced mast cell activation: biologic relevance in the inflammatory context."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6178551",
                    "endSection": "abstract",
                    "offsetInBeginSection": 498,
                    "offsetInEndSection": 915,
                    "text": "A number of biologic consequences are generated in response to these mediators and these include: increased vascular permeability, vasodilation, smooth muscle spasm, polymorphonuclear leukocyte chemotaxis, stimulation of adenylate and guanylate cyclase, superoxide radical generation, prostaglandin formation, mucous and gastric acid secretion, hypotension, tissue destruction, and mononuclear leukocyte infiltration."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24903914",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 171,
                    "text": "Mast cells are important effector cells of the immune system and recent studies show that they have immunomodulatory roles in diverse processes in both health and disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9354811",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1123,
                    "offsetInEndSection": 1348,
                    "text": "Biological functions of mast cells appear to include a role in innate immunity, involvement in host defense mechanisms against parasitic infestations, immunomodulation of the immune system, and tissue repair and angiogenesis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10359893",
                    "endSection": "abstract",
                    "offsetInBeginSection": 335,
                    "offsetInEndSection": 501,
                    "text": "OBJECTIVE\nWe sought to determine the ability of HgCl2 to degranulate murine mast cells and promote cytokine secretion and whether this was an active biologic process."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22906983",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1034,
                    "offsetInEndSection": 1327,
                    "text": "At 100 mg/kg, a concentration 10 times higher than that which inhibited PSA in rats, cromolyn significantly inhibited the increases in plasma concentrations of mouse mast cell protease-1 (but not of histamine) during PSA, but had no effect on the reduction in body temperature in this setting."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17386403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 330,
                    "offsetInEndSection": 512,
                    "text": "Since mast cells clearly play both physiological and pathophysiological functions in the body, it is important to learn about the components of mast cells that drive these responses."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22706316",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1076,
                    "offsetInEndSection": 1299,
                    "text": "Lipid body accumulation in mast cells is mechanistically distinct from the process in adipocytes; for example, it is independent of PPAR\u03b3 up-regulation and does not involve significant accumulation of conjugated glycerides."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/30188629",
                    "endSection": "abstract",
                    "offsetInBeginSection": 139,
                    "offsetInEndSection": 342,
                    "text": "This may be associated with mast cells, which are found in all body tissues of an organism, secrete a wide range of biologically active substances and are important in the regulation of repair processes."
                }
            ]
        },
        {
            "body": "What are the 3 types of ultraviolet (UV) solar radiation?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25040832",
                "http://www.ncbi.nlm.nih.gov/pubmed/12821280",
                "http://www.ncbi.nlm.nih.gov/pubmed/9096671",
                "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                "http://www.ncbi.nlm.nih.gov/pubmed/21192130",
                "http://www.ncbi.nlm.nih.gov/pubmed/24891049",
                "http://www.ncbi.nlm.nih.gov/pubmed/25041067",
                "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                "http://www.ncbi.nlm.nih.gov/pubmed/9577442",
                "http://www.ncbi.nlm.nih.gov/pubmed/11920550"
            ],
            "id": "5aae6a86fcf456587200000e",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9577442",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "OBJECTIVE\nTo determine the value of shade in protecting humans from solar ultraviolet (UV) radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24891049",
                    "endSection": "abstract",
                    "offsetInBeginSection": 103,
                    "offsetInEndSection": 177,
                    "text": "Solar radiation is made up of ultraviolet, visible and infrared radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11920550",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 593,
                    "text": "The purpose of the current study was to determine how many types of cancer are affected by solar radiation and how many premature deaths from cancer occur due to insufficient ultraviolet (UV)-B radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21192130",
                    "endSection": "abstract",
                    "offsetInBeginSection": 512,
                    "offsetInEndSection": 1119,
                    "text": "It had two fixed radiation sensors total solar and ultraviolet A radiation sensor manual ultraviolet calibrated according to the erythemal response of skin measuring human ultraviolet index and the maximum exposure timer ecommended for different skin types (Safesun from Optix Tech, Inc.).The aim of this study was to measure the rate and exposure ultraviolet (UV) to evaluate the erythemal effect on most sensitive areas of the face and neck to noon fotoexposici\u00f3n solar in the four annual seasons, and thus promote extending protection regulations to prevent the effects harmful UV non-ionizing radiation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25041067",
                    "endSection": "abstract",
                    "offsetInBeginSection": 572,
                    "offsetInEndSection": 849,
                    "text": "In seedlings under water deficit, UV attenuation reduced height growth, leaf production and leaf length compared with seedlings receiving the full spectrum of solar radiation, whereas the growth and morphology of well-watered seedlings was largely unaffected by UV attenuation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24483759",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 170,
                    "text": "Terrestrial solar ultraviolet (UV) radiation has significant implications for human health and increasing levels are a key concern regarding the impact of climate change."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9096671",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1067,
                    "offsetInEndSection": 1215,
                    "text": "SPF 30 and 45 sunscreens also blocked activation of tumor antigen-specific suppressor T-lymphocytes in mice exposed to solar simulator UV radiation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17204418",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 259,
                    "text": "Sunlight, skin cancer and vitamin D: What are the conclusions of recent findings that protection against solar ultraviolet (UV) radiation causes 25-hydroxyvitamin D deficiency in solid organ-transplant recipients, xeroderma pigmentosum, and other risk groups?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12821280",
                    "endSection": "abstract",
                    "offsetInBeginSection": 194,
                    "offsetInEndSection": 371,
                    "text": "Among types of solar radiation, ultraviolet B (290-320 nm) radiation is highly mutagenic and carcinogenic in animal experiments compared to ultraviolet A (320-400 nm) radiation."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25040832",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 130,
                    "text": "Epidermal UV-A absorbance and whole-leaf flavonoid composition in pea respond more to solar blue light than to solar UV radiation."
                }
            ]
        },
        {
            "body": "Please list 10 conditions which play a role in causing atrial fibrillation.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                "http://www.ncbi.nlm.nih.gov/pubmed/11978585",
                "http://www.ncbi.nlm.nih.gov/pubmed/16793213",
                "http://www.ncbi.nlm.nih.gov/pubmed/12781903",
                "http://www.ncbi.nlm.nih.gov/pubmed/10535368",
                "http://www.ncbi.nlm.nih.gov/pubmed/7759722",
                "http://www.ncbi.nlm.nih.gov/pubmed/12395678",
                "http://www.ncbi.nlm.nih.gov/pubmed/9809896",
                "http://www.ncbi.nlm.nih.gov/pubmed/15851612"
            ],
            "id": "5aaef38dfcf456587200000f",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15851612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 173,
                    "text": "BACKGROUND\nCa2+ leak from the sarcoplasmic reticulum (SR) may play an important role in triggering and/or maintaining atrial arrhythmias, including atrial fibrillation (AF)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9809896",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 178,
                    "text": "Atrial fibrillation (AF) is an arrhythmia associated with a wide variety of cardiac conditions, and it carries a risk of thromboembolism which varies with the underlying disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12395678",
                    "endSection": "abstract",
                    "offsetInBeginSection": 238,
                    "offsetInEndSection": 439,
                    "text": "Among the causes in our country, rheumatic mitral valvular disease topped the list followed by rheumatic multiple valvular disease IHD, HHD; lone atrial fibrillation came in the aetiology sequentially."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7759722",
                    "endSection": "abstract",
                    "offsetInBeginSection": 212,
                    "offsetInEndSection": 390,
                    "text": "BACKGROUND\nSubstantial animal data indicate that vagally induced dispersion of atrial refractoriness plays a central role in the induction and maintenance of atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10535368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 213,
                    "offsetInEndSection": 476,
                    "text": "Despite the inherent difficulty in identifying the causes of postoperative atrial fibrillation, several important observations have been made during the recent past that may play a role in treating or even preventing this common and serious postoperative problem."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12781903",
                    "endSection": "abstract",
                    "offsetInBeginSection": 234,
                    "offsetInEndSection": 407,
                    "text": "Although the relation between the 2 conditions has long been known, the treatment of hypertension is not currently a focus in the clinical management of atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16793213",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1291,
                    "offsetInEndSection": 1434,
                    "text": "Most of these cytokines play a crucial role in inflammation response that associate with the initiating and maintenance of atrial fibrillation."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/12693508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 314,
                    "text": "5-Hydroxytryptamine, a recent addition to the list of hormonal triggers for atrial fibrillation (AF), may play a pivotal role in the induction of AF related not only to cardiac surgery but also to acute coronary syndromes, valvular heart disease, cardiomyopathies, alcoholism, aging, and conducting tissue disease."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11978585",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 262,
                    "text": "The authors used death certificate data to evaluate national trends in the reporting of atrial fibrillation as an underlying or contributory cause of death for groups defined by age (45 years or older), sex, and race (Black vs. White) and to examine comorbidity."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19151857",
                    "endSection": "abstract",
                    "offsetInBeginSection": 288,
                    "offsetInEndSection": 453,
                    "text": "Of the long list of various cardiac conditions associated with an increased risk of cardioembolic strokes, non-valvular atrial fibrillation is the most common cause."
                }
            ]
        },
        {
            "body": "Is p53 a transcription factor?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                "http://www.ncbi.nlm.nih.gov/pubmed/7651386",
                "http://www.ncbi.nlm.nih.gov/pubmed/8418500",
                "http://www.ncbi.nlm.nih.gov/pubmed/9215863",
                "http://www.ncbi.nlm.nih.gov/pubmed/27334938",
                "http://www.ncbi.nlm.nih.gov/pubmed/20679336",
                "http://www.ncbi.nlm.nih.gov/pubmed/25486564",
                "http://www.ncbi.nlm.nih.gov/pubmed/17762884",
                "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                "http://www.ncbi.nlm.nih.gov/pubmed/16264274"
            ],
            "id": "5ac0817cd0c506ce46000001",
            "snippets": [
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16264274",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 82,
                    "text": "Transcription repression of a CCAAT-binding transcription factor CBF/HSP70 by p53."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25486564",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 67,
                    "text": "The transcription factor p53: not a repressor, solely an activator."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9215863",
                    "endSection": "abstract",
                    "offsetInBeginSection": 332,
                    "offsetInEndSection": 419,
                    "text": "p53 is a transcription factor which is involved in cell cycle regulation and apoptosis."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25755280",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "PATZ1 Is a DNA Damage-Responsive Transcription Factor That Inhibits p53 Function."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27334938",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 319,
                    "text": "The protein product of the Homo sapiens TP53 gene is a transcription factor (p53) that regulates the expression of genes critical for the response to DNA damage and tumor suppression, including genes involved in cell cycle arrest, apoptosis, DNA repair, metabolism, and a number of other tumorigenesis-related pathways."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/7651386",
                    "endSection": "abstract",
                    "offsetInBeginSection": 135,
                    "offsetInEndSection": 241,
                    "text": "p53, a transcription factor, controls the expression of genes, leading to cell cycle arrest and apoptosis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8418500",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 100,
                    "text": "The tumor suppressor p53 is a nuclear phosphoprotein with characteristics of a transcription factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20679336",
                    "endSection": "abstract",
                    "offsetInBeginSection": 419,
                    "offsetInEndSection": 486,
                    "text": "Indeed p53 is the most well studied mammalian transcription factor."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17762884",
                    "endSection": "abstract",
                    "offsetInBeginSection": 93,
                    "offsetInEndSection": 279,
                    "text": "Here, we report that the human pituitary homeobox 1 (hPitx1) transcription factor increases the expression of p53 at the mRNA and protein levels in human mammary carcinoma (MCF-7) cells."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/8862400",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 69,
                    "text": "Regulation of p53 gene expression by a poxviral transcription factor."
                }
            ]
        },
        {
            "body": "Is Cystatin D a biomarker?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                "http://www.ncbi.nlm.nih.gov/pubmed/24713815",
                "http://www.ncbi.nlm.nih.gov/pubmed/26066476",
                "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                "http://www.ncbi.nlm.nih.gov/pubmed/25664059",
                "http://www.ncbi.nlm.nih.gov/pubmed/26724852",
                "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                "http://www.ncbi.nlm.nih.gov/pubmed/23463154"
            ],
            "id": "5a9d9ab94e03427e73000003",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23463154",
                    "endSection": "abstract",
                    "offsetInBeginSection": 144,
                    "offsetInEndSection": 256,
                    "text": "Serum cystatin C is a novel biomarker that has emerged as a possible diagnostic alternative to serum creatinine."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25664059",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 66,
                    "text": "Serum cystatin C as a potential biomarker for the evaluation COPD."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21377848",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 134,
                    "text": "Urinary cystatin C as a biomarker for acute kidney injury and its immunohistochemical localization in kidney in the CDDP-treated rats."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26724852",
                    "endSection": "abstract",
                    "offsetInBeginSection": 229,
                    "offsetInEndSection": 392,
                    "text": "This study was designed to discover whether plasma NGAL is as a biomarker superior to serum creatinine and cystatin C in detecting AKI in severely burned patients."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22795897",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 146,
                    "text": "Urinary cystatin C as a biomarker for diabetic nephropathy and its immunohistochemical localization in kidney in Zucker diabetic fatty (ZDF) rats."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26066476",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 68,
                    "text": "Cystatin C as a biomarker for estimating glomerular filtration rate."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21918259",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 60,
                    "text": "[Urinary cystatin C as a biomarker of renal tubular injury]."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24713815",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1258,
                    "offsetInEndSection": 1376,
                    "text": "Cystatin C is more sensitive as an early biomarker of acute kidney injury in comparison with kidney injury molecule-1."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27208743",
                    "endSection": "abstract",
                    "offsetInBeginSection": 989,
                    "offsetInEndSection": 1188,
                    "text": "CONCLUSION\nADAMTS13 activity, d-Dimer and cystatin C are associated with retinopathy in type 1 diabetic patients and are promising biomarkers for the diagnosis and monitoring of diabetic retinopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27861242",
                    "endSection": "abstract",
                    "offsetInBeginSection": 323,
                    "offsetInEndSection": 437,
                    "text": "Cystatin C, a biomarker of kidney functioning that has been linked to poor health outcomes, was measured in blood."
                }
            ]
        },
        {
            "body": "What causes leishmaniasis?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18457726",
                "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                "http://www.ncbi.nlm.nih.gov/pubmed/15797810",
                "http://www.ncbi.nlm.nih.gov/pubmed/25228325",
                "http://www.ncbi.nlm.nih.gov/pubmed/25988048",
                "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                "http://www.ncbi.nlm.nih.gov/pubmed/6623585",
                "http://www.ncbi.nlm.nih.gov/pubmed/11175518",
                "http://www.ncbi.nlm.nih.gov/pubmed/16198385",
                "http://www.ncbi.nlm.nih.gov/pubmed/15071036"
            ],
            "id": "5abcf0b0fcf4565872000024",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/6623585",
                    "endSection": "abstract",
                    "offsetInBeginSection": 375,
                    "offsetInEndSection": 514,
                    "text": "Visceral leishmaniasis must be considered as a possible cause of fever and splenomegaly in The Gambia and in adjacent parts of West Africa."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/11175518",
                    "endSection": "abstract",
                    "offsetInBeginSection": 413,
                    "offsetInEndSection": 548,
                    "text": "Human Leishmania infections cause cutaneous lesions, with a minority of L. (Viannia) infections leading to mucocutaneous leishmaniasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16198385",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 206,
                    "text": "Leishmania amazonensis is widely recognised as a cause of cutaneous leishmaniasis in Latin America, but it can also disseminate to produce atypical visceral leishmaniasis with hepatitis and lymphadenopathy."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15071036",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 126,
                    "text": "Leishmania donovani in India causes visceral infection (kala-azar) and dermal infection (post-kala-azar dermal leishmaniasis)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25988048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 156,
                    "offsetInEndSection": 331,
                    "text": "The protozoa is obliged intracellularly and causes a wide spectrum of clinical syndromes: VL ('kala azar'), cutaneous leishmaniasis and mucocutaneous leishmaniasis (espundia)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25228325",
                    "endSection": "abstract",
                    "offsetInBeginSection": 491,
                    "offsetInEndSection": 612,
                    "text": "L. (L.)\u00a0donovani usually causes visceral leishmaniasis, but in this case, the patient manifested cutaneous leishmaniasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15797810",
                    "endSection": "abstract",
                    "offsetInBeginSection": 270,
                    "offsetInEndSection": 445,
                    "text": "This review focuses on host responses to infection with the species that cause visceral leishmaniasis, as they contrast with species causing localized cutaneous leishmaniasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18626612",
                    "endSection": "abstract",
                    "offsetInBeginSection": 626,
                    "offsetInEndSection": 783,
                    "text": "In contrast, New World leishmaniasis is caused by leishmania found in Central and South America and cause may cutaneous, mucocutaneous and visceral findings."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18457726",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1191,
                    "offsetInEndSection": 1294,
                    "text": "Our case is also unusual in that zymodeme MON-80 is only rarely a cause of Mediterranean leishmaniasis."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23219435",
                    "endSection": "abstract",
                    "offsetInBeginSection": 409,
                    "offsetInEndSection": 520,
                    "text": "However, in Sri Lanka, L. donovani causes mainly cutaneous leishmaniasis, while visceral leishmaniasis is rare."
                }
            ]
        },
        {
            "body": "Please list 7 classes of drugs that interact with Warfarin.",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                "http://www.ncbi.nlm.nih.gov/pubmed/21359645",
                "http://www.ncbi.nlm.nih.gov/pubmed/9707357",
                "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
                "http://www.ncbi.nlm.nih.gov/pubmed/23194153",
                "http://www.ncbi.nlm.nih.gov/pubmed/22717419",
                "http://www.ncbi.nlm.nih.gov/pubmed/16858720",
                "http://www.ncbi.nlm.nih.gov/pubmed/16874847",
                "http://www.ncbi.nlm.nih.gov/pubmed/25537751"
            ],
            "id": "5abce6acfcf4565872000022",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25537751",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1254,
                    "offsetInEndSection": 1442,
                    "text": "Among incident users, 57.1% purchased potentially interacting drugs during the 3-month period after initiation, while 9.0% purchased interacting drugs that should be avoided with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16874847",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1277,
                    "offsetInEndSection": 1432,
                    "text": "CONCLUSIONS\nAbout a half of patients receiving warfarin therapy was prescribed concomitant drug(s) that has a high potential of interactions with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16858720",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1224,
                    "offsetInEndSection": 1406,
                    "text": "A significant proportion of warfarin-related cerebral haemorrhages might have been prevented if greater caution had been taken when prescribing drugs known to interact with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15585436",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1698,
                    "offsetInEndSection": 1893,
                    "text": "The high percentage of patients taking drugs that may increase INR or bleeding risk is a reminder that bleeding events are a likely adverse outcome of combining drugs that interact with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22717419",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1089,
                    "offsetInEndSection": 1212,
                    "text": "RESULTS\nApproximately 80% of AF patients were prescribed at least 1 warfarin-potentiating medication while taking warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9707357",
                    "endSection": "abstract",
                    "offsetInBeginSection": 485,
                    "offsetInEndSection": 634,
                    "text": "Of 35 patients reviewed, 7 had a predisposing condition such as peptic ulcer and 19 received drugs or folk medicines that can interact with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21359645",
                    "endSection": "abstract",
                    "offsetInBeginSection": 982,
                    "offsetInEndSection": 1376,
                    "text": "As the list of drugs and supplements that interact with warfarin is continuously expanding, and the knowledge on drug interactions with the novel oral anticoagulants is still in its infancy, clinicians need to be vigilant when initiating any of these agents or when any changes in the patient's medication profile occur and perform a close screening for potential drug and dietary interactions."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23194153",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1005,
                    "offsetInEndSection": 1228,
                    "text": "Among 873 interacting agents dispensed to residents while continuously using warfarin (AnalytiCare database), 360 (41%) were changed (added or withdrawn), while 513 (59%) were maintained over two consecutive 45-day periods."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21397772",
                    "endSection": "abstract",
                    "offsetInBeginSection": 399,
                    "offsetInEndSection": 754,
                    "text": "METHODS\nWe examined the official labeling information approved by the US Food and Drug Administration for the 50 drugs, biologics, and drug classes that were commonly identified by 3 drug information compendia--Clinical Pharmacology, ePocrates(\u00ae), and Micromedex(\u00ae)--and the warfarin US prescribing information (PI) as having an interaction with warfarin."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19587643",
                    "endSection": "abstract",
                    "offsetInBeginSection": 389,
                    "offsetInEndSection": 521,
                    "text": "The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin."
                }
            ]
        },
        {
            "body": "What part of the body is affected by mesotheliomia?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/17509761",
                "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                "http://www.ncbi.nlm.nih.gov/pubmed/16051171",
                "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                "http://www.ncbi.nlm.nih.gov/pubmed/25879009",
                "http://www.ncbi.nlm.nih.gov/pubmed/26834368",
                "http://www.ncbi.nlm.nih.gov/pubmed/16163658",
                "http://www.ncbi.nlm.nih.gov/pubmed/25274322",
                "http://www.ncbi.nlm.nih.gov/pubmed/9973880",
                "http://www.ncbi.nlm.nih.gov/pubmed/23635375"
            ],
            "id": "5a74eaa50384be955100000b",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/22879850",
                    "endSection": "abstract",
                    "offsetInBeginSection": 628,
                    "offsetInEndSection": 764,
                    "text": "Symptoms vary from person to person, and may come and go, depend on what part of the body is affected, can be mild, moderate, or severe."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23635375",
                    "endSection": "abstract",
                    "offsetInBeginSection": 573,
                    "offsetInEndSection": 764,
                    "text": "Part B was a two part questionnaire for children, including the children's expectation on their own body size and their consciousness in terms of body size evaluation by parents and teachers."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/9973880",
                    "endSection": "abstract",
                    "offsetInBeginSection": 433,
                    "offsetInEndSection": 554,
                    "text": "A large sample of MMH claims was analysed and stratified with respect to body part affected and the nature of the injury."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16051171",
                    "endSection": "abstract",
                    "offsetInBeginSection": 240,
                    "offsetInEndSection": 410,
                    "text": "Here, we demonstrate that an intrinsic primary quality of a tactile object, for example its size, is directly affected by the perceived size of the body part touching it."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16163658",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1372,
                    "offsetInEndSection": 1619,
                    "text": "These movements appear in the non-affected part of the body throughout cerebrovascular disease evolution, and which could be caused by maintained hypersolicitation of the unaffected part of the body and the neuroplastic process following a stroke."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25879009",
                    "endSection": "abstract",
                    "offsetInBeginSection": 523,
                    "offsetInEndSection": 631,
                    "text": "However, if the tourniquet is not cut through, the affected body part may become ischemic and even necrotic."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25274322",
                    "endSection": "abstract",
                    "offsetInBeginSection": 413,
                    "offsetInEndSection": 565,
                    "text": "These results highlighted the importance of assessing changes in patients' pain processes to determine the part of the body where TLT should be applied."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26834368",
                    "endSection": "abstract",
                    "offsetInBeginSection": 97,
                    "offsetInEndSection": 224,
                    "text": "Because stroke immobilizes the affected body part, balance training uses the healthy body part to complete the target movement."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17509761",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 175,
                    "text": "In spite of pain in the CRPS limb, clinical observations show patients pay little attention to, and fail to care for, their affected limb as if it were not part of their body."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26007284",
                    "endSection": "abstract",
                    "offsetInBeginSection": 573,
                    "offsetInEndSection": 796,
                    "text": "For PTs specialized in acute care, geriatrics and pediatrics, the body part most commonly affected was the low back, while for PTs specialized in orthopedics and neurology, the body part most commonly affected was the neck."
                }
            ]
        },
        {
            "body": "What is BORSA?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                "http://www.ncbi.nlm.nih.gov/pubmed/21875361",
                "http://www.ncbi.nlm.nih.gov/pubmed/18819540",
                "http://www.ncbi.nlm.nih.gov/pubmed/18630132",
                "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                "http://www.ncbi.nlm.nih.gov/pubmed/21337531",
                "http://www.ncbi.nlm.nih.gov/pubmed/10834971",
                "http://www.ncbi.nlm.nih.gov/pubmed/2069374",
                "http://www.ncbi.nlm.nih.gov/pubmed/26064878"
            ],
            "id": "5aae6499fcf456587200000c",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18630132",
                    "endSection": "abstract",
                    "offsetInBeginSection": 444,
                    "offsetInEndSection": 658,
                    "text": "hospital associated MRSA (HA-MRSA) and community associated MRSA (CA-MRSA), the presence of homogeneous and heterogeneous type of methicillin resistance, and border-line resistance in Staphylococcus aureus (BORSA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10834971",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1293,
                    "offsetInEndSection": 1363,
                    "text": "The BBL Crystal MRSA ID test misclassified four BORSA strains as MRSA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26064878",
                    "endSection": "abstract",
                    "offsetInBeginSection": 607,
                    "offsetInEndSection": 701,
                    "text": "BORSA phenotype was found in 14% S. aureus isolates from pigs and 10% isolates from pork meat."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18819540",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1786,
                    "offsetInEndSection": 1950,
                    "text": "Because one fourth of our staphylococcus strains are mecA negative BORSA and there is no alternative for vancomycin against mecA positive MRSA and Enterococcus spp."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2069374",
                    "endSection": "abstract",
                    "offsetInBeginSection": 741,
                    "offsetInEndSection": 956,
                    "text": "Experimental aortic endocarditis was induced in rabbits by the following three strains: beta-lactamase-producing BORSA strain VP-986, beta-lactamase-producing ORSA strain 67-0, and its beta-lactamase-negative clone."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15770100",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 101,
                    "text": "An outbreak of borderline oxacillin-resistant Staphylococcus aureus (BORSA) in a dermatological unit."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/2261916",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1066,
                    "offsetInEndSection": 1175,
                    "text": "This clearly shows that BORSA may be misidentified as MRSA while heteroresistant MRSA may appear to be BORSA."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21875361",
                    "endSection": "abstract",
                    "offsetInBeginSection": 151,
                    "offsetInEndSection": 331,
                    "text": "Among them, 12 isolates were methicillin-susceptible S. aureus (MSSA), 18 were borderline-oxacillin-resistant S. aureus (BORSA), and 40 were methicillin-resistant S. aureus (MRSA)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21337531",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1218,
                    "offsetInEndSection": 1332,
                    "text": "The majority of BORSA isolates were hyper \u03b2-lactamase producers and susceptible to a greater range of antibiotics."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28893360",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 159,
                    "text": "Borderline oxacillin-resistant Staphylococcus aureus (BORSA) represents a quite poorly understood and inadequately defined phenotype of methicillin resistance."
                }
            ]
        },
        {
            "body": "Which gene is responsible for proper speech development?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                "http://www.ncbi.nlm.nih.gov/pubmed/17565757",
                "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                "http://www.ncbi.nlm.nih.gov/pubmed/21108403",
                "http://www.ncbi.nlm.nih.gov/pubmed/27075776",
                "http://www.ncbi.nlm.nih.gov/pubmed/27771768",
                "http://www.ncbi.nlm.nih.gov/pubmed/10880297",
                "http://www.ncbi.nlm.nih.gov/pubmed/23099646"
            ],
            "id": "5ace12be0340b9f058000007",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/10880297",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1824,
                    "offsetInEndSection": 1960,
                    "text": "These studies represent further steps toward the isolation of the first gene to be implicated in the development of speech and language."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/23099646",
                    "endSection": "abstract",
                    "offsetInBeginSection": 400,
                    "offsetInEndSection": 603,
                    "text": "We have identified a 69 kb deletion including the 5' region of the DYRK1A gene in a patient with growth retardation, primary microcephaly, facial dysmorphism, seizures, ataxic gait, absent speech and ID."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27075776",
                    "endSection": "abstract",
                    "offsetInBeginSection": 794,
                    "offsetInEndSection": 993,
                    "text": "Our study suggests that a small region on chromosome 7q31.3 encompassing four genes, CFTR, CTTNBP2, NAA38, and ANKRD7, may represent a new locus for congenital hearing loss and/or speech development."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21108403",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1131,
                    "offsetInEndSection": 1408,
                    "text": "CNTNAP2 is known to be involved in the cause of language and speech disorders and autism spectrum disorder and is in the same pathway as FOXP2, another important language gene, which makes it a candidate gene for causal studies speech and language disorders such as stuttering."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25269856",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 83,
                    "text": "BACKGROUND\nMutations in the human FOXP2 gene cause speech and language impairments."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26980647",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 89,
                    "text": "The FOXP2 gene is important for the development of proper speech motor control in humans."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27771768",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 44,
                    "text": "Advances in genetic hearing loss: CIB2 gene."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17565757",
                    "endSection": "abstract",
                    "offsetInBeginSection": 815,
                    "offsetInEndSection": 1064,
                    "text": "Although deletion and duplication of the WBS region have very different effects, both cause forms of language impairment and suggest that dosage-sensitive genes within the region are important for the proper development of human speech and language."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/20571508",
                    "endSection": "abstract",
                    "offsetInBeginSection": 443,
                    "offsetInEndSection": 605,
                    "text": "Recently, a child was reported who presented with a 3p13-14.1 deletion of four genes, including FOXP1, and a constellation of deficits that included speech delay."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/18554997",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 93,
                    "text": "Possible mechanisms and gene involvement in speech problems in the 22q11.2 deletion syndrome."
                }
            ]
        },
        {
            "body": "What is PNPPP?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                "http://www.ncbi.nlm.nih.gov/pubmed/21747892"
            ],
            "id": "5a9da59c4e03427e73000005",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/21747892",
                    "endSection": "abstract",
                    "offsetInBeginSection": 654,
                    "offsetInEndSection": 926,
                    "text": "The extract, when tested colorimetrically for its inhibitory activities on phosphordiesterase-5 (PDE-5) in vitro towards p-nitrophenyl phenyl phosphate (PNPPP), was observed to induce significant dose-dependent inhibition of PDE-5, with an ID(50) of 0.161\u2009mg/ml (P < .05)."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24201366",
                    "endSection": "abstract",
                    "offsetInBeginSection": 165,
                    "offsetInEndSection": 531,
                    "text": "In the + MP transgenic plants, as compared with non-transgenic and - MP plants, higher hydrolytic activities were found on the following substrates: bis-(nitrophenyl)-phosphate (BPNPP, phosphodiesterase), p-nitrophenyl-(phenyl)-phosphate (PNPPP, nucleotidephosphodiesterase) and thymidine-3'-monophosphate p-nitrophenyl ester (T3MPP; 3'nucleotide phosphodiesterase.)"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/25658120",
                    "endSection": "abstract",
                    "offsetInBeginSection": 919,
                    "offsetInEndSection": 1050,
                    "text": "PdeM is a monomer of 29.3 kDa, which exhibits optimum activity at 25\u00b0C and pH 8.5, but low affinity for bis(pNPP) as well as pNPPP."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26551787",
                    "endSection": "abstract",
                    "offsetInBeginSection": 520,
                    "offsetInEndSection": 722,
                    "text": "CONCLUSION\nPNPPP efficiently controls for non-disease-related variance, allowing both for efficient discovery of novel biomarkers and for covariate-independent linear cut-offs suitable for clinical use."
                }
            ]
        },
        {
            "body": "What is Mendelian randomization?",
            "documents": [
                "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                "http://www.ncbi.nlm.nih.gov/pubmed/19432981",
                "http://www.ncbi.nlm.nih.gov/pubmed/24681576",
                "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                "http://www.ncbi.nlm.nih.gov/pubmed/28527048",
                "http://www.ncbi.nlm.nih.gov/pubmed/28055004",
                "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                "http://www.ncbi.nlm.nih.gov/pubmed/15321841",
                "http://www.ncbi.nlm.nih.gov/pubmed/27486138"
            ],
            "id": "5a9da37e4e03427e73000004",
            "snippets": [
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28527048",
                    "endSection": "abstract",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 121,
                    "text": "Mendelian randomization-Egger (MR-Egger) is an analysis method for Mendelian randomization using summarized genetic data."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/17715159",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 81,
                    "text": "Mendelian randomization as an instrumental variable approach to causal inference."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/27486138",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 84,
                    "text": "Mendelian Randomization as an Approach to Assess Causality Using Observational Data."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/24681576",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 53,
                    "text": "Methodological challenges in mendelian randomization."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/15321841",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 105,
                    "text": "An integrated approach to the meta-analysis of genetic association studies using Mendelian randomization."
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/28055004",
                    "endSection": "abstract",
                    "offsetInBeginSection": 675,
                    "offsetInEndSection": 765,
                    "text": "More recently, Mendelian randomization studies have preceded randomized controlled trials."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/16410347",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 108,
                    "text": "Limits to causal inference based on Mendelian randomization: a comparison with randomized controlled trials."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26291580",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 87,
                    "text": "Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors."
                },
                {
                    "beginSection": "title",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/19432981",
                    "endSection": "title",
                    "offsetInBeginSection": 0,
                    "offsetInEndSection": 92,
                    "text": "Can we apply the Mendelian randomization methodology without considering epigenetic effects?"
                },
                {
                    "beginSection": "abstract",
                    "document": "http://www.ncbi.nlm.nih.gov/pubmed/26201704",
                    "endSection": "abstract",
                    "offsetInBeginSection": 1092,
                    "offsetInEndSection": 1188,
                    "text": "CONCLUSIONS\nMendelian randomization and path models use different concepts for causal inference."
                }
            ]
        }
    ]
}